<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="d2145685-4182-4f95-bb20-81365442c623" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;issue:issue:pii\:S0092867420X00250;wgroup:string:Default Website Group;subPage:string:Full Text;article:article:pii\:S0092867421013167">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)01316-7">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/20c9bcef-348b-4743-96da-ee52fb88f4ae/fx1.jpg">
    


        <meta property="og:description" content="A selective M1 receptor agonist, developed using structure-guided synthesis, exhibits
pro-cognitive effects in animal models of Alzheimer’s disease and activates brain
regions associated with learning and memory in humans.">
    











        <meta name="twitter:title" content="From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/20c9bcef-348b-4743-96da-ee52fb88f4ae/fx1.jpg">
    


        <meta name="twitter:description" content="A selective M1 receptor agonist, developed using structure-guided synthesis, exhibits
pro-cognitive effects in animal models of Alzheimer’s disease and activates brain
regions associated with learning and memory in humans.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)01316-7">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease"> <meta name="citation_date" content="2021/11/24"> <meta name="citation_volume" content="184"> <meta name="citation_issue" content="24"> <meta name="citation_firstpage" content="5886"> <meta name="citation_lastpage" content="5901.e22"> <meta name="citation_pmid" content="34822784"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867421013167"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867421013167"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867421013167"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.11.001"> <meta name="citation_pmid" content="34822784"> <meta name="citation_author" content="Alastair J.H. Brown"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Sophie J. Bradley"><meta name="citation_author_orcid" content="0000-0002-0035-4090"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author_institution" content="The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK"><meta name="citation_author" content="Fiona H. Marshall"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Giles A. Brown"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Kirstie A. Bennett"><meta name="citation_author_orcid" content="0000-0002-6469-2486"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Jason Brown"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Julie E. Cansfield"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="David M. Cross"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author_institution" content="Cross Pharma Consulting Ltd, 20-22 Wenlock Road, London, N17GU, UK"><meta name="citation_author" content="Chris de Graaf"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Brian D. Hudson"><meta name="citation_author_orcid" content="0000-0001-7059-0091"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Louis Dwomoh"><meta name="citation_author_orcid" content="0000-0001-7024-6450"><meta name="citation_author_institution" content="The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK"><meta name="citation_author" content="João M. Dias"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="James C. Errey"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Edward Hurrell"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Jan Liptrot"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Giulio Mattedi"><meta name="citation_author_orcid" content="0000-0002-7290-694X"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Colin Molloy"><meta name="citation_author_orcid" content="0000-0001-7179-7721"><meta name="citation_author_institution" content="The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK"><meta name="citation_author" content="Pradeep J. Nathan"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author_institution" content="Brain Mapping Unit, University of Cambridge, Department of Psychiatry, Herchel Smith Building, Cambridge, CB20SZ, UK"><meta name="citation_author" content="Krzysztof Okrasa"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Greg Osborne"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Jayesh C. Patel"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Mark Pickworth"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Nathan Robertson"><meta name="citation_author_orcid" content="0000-0002-5449-2501"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Shahram Shahabi"><meta name="citation_author_institution" content="Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK"><meta name="citation_author" content="Christoffer Bundgaard"><meta name="citation_author_institution" content="Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK"><meta name="citation_author_institution" content="H. Lundbeck A/S, Neuroscience Research, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark"><meta name="citation_author" content="Keith Phillips"><meta name="citation_author_institution" content="Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK"><meta name="citation_author" content="Lisa M. Broad"><meta name="citation_author_institution" content="Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK"><meta name="citation_author" content="Anushka V. Goonawardena"><meta name="citation_author_institution" content="Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA"><meta name="citation_author" content="Stephen R. Morairty"><meta name="citation_author_institution" content="Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA"><meta name="citation_author" content="Michael Browning"><meta name="citation_author_orcid" content="0000-0001-9108-3144"><meta name="citation_author_institution" content="University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK"><meta name="citation_author_institution" content="P1vital, Manor house, Howbery Buisness Park, Wallingford, OX108BA, UK"><meta name="citation_author" content="Francesca Perini"><meta name="citation_author_orcid" content="0000-0001-6558-5060"><meta name="citation_author_institution" content="Centre for Cognitive Neuroscience - Duke-NUS Medical School, 8 College Road, 169857, Singapore"><meta name="citation_author" content="Gerard R. Dawson"><meta name="citation_author_orcid" content="0000-0002-8624-7500"><meta name="citation_author_institution" content="University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK"><meta name="citation_author" content="John F.W. Deakin"><meta name="citation_author_institution" content="Neuroscience and Psychiatry Unit, University of Manchester, Manchester, M139PT UK"><meta name="citation_author" content="Robert T. Smith"><meta name="citation_author_orcid" content="0000-0002-2086-9550"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Patrick M. Sexton"><meta name="citation_author_institution" content="Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia"><meta name="citation_author_institution" content="ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia"><meta name="citation_author" content="Julie Warneck"><meta name="citation_author_orcid" content="0000-0002-8846-4445"><meta name="citation_author_institution" content="Protogenia Consulting Ltd, PO-Box 289, Ely, CB79DR, UK"><meta name="citation_author" content="Mary Vinson"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Tim Tasker"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Benjamin G. Tehan"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Barry Teobald"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Arthur Christopoulos"><meta name="citation_author_institution" content="Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia"><meta name="citation_author" content="Christopher J. Langmead"><meta name="citation_author_orcid" content="0000-0003-3483-1120"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author_institution" content="Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia"><meta name="citation_author" content="Ali Jazayeri"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Robert M. Cooke"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Prakash Rucktooa"><meta name="citation_author_orcid" content="0000-0003-2050-7389"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Miles S. Congreve"><meta name="citation_author_orcid" content="0000-0003-1913-0318"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Malcolm Weir"><meta name="citation_author_email" content="malcolm.weir@soseiheptares.com"><meta name="citation_author_institution" content="Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK"><meta name="citation_author" content="Andrew B. Tobin"><meta name="citation_author_email" content="andrew.tobin@glasgow.ac.uk"><meta name="citation_author_institution" content="The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK"><meta name="citation_keywords" content="Alzheimer's disease; G protein coupled receptors; muscarinic receptor; M1 muscarinic acetylcholine receptor; structural based drug design; neurodegeneration; prion disease"><meta name="citation_reference" content="citation_title=Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors; citation_author=A. Alt; citation_author=A. Pendri; citation_author=R.L. Bertekap; citation_author=G. Li; citation_author=Y. Benitex; citation_author=M. Nophsker; citation_author=K.L. Rockwell; citation_author=N.T. Burford; citation_author=C.S. Sum; citation_author=J. Chen; citation_author=et al.; citation_journal_title=J.&nbsp;Pharmacol. Exp. Ther.; citation_volume=356; citation_firstpage=293; citation_lastpage=304; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Age-related neural activity during allocentric spatial memory; citation_author=E. Antonova; citation_author=D. Parslow; citation_author=M. Brammer; citation_author=G.R. Dawson; citation_author=S.H. Jackson; citation_author=R.G. Morris; citation_journal_title=Memory; citation_volume=17; citation_firstpage=125; citation_lastpage=143; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze; citation_author=E. Antonova; citation_author=D. Parslow; citation_author=M. Brammer; citation_author=A. Simmons; citation_author=S. Williams; citation_author=G.R. Dawson; citation_author=R. Morris; citation_journal_title=J.&nbsp;Psychopharmacol.; citation_volume=25; citation_firstpage=1256; citation_lastpage=1265; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs; citation_author=J.A. Araujo; citation_author=N.H. Greig; citation_author=D.K. Ingram; citation_author=J. Sandin; citation_author=C. de Rivera; citation_author=N.W. Milgram; citation_journal_title=J.&nbsp;Alzheimers Dis.; citation_volume=26; citation_firstpage=143; citation_lastpage=155; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor; citation_author=V.A. Avlani; citation_author=C.J. Langmead; citation_author=E. Guida; citation_author=M.D. Wood; citation_author=B.G. Tehan; citation_author=H.J. Herdon; citation_author=J.M. Watson; citation_author=P.M. Sexton; citation_author=A. Christopoulos; citation_journal_title=Mol. Pharmacol.; citation_volume=78; citation_firstpage=94; citation_lastpage=104; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=The cholinergic hypothesis of geriatric memory dysfunction; citation_author=R.T. Bartus; citation_author=R.L. Dean; citation_author=B. Beer; citation_author=A.S. Lippa; citation_journal_title=Science; citation_volume=217; citation_firstpage=408; citation_lastpage=414; citation_publication_date=1982; "><meta name="citation_reference" content="citation_title=Gamma, alpha, delta, and theta oscillations govern cognitive processes; citation_author=E. Başar; citation_author=C. Başar-Eroglu; citation_author=S. Karakaş; citation_author=M. Schürmann; citation_journal_title=Int. J. Psychophysiol.; citation_volume=39; citation_firstpage=241; citation_lastpage=248; citation_publication_date=2001; "><meta name="citation_reference" content="citation_title=iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM; citation_author=T.G. Battye; citation_author=L. Kontogiannis; citation_author=O. Johnson; citation_author=H.R. Powell; citation_author=A.G. Leslie; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=67; citation_firstpage=271; citation_lastpage=281; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Classics in Chemical Neuroscience: Xanomeline; citation_author=A.M. Bender; citation_author=C.K. Jones; citation_author=C.W. Lindsley; citation_journal_title=ACS Chem. Neurosci.; citation_volume=8; citation_firstpage=435; citation_lastpage=443; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease; citation_author=N.C. Bodick; citation_author=W.W. Offen; citation_author=A.I. Levey; citation_author=N.R. Cutler; citation_author=S.G. Gauthier; citation_author=A. Satlin; citation_author=H.E. Shannon; citation_author=G.D. Tollefson; citation_author=K. Rasmussen; citation_author=F.P. Bymaster; citation_author=et al.; citation_journal_title=Arch. Neurol.; citation_volume=54; citation_firstpage=465; citation_lastpage=473; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease; citation_author=N.C. Bodick; citation_author=W.W. Offen; citation_author=H.E. Shannon; citation_author=J. Satterwhite; citation_author=R. Lucas; citation_author=R. van Lier; citation_author=S.M. Paul; citation_journal_title=Alzheimer Dis. Assoc. Disord.; citation_volume=11; citation_number=Suppl 4; citation_firstpage=S16; citation_lastpage=S22; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss; citation_author=S.J. Bradley; citation_author=J.M. Bourgognon; citation_author=H.E. Sanger; citation_author=N. Verity; citation_author=A.J. Mogg; citation_author=D.J. White; citation_author=A.J. Butcher; citation_author=J.A. Moreno; citation_author=C. Molloy; citation_author=T. Macedo-Hatch; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=127; citation_firstpage=487; citation_lastpage=499; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes; citation_author=S.J. Bradley; citation_author=C. Molloy; citation_author=C. Bundgaard; citation_author=A.J. Mogg; citation_author=K.J. Thompson; citation_author=L. Dwomoh; citation_author=H.E. Sanger; citation_author=M.D. Crabtree; citation_author=S.M. Brooke; citation_author=P.M. Sexton; citation_author=et al.; citation_journal_title=Mol. Pharmacol.; citation_volume=93; citation_firstpage=645; citation_lastpage=656; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs; citation_author=S.J. Bradley; citation_author=C. Molloy; citation_author=P. Valuskova; citation_author=L. Dwomoh; citation_author=M. Scarpa; citation_author=M. Rossi; citation_author=L. Finlayson; citation_author=K.A. Svensson; citation_author=E. Chernet; citation_author=V.N. Barth; citation_author=et al.; citation_journal_title=Nat. Chem. Biol.; citation_volume=16; citation_firstpage=240; citation_lastpage=249; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia; citation_author=S.K. Brannan; citation_author=S. Sawchak; citation_author=A.C. Miller; citation_author=J.A. Lieberman; citation_author=S.M. Paul; citation_author=A. Breier; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=384; citation_firstpage=717; citation_lastpage=726; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists; citation_author=B. Budzik; citation_author=V. Garzya; citation_author=D. Shi; citation_author=G. Walker; citation_author=M. Woolley-Roberts; citation_author=J. Pardoe; citation_author=A. Lucas; citation_author=B. Tehan; citation_author=R.A. Rivero; citation_author=C.J. Langmead; citation_author=et al.; citation_journal_title=ACS Med. Chem. Lett.; citation_volume=1; citation_firstpage=244; citation_lastpage=248; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=MolProbity: all-atom structure validation for macromolecular crystallography; citation_author=V.B. Chen; citation_author=W.B. Arendall; citation_author=J.J. Headd; citation_author=D.A. Keedy; citation_author=R.M. Immormino; citation_author=G.J. Kapral; citation_author=L.W. Murray; citation_author=J.S. Richardson; citation_author=D.C. Richardson; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=12; citation_lastpage=21; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction; citation_author=Y. Cheng; citation_author=W.H. Prusoff; citation_journal_title=Biochem. Pharmacol.; citation_volume=22; citation_firstpage=3099; citation_lastpage=3108; citation_publication_date=1973; "><meta name="citation_reference" content="citation_title=High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor; citation_author=V. Cherezov; citation_author=D.M. Rosenbaum; citation_author=M.A. Hanson; citation_author=S.G. Rasmussen; citation_author=F.S. Thian; citation_author=T.S. Kobilka; citation_author=H.J. Choi; citation_author=P. Kuhn; citation_author=W.I. Weis; citation_author=B.K. Kobilka; citation_author=R.C. Stevens; citation_journal_title=Science; citation_volume=318; citation_firstpage=1258; citation_lastpage=1265; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Assessing rodent hippocampal involvement in the novel object recognition task. A review; citation_author=S.J. Cohen; citation_author=R.W. Stackman; citation_journal_title=Behav. Brain Res.; citation_volume=285; citation_firstpage=105; citation_lastpage=117; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs; citation_author=M. Congreve; citation_author=C. Oswald; citation_author=F.H. Marshall; citation_journal_title=Trends Pharmacol. Sci.; citation_volume=38; citation_firstpage=837; citation_lastpage=847; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders; citation_author=P.J. Conn; citation_author=A. Christopoulos; citation_author=C.W. Lindsley; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=8; citation_firstpage=41; citation_lastpage=54; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders; citation_author=P.J. Conn; citation_author=C.K. Jones; citation_author=C.W. Lindsley; citation_journal_title=Trends Pharmacol. Sci.; citation_volume=30; citation_firstpage=148; citation_lastpage=155; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial; citation_author=C. Courtney; citation_author=D. Farrell; citation_author=R. Gray; citation_author=R. Hills; citation_author=L. Lynch; citation_author=E. Sellwood; citation_author=S. Edwards; citation_author=W. Hardyman; citation_author=J. Raftery; citation_author=P. Crome; citation_author=AD2000 Collaborative Group; citation_author=et al.; citation_journal_title=Lancet; citation_volume=363; citation_firstpage=2105; citation_lastpage=2115; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects; citation_author=J.E. Davoren; citation_author=C.W. Lee; citation_author=M. Garnsey; citation_author=M.A. Brodney; citation_author=J. Cordes; citation_author=K. Dlugolenski; citation_author=J.R. Edgerton; citation_author=A.R. Harris; citation_author=C.J. Helal; citation_author=S. Jenkinson; citation_author=et al.; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=59; citation_firstpage=6313; citation_lastpage=6328; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity; citation_author=J.E. Davoren; citation_author=M. Garnsey; citation_author=B. Pettersen; citation_author=M.A. Brodney; citation_author=J.R. Edgerton; citation_author=J.P. Fortin; citation_author=S. Grimwood; citation_author=A.R. Harris; citation_author=S. Jenkinson; citation_author=T. Kenakin; citation_author=et al.; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=60; citation_firstpage=6649; citation_lastpage=6663; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models; citation_author=G.J. Digby; citation_author=M.J. Noetzel; citation_author=M. Bubser; citation_author=T.J. Utley; citation_author=A.G. Walker; citation_author=N.E. Byun; citation_author=E.P. Lebois; citation_author=Z. Xiang; citation_author=D.J. Sheffler; citation_author=H.P. Cho; citation_author=et al.; citation_journal_title=J.&nbsp;Neurosci.; citation_volume=32; citation_firstpage=8532; citation_lastpage=8544; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine; citation_author=A.S. Doré; citation_author=N. Robertson; citation_author=J.C. Errey; citation_author=I. Ng; citation_author=K. Hollenstein; citation_author=B. Tehan; citation_author=E. Hurrell; citation_author=K. Bennett; citation_author=M. Congreve; citation_author=F. Magnani; citation_author=et al.; citation_journal_title=Structure; citation_volume=19; citation_firstpage=1283; citation_lastpage=1293; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=A second wind for the cholinergic system in Alzheimer’s therapy; citation_author=V. Douchamps; citation_author=C. Mathis; citation_journal_title=Behav. Pharmacol.; citation_volume=28; citation_firstpage=112; citation_lastpage=123; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations; citation_author=R.O. Dror; citation_author=D.H. Arlow; citation_author=D.W. Borhani; citation_author=M.O. Jensen; citation_author=S. Piana; citation_author=D.E. Shaw; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=106; citation_firstpage=4689; citation_lastpage=4694; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Features and development of Coot; citation_author=P. Emsley; citation_author=B. Lohkamp; citation_author=W.G. Scott; citation_author=K. Cowtan; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=486; citation_lastpage=501; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events; citation_author=J.L. Engers; citation_author=E.S. Childress; citation_author=M.F. Long; citation_author=R.A. Capstick; citation_author=V.B. Luscombe; citation_author=H.P. Cho; citation_author=J.W. Dickerson; citation_author=J.M. Rook; citation_author=A.L. Blobaum; citation_author=C.M. Niswender; citation_author=et al.; citation_journal_title=ACS Med. Chem. Lett.; citation_volume=9; citation_firstpage=917; citation_lastpage=922; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Scaling and assessment of data quality; citation_author=P. Evans; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=62; citation_firstpage=72; citation_lastpage=82; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=How good are my data and what is the resolution?; citation_author=P.R. Evans; citation_author=G.N. Murshudov; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=69; citation_firstpage=1204; citation_lastpage=1214; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases; citation_author=C.C. Felder; citation_author=P.J. Goldsmith; citation_author=K. Jackson; citation_author=H.E. Sanger; citation_author=D.A. Evans; citation_author=A.J. Mogg; citation_author=L.M. Broad; citation_journal_title=Neuropharmacology; citation_volume=136; citation_firstpage=449; citation_lastpage=458; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Structure-Based Design and Discovery of New M2 Receptor Agonists; citation_author=I. Fish; citation_author=A. Stößel; citation_author=K. Eitel; citation_author=C. Valant; citation_author=S. Albold; citation_author=H. Huebner; citation_author=D. Möller; citation_author=M.J. Clark; citation_author=R.K. Sunahara; citation_author=A. Christopoulos; citation_author=et al.; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=60; citation_firstpage=9239; citation_lastpage=9250; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=The cholinergic hypothesis of Alzheimer’s disease: a review of progress; citation_author=P.T. Francis; citation_author=A.M. Palmer; citation_author=M. Snape; citation_author=G.K. Wilcock; citation_journal_title=J.&nbsp;Neurol. Neurosurg. Psychiatry; citation_volume=66; citation_firstpage=137; citation_lastpage=147; citation_publication_date=1999; "><meta name="citation_reference" content="citation_title=Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model; citation_author=A. Ghoshal; citation_author=J.M. Rook; citation_author=J.W. Dickerson; citation_author=G.N. Roop; citation_author=R.D. Morrison; citation_author=N. Jalan-Sakrikar; citation_author=A. Lamsal; citation_author=M.J. Noetzel; citation_author=M.S. Poslusney; citation_author=M.R. Wood; citation_author=et al.; citation_journal_title=Neuropsychopharmacology; citation_volume=41; citation_firstpage=598; citation_lastpage=610; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands; citation_author=J.A. Goodwin; citation_author=E.C. Hulme; citation_author=C.J. Langmead; citation_author=B.G. Tehan; citation_journal_title=Mol. Pharmacol.; citation_volume=72; citation_firstpage=1484; citation_lastpage=1496; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=A new method for off-line removal of ocular artifact; citation_author=G. Gratton; citation_author=M.G. Coles; citation_author=E. Donchin; citation_journal_title=Electroencephalogr. Clin. Neurophysiol.; citation_volume=55; citation_firstpage=468; citation_lastpage=484; citation_publication_date=1983; "><meta name="citation_reference" content="citation_title=Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice; citation_author=S.E. Hamilton; citation_author=M.D. Loose; citation_author=M. Qi; citation_author=A.I. Levey; citation_author=B. Hille; citation_author=G.S. McKnight; citation_author=R.L. Idzerda; citation_author=N.M. Nathanson; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=94; citation_firstpage=13311; citation_lastpage=13316; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=The functional significance of delta oscillations in cognitive processing; citation_author=T. Harmony; citation_journal_title=Front. Integr. Nuerosci.; citation_volume=7; citation_firstpage=83; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Canonical dynamics: Equilibrium phase-space distributions; citation_author=W.G. Hoover; citation_journal_title=Phys Rev A Gen Physiol; citation_volume=31; citation_firstpage=1695; citation_lastpage=1697; citation_publication_date=1985; "><meta name="citation_reference" content="citation_title=The tolerability and safety of cholinesterase inhibitors in the treatment of dementia; citation_author=F. Inglis; citation_journal_title=Int. J. Clin. Pract. Suppl.; citation_number=127; citation_firstpage=45; citation_lastpage=63; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Generic GPCR residue numbers - aligning topology maps while minding the gaps; citation_author=V. Isberg; citation_author=C. de Graaf; citation_author=A. Bortolato; citation_author=V. Cherezov; citation_author=V. Katritch; citation_author=F.H. Marshall; citation_author=S. Mordalski; citation_author=J.P. Pin; citation_author=R.C. Stevens; citation_author=G. Vriend; citation_author=D.E. Gloriam; citation_journal_title=Trends Pharmacol. Sci.; citation_volume=36; citation_firstpage=22; citation_lastpage=31; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Structurally Enabled Discovery of Adenosine A2A Receptor Antagonists; citation_author=A. Jazayeri; citation_author=S.P. Andrews; citation_author=F.H. Marshall; citation_journal_title=Chem. Rev.; citation_volume=117; citation_firstpage=21; citation_lastpage=37; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Xds; citation_author=W. Kabsch; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=66; citation_firstpage=125; citation_lastpage=132; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Measurements of ligand bias and functional affinity; citation_author=T. Kenakin; citation_author=A. Christopoulos; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=12; citation_firstpage=483; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study; citation_author=A.J. Kooistra; citation_author=R. Leurs; citation_author=I.J. de Esch; citation_author=C. de Graaf; citation_journal_title=J.&nbsp;Chem. Inf. Model.; citation_volume=55; citation_firstpage=1045; citation_lastpage=1061; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Function-specific virtual screening for GPCR ligands using a combined scoring method; citation_author=A.J. Kooistra; citation_author=H.F. Vischer; citation_author=D. McNaught-Flores; citation_author=R. Leurs; citation_author=I.J. de Esch; citation_author=C. de Graaf; citation_journal_title=Sci. Rep.; citation_volume=6; citation_firstpage=28288; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1; citation_author=C.J. Langmead; citation_author=N.E. Austin; citation_author=C.L. Branch; citation_author=J.T. Brown; citation_author=K.A. Buchanan; citation_author=C.H. Davies; citation_author=I.T. Forbes; citation_author=V.A. Fry; citation_author=J.J. Hagan; citation_author=H.J. Herdon; citation_author=et al.; citation_journal_title=Br. J. Pharmacol.; citation_volume=154; citation_firstpage=1104; citation_lastpage=1115; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Epock: rapid analysis of protein pocket dynamics; citation_author=B. Laurent; citation_author=M. Chavent; citation_author=T. Cragnolini; citation_author=A.C. Dahl; citation_author=S. Pasquali; citation_author=P. Derreumaux; citation_author=M.S. Sansom; citation_author=M. Baaden; citation_journal_title=Bioinformatics; citation_volume=31; citation_firstpage=1478; citation_lastpage=1480; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors; citation_author=G. Lebon; citation_author=C.J. Langmead; citation_author=B.G. Tehan; citation_author=E.C. Hulme; citation_journal_title=Mol. Pharmacol.; citation_volume=75; citation_firstpage=331; citation_lastpage=341; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies; citation_author=F. Magnani; citation_author=M.J. Serrano-Vega; citation_author=Y. Shibata; citation_author=S. Abdul-Hussein; citation_author=G. Lebon; citation_author=J. Miller-Gallacher; citation_author=A. Singhal; citation_author=A. Strege; citation_author=J.A. Thomas; citation_author=C.G. Tate; citation_journal_title=Nat. Protoc.; citation_volume=11; citation_firstpage=1554; citation_lastpage=1571; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder; citation_author=J. Maksymetz; citation_author=M.E. Joffe; citation_author=S.P. Moran; citation_author=B.J. Stansley; citation_author=B. Li; citation_author=K. Temple; citation_author=D.W. Engers; citation_author=J.J. Lawrence; citation_author=C.W. Lindsley; citation_author=P.J. Conn; citation_journal_title=Biol. Psychiatry; citation_volume=85; citation_firstpage=989; citation_lastpage=1000; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis; citation_author=G. Mallucci; citation_author=A. Dickinson; citation_author=J. Linehan; citation_author=P.C. Klöhn; citation_author=S. Brandner; citation_author=J. Collinge; citation_journal_title=Science; citation_volume=302; citation_firstpage=871; citation_lastpage=874; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Phaser crystallographic software; citation_author=A.J. McCoy; citation_author=R.W. Grosse-Kunstleve; citation_author=P.D. Adams; citation_author=M.D. Winn; citation_author=L.C. Storoni; citation_author=R.J. Read; citation_journal_title=J.&nbsp;Appl. Cryst.; citation_volume=40; citation_firstpage=658; citation_lastpage=674; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=GPCRM: a homology modeling web service with triple membrane-fitted quality assessment of GPCR models; citation_author=P. Miszta; citation_author=P. Pasznik; citation_author=J. Jakowiecki; citation_author=A. Sztyler; citation_author=D. Latek; citation_author=S. Filipek; citation_journal_title=Nucleic Acids Res.; citation_volume=46; citation_number=W1; citation_firstpage=W387; citation_lastpage=W395; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition; citation_author=S.P. Moran; citation_author=J.W. Dickerson; citation_author=H.P. Cho; citation_author=Z. Xiang; citation_author=J. Maksymetz; citation_author=D.H. Remke; citation_author=X. Lv; citation_author=C.A. Doyle; citation_author=D.H. Rajan; citation_author=C.M. Niswender; citation_author=et al.; citation_journal_title=Neuropsychopharmacology; citation_volume=43; citation_firstpage=1763; citation_lastpage=1771; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks; citation_author=T. Myhrer; citation_journal_title=Brain Res. Brain Res. Rev.; citation_volume=41; citation_firstpage=268; citation_lastpage=287; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET; citation_author=Y. Namkung; citation_author=C. Le Gouill; citation_author=V. Lukashova; citation_author=H. Kobayashi; citation_author=M. Hogue; citation_author=E. Khoury; citation_author=M. Song; citation_author=M. Bouvier; citation_author=S.A. Laporte; citation_journal_title=Nat. Commun.; citation_volume=7; citation_firstpage=12178; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction; citation_author=P.J. Nathan; citation_author=J. Watson; citation_author=J. Lund; citation_author=C.H. Davies; citation_author=G. Peters; citation_author=C.M. Dodds; citation_author=B. Swirski; citation_author=P. Lawrence; citation_author=G.D. Bentley; citation_author=B.V. O’Neill; citation_author=et al.; citation_journal_title=Int J Neuropsychopharmacol; citation_volume=16; citation_firstpage=721; citation_lastpage=731; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome; citation_author=R.H.J. Olsen; citation_author=J.F. DiBerto; citation_author=J.G. English; citation_author=A.M. Glaudin; citation_author=B.E. Krumm; citation_author=S.T. Slocum; citation_author=T. Che; citation_author=A.C. Gavin; citation_author=J.D. McCorvy; citation_author=B.L. Roth; citation_author=R.T. Strachan; citation_journal_title=Nat. Chem. Biol.; citation_volume=16; citation_firstpage=841; citation_lastpage=849; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=M1 muscarinic receptor signaling in mouse hippocampus and cortex; citation_author=A.C. Porter; citation_author=F.P. Bymaster; citation_author=N.W. DeLapp; citation_author=M. Yamada; citation_author=J. Wess; citation_author=S.E. Hamilton; citation_author=N.M. Nathanson; citation_author=C.C. Felder; citation_journal_title=Brain Res.; citation_volume=944; citation_firstpage=82; citation_lastpage=89; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Crystal structure of the human beta2 adrenergic G-protein-coupled receptor; citation_author=S.G. Rasmussen; citation_author=H.J. Choi; citation_author=D.M. Rosenbaum; citation_author=T.S. Kobilka; citation_author=F.S. Thian; citation_author=P.C. Edwards; citation_author=M. Burghammer; citation_author=V.R. Ratnala; citation_author=R. Sanishvili; citation_author=R.F. Fischetti; citation_author=et al.; citation_journal_title=Nature; citation_volume=450; citation_firstpage=383; citation_lastpage=387; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery; citation_author=N. Robertson; citation_author=A. Jazayeri; citation_author=J. Errey; citation_author=A. Baig; citation_author=E. Hurrell; citation_author=A. Zhukov; citation_author=C.J. Langmead; citation_author=M. Weir; citation_author=F.H. Marshall; citation_journal_title=Neuropharmacology; citation_volume=60; citation_firstpage=36; citation_lastpage=44; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Diverse Effects on M1 Signaling and Adverse Effect Liability within a Series of M1 Ago-PAMs; citation_author=J.M. Rook; citation_author=M. Abe; citation_author=H.P. Cho; citation_author=K.D. Nance; citation_author=V.B. Luscombe; citation_author=J.J. Adams; citation_author=J.W. Dickerson; citation_author=D.H. Remke; citation_author=P.M. Garcia-Barrantes; citation_author=D.W. Engers; citation_author=et al.; citation_journal_title=ACS Chem. Neurosci.; citation_volume=8; citation_firstpage=866; citation_lastpage=883; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules; citation_author=K. Roos; citation_author=C. Wu; citation_author=W. Damm; citation_author=M. Reboul; citation_author=J.M. Stevenson; citation_author=C. Lu; citation_author=M.K. Dahlgren; citation_author=S. Mondal; citation_author=W. Chen; citation_author=L. Wang; citation_author=et al.; citation_journal_title=J.&nbsp;Chem. Theory Comput.; citation_volume=15; citation_firstpage=1863; citation_lastpage=1874; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function; citation_author=D.M. Rosenbaum; citation_author=V. Cherezov; citation_author=M.A. Hanson; citation_author=S.G. Rasmussen; citation_author=F.S. Thian; citation_author=T.S. Kobilka; citation_author=H.J. Choi; citation_author=X.J. Yao; citation_author=W.I. Weis; citation_author=R.C. Stevens; citation_author=B.K. Kobilka; citation_journal_title=Science; citation_volume=318; citation_firstpage=1266; citation_lastpage=1273; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia; citation_author=A. Shekhar; citation_author=W.Z. Potter; citation_author=J. Lightfoot; citation_author=J. Lienemann; citation_author=S. Dubé; citation_author=C. Mallinckrodt; citation_author=F.P. Bymaster; citation_author=D.L. McKinzie; citation_author=C.C. Felder; citation_journal_title=Am. J. Psychiatry; citation_volume=165; citation_firstpage=1033; citation_lastpage=1039; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning; citation_author=J.K. Shirey; citation_author=A.E. Brady; citation_author=P.J. Jones; citation_author=A.A. Davis; citation_author=T.M. Bridges; citation_author=J.P. Kennedy; citation_author=S.B. Jadhav; citation_author=U.N. Menon; citation_author=Z. Xiang; citation_author=M.L. Watson; citation_author=et al.; citation_journal_title=J.&nbsp;Neurosci.; citation_volume=29; citation_firstpage=14271; citation_lastpage=14286; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Biased signalling: from simple switches to allosteric microprocessors; citation_author=J.S. Smith; citation_author=R.J. Lefkowitz; citation_author=S. Rajagopal; citation_journal_title=Nat. Rev. Drug Discov.; citation_volume=17; citation_firstpage=243; citation_lastpage=260; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor; citation_author=P.J. Snyder; citation_author=M.M. Bednar; citation_author=J.R. Cromer; citation_author=P. Maruff; citation_journal_title=Alzheimers Dement.; citation_volume=1; citation_firstpage=126; citation_lastpage=135; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Crystal structures of the M1 and M4 muscarinic acetylcholine receptors; citation_author=D.M. Thal; citation_author=B. Sun; citation_author=D. Feng; citation_author=V. Nawaratne; citation_author=K. Leach; citation_author=C.C. Felder; citation_author=M.G. Bures; citation_author=D.A. Evans; citation_author=W.I. Weis; citation_author=P. Bachhawat; citation_author=et al.; citation_journal_title=Nature; citation_volume=531; citation_firstpage=335; citation_lastpage=340; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease; citation_author=S. Thompson; citation_author=K.L. Lanctôt; citation_author=N. Herrmann; citation_journal_title=Expert Opin. Drug Saf.; citation_volume=3; citation_firstpage=425; citation_lastpage=440; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy; citation_author=E.T. van der Westhuizen; citation_author=B. Breton; citation_author=A. Christopoulos; citation_author=M. Bouvier; citation_journal_title=Mol. Pharmacol.; citation_volume=85; citation_firstpage=492; citation_lastpage=509; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data; citation_author=M. Vass; citation_author=S. Podlewska; citation_author=I.J.P. de Esch; citation_author=A.J. Bojarski; citation_author=R. Leurs; citation_author=A.J. Kooistra; citation_author=C. de Graaf; citation_journal_title=J.&nbsp;Med. Chem.; citation_volume=62; citation_firstpage=3784; citation_lastpage=3839; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer’s disease; citation_author=T. Voss; citation_author=J. Li; citation_author=J. Cummings; citation_author=M. Farlow; citation_author=C. Assaid; citation_author=S. Froman; citation_author=H. Leibensperger; citation_author=L. Snow-Adami; citation_author=K.B. McMahon; citation_author=M. Egan; citation_author=D. Michelson; citation_journal_title=Alzheimers Dement (N Y); citation_volume=4; citation_firstpage=173; citation_lastpage=181; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Crystal structure of the M5 muscarinic acetylcholine receptor; citation_author=Z. Vuckovic; citation_author=P.R. Gentry; citation_author=A.E. Berizzi; citation_author=K. Hirata; citation_author=S. Varghese; citation_author=G. Thompson; citation_author=E.T. van der Westhuizen; citation_author=W.A.C. Burger; citation_author=R. Rahmani; citation_author=C. Valant; citation_author=et al.; citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_volume=116; citation_firstpage=26001; citation_lastpage=26007; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Structure of a beta1-adrenergic G-protein-coupled receptor; citation_author=T. Warne; citation_author=M.J. Serrano-Vega; citation_author=J.G. Baker; citation_author=R. Moukhametzianov; citation_author=P.C. Edwards; citation_author=R. Henderson; citation_author=A.G. Leslie; citation_author=C.G. Tate; citation_author=G.F. Schertler; citation_journal_title=Nature; citation_volume=454; citation_firstpage=486; citation_lastpage=491; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor; citation_author=T. Warne; citation_author=R. Moukhametzianov; citation_author=J.G. Baker; citation_author=R. Nehmé; citation_author=P.C. Edwards; citation_author=A.G. Leslie; citation_author=G.F. Schertler; citation_author=C.G. Tate; citation_journal_title=Nature; citation_volume=469; citation_firstpage=241; citation_lastpage=244; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Overview of the CCP4 suite and current developments; citation_author=M.D. Winn; citation_author=C.C. Ballard; citation_author=K.D. Cowtan; citation_author=E.J. Dodson; citation_author=P. Emsley; citation_author=P.R. Evans; citation_author=R.M. Keegan; citation_author=E.B. Krissinel; citation_author=A.G. Leslie; citation_author=A. McCoy; citation_author=et al.; citation_journal_title=Acta Crystallogr. D Biol. Crystallogr.; citation_volume=67; citation_firstpage=235; citation_lastpage=242; citation_publication_date=2011; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Current therapies for Alzheimer's disease seek to correct for defective cholinergic transmission by preventing the breakdown of acetylcholine through inhibition of acetylcholinesterase, these however have limited clinical efficacy. An alternative approach is to directly activate cholinergic receptors responsible for learning and memory. The M1-muscarinic acetylcholine (M1) receptor is the target of choice but has been hampered by adverse effects. Here we aimed to design the drug properties needed for a well-tolerated M1-agonist with the potential to alleviate cognitive loss by taking a stepwise translational approach from atomic structure, cell/tissue-based assays, evaluation in preclinical species, clinical safety testing, and finally establishing activity in memory centers in humans. Through this approach, we rationally designed the <b>optimal properties, including selectivity and partial agonism</b>, into HTL9936—a potential candidate for the treatment of memory loss in Alzheimer's disease. More broadly, this demonstrates a strategy for targeting difficult GPCR targets from structure to clinic.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=6643&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)01316-7&amp;be=3105&amp;fe=6602&amp;dc=6389&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749591929487,%22n%22:0,%22f%22:2510,%22dn%22:2511,%22dne%22:2511,%22c%22:2511,%22s%22:2511,%22ce%22:2511,%22rq%22:2512,%22rp%22:3089,%22rpe%22:3793,%22dl%22:3095,%22di%22:4058,%22ds%22:6389,%22de%22:6400,%22dc%22:6602,%22l%22:6602,%22le%22:6634%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)01316-7"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)01316-7"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-948128" aria-expanded="false" aria-controls="login-links-948128" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-948128" id="login-links--948128" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-948128" data-opens="#links-dialog-948128" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-948128" aria-modal="true"><button data-closes="#links-dialog-948128" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901316-7" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.11.001">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail long-title" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)01316-7" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(20)X0025-0"><span>Volume 184</span>, <span>Issue 24</span></a></span><span class="meta-panel__pages"><span>p5886-5901.e22</span></span><span class="meta-panel__onlineDate">November 24, 2021</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=24&amp;pii=S0092-8674%2820%29X0025-0" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Alastair J.H.</span> <span property="familyName">Brown</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Alastair J.H.</span> <span property="familyName">Brown</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">22</div><div id="fn8"><div id="ntpara0045" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Brown/Alastair+J+H" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">22</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Sophie J.</span> <span property="familyName">Bradley</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sophie J.</span> <span property="familyName">Bradley</span> <a class="orcid-id" href="https://orcid.org/0000-0002-0035-4090" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-0035-4090</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">22</div><div id="fn8"><div id="ntpara0045" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Bradley/Sophie+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a role="doc-noteref">22</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Fiona H.</span> <span property="familyName">Marshall</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Fiona H.</span> <span property="familyName">Marshall</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">Present address: Merck Research Laboratories, Rahway, NJ 07065, USA</div></div></div><div role="doc-footnote" data-has="label"><div class="label">22</div><div id="fn8"><div id="ntpara0045" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Marshall/Fiona+H" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">15</a>,<a role="doc-noteref">22</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Giles A.</span> <span property="familyName">Brown</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Giles A.</span> <span property="familyName">Brown</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">16</div><div id="fn2"><div id="ntpara0015" role="paragraph">Present address: OMass Therapeutics, The Schrödinger Building, Heatley Road, The Oxford Science Park, Oxford OX4 4GE, UK</div></div></div><div role="doc-footnote" data-has="label"><div class="label">22</div><div id="fn8"><div id="ntpara0045" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Brown/Giles+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">16</a>,<a role="doc-noteref">22</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Kirstie A.</span> <span property="familyName">Bennett</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Kirstie A.</span> <span property="familyName">Bennett</span> <a class="orcid-id" href="https://orcid.org/0000-0002-6469-2486" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-6469-2486</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Bennett/Kirstie+A" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Jason</span> <span property="familyName">Brown</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jason</span> <span property="familyName">Brown</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Brown/Jason" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Julie E.</span> <span property="familyName">Cansfield</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Julie E.</span> <span property="familyName">Cansfield</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Cansfield/Julie+E" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">David M.</span> <span property="familyName">Cross</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">David M.</span> <span property="familyName">Cross</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Cross Pharma Consulting Ltd, 20-22 Wenlock Road, London, N17GU, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Cross/David+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Chris</span> <span property="familyName">de Graaf</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Chris</span> <span property="familyName">de Graaf</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/de+Graaf/Chris" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Brian D.</span> <span property="familyName">Hudson</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Brian D.</span> <span property="familyName">Hudson</span> <a class="orcid-id" href="https://orcid.org/0000-0001-7059-0091" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-7059-0091</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Hudson/Brian+D" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Louis</span> <span property="familyName">Dwomoh</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Louis</span> <span property="familyName">Dwomoh</span> <a class="orcid-id" href="https://orcid.org/0000-0001-7024-6450" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-7024-6450</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Dwomoh/Louis" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">João M.</span> <span property="familyName">Dias</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">João M.</span> <span property="familyName">Dias</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">17</div><div id="fn3"><div id="ntpara0020" role="paragraph">Present address: Pfizer, Structural Biology and Biophysics, East 42<sup>nd</sup> Street, New York City, NY 10017, USA</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Dias/Jo%C3%A3o+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">17</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">James C.</span> <span property="familyName">Errey</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">James C.</span> <span property="familyName">Errey</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">18</div><div id="fn4"><div id="ntpara0025" role="paragraph">Present address: Evotec (UK) Ltd., 114 Innovation Dr, Milton Park, Milton, Abingdon OX14 4RZ, UK</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Errey/James+C" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">18</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Edward</span> <span property="familyName">Hurrell</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Edward</span> <span property="familyName">Hurrell</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Hurrell/Edward" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Jan</span> <span property="familyName">Liptrot</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jan</span> <span property="familyName">Liptrot</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Liptrot/Jan" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">Giulio</span> <span property="familyName">Mattedi</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Giulio</span> <span property="familyName">Mattedi</span> <a class="orcid-id" href="https://orcid.org/0000-0002-7290-694X" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-7290-694X</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Mattedi/Giulio" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Colin</span> <span property="familyName">Molloy</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Colin</span> <span property="familyName">Molloy</span> <a class="orcid-id" href="https://orcid.org/0000-0001-7179-7721" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-7179-7721</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Molloy/Colin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Pradeep J.</span> <span property="familyName">Nathan</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Pradeep J.</span> <span property="familyName">Nathan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Brain Mapping Unit, University of Cambridge, Department of Psychiatry, Herchel Smith Building, Cambridge, CB20SZ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Nathan/Pradeep+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Krzysztof</span> <span property="familyName">Okrasa</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Krzysztof</span> <span property="familyName">Okrasa</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Okrasa/Krzysztof" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Greg</span> <span property="familyName">Osborne</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Greg</span> <span property="familyName">Osborne</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Osborne/Greg" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Jayesh C.</span> <span property="familyName">Patel</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jayesh C.</span> <span property="familyName">Patel</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Patel/Jayesh+C" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Mark</span> <span property="familyName">Pickworth</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Mark</span> <span property="familyName">Pickworth</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Pickworth/Mark" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Nathan</span> <span property="familyName">Robertson</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nathan</span> <span property="familyName">Robertson</span> <a class="orcid-id" href="https://orcid.org/0000-0002-5449-2501" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-5449-2501</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn5"><div id="ntpara0030" role="paragraph">Present address: OXGENE Biotechnology, Medawar Centre, Robert Robinson Ave, Littlemore, Oxford, OX44HG, UK</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Robertson/Nathan" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">19</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Shahram</span> <span property="familyName">Shahabi</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Shahram</span> <span property="familyName">Shahabi</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Shahabi/Shahram" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Christoffer</span> <span property="familyName">Bundgaard</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christoffer</span> <span property="familyName">Bundgaard</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">H. Lundbeck A/S, Neuroscience Research, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark</span></div></div><div class="core-author-link"><a href="/authored-by/Bundgaard/Christoffer" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Keith</span> <span property="familyName">Phillips</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Keith</span> <span property="familyName">Phillips</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Phillips/Keith" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">Lisa M.</span> <span property="familyName">Broad</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Lisa M.</span> <span property="familyName">Broad</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Broad/Lisa+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au28" aria-controls="axel_author_au28"><span property="givenName">Anushka V.</span> <span property="familyName">Goonawardena</span></a><div id="au28" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Anushka V.</span> <span property="familyName">Goonawardena</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Goonawardena/Anushka+V" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au29" aria-controls="axel_author_au29"><span property="givenName">Stephen R.</span> <span property="familyName">Morairty</span></a><div id="au29" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Stephen R.</span> <span property="familyName">Morairty</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Morairty/Stephen+R" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au30" aria-controls="axel_author_au30"><span property="givenName">Michael</span> <span property="familyName">Browning</span></a><div id="au30" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Michael</span> <span property="familyName">Browning</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9108-3144" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9108-3144</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">P1vital, Manor house, Howbery Buisness Park, Wallingford, OX108BA, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Browning/Michael" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au31" aria-controls="axel_author_au31"><span property="givenName">Francesca</span> <span property="familyName">Perini</span></a><div id="au31" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Francesca</span> <span property="familyName">Perini</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6558-5060" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6558-5060</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Centre for Cognitive Neuroscience - Duke-NUS Medical School, 8 College Road, 169857, Singapore</span></div></div><div class="core-author-link"><a href="/authored-by/Perini/Francesca" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au32" aria-controls="axel_author_au32"><span property="givenName">Gerard R.</span> <span property="familyName">Dawson</span></a><div id="au32" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Gerard R.</span> <span property="familyName">Dawson</span> <a class="orcid-id" href="https://orcid.org/0000-0002-8624-7500" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-8624-7500</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Dawson/Gerard+R" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au33" aria-controls="axel_author_au33"><span property="givenName">John F.W.</span> <span property="familyName">Deakin</span></a><div id="au33" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">John F.W.</span> <span property="familyName">Deakin</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Neuroscience and Psychiatry Unit, University of Manchester, Manchester, M139PT UK</span></div></div><div class="core-author-link"><a href="/authored-by/Deakin/John+F+W" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au34" aria-controls="axel_author_au34"><span property="givenName">Robert T.</span> <span property="familyName">Smith</span></a><div id="au34" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robert T.</span> <span property="familyName">Smith</span> <a class="orcid-id" href="https://orcid.org/0000-0002-2086-9550" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-2086-9550</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Smith/Robert+T" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au35" aria-controls="axel_author_au35"><span property="givenName">Patrick M.</span> <span property="familyName">Sexton</span></a><div id="au35" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Patrick M.</span> <span property="familyName">Sexton</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia</span></div><div property="affiliation" typeof="Organization"><span property="name">ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia</span></div></div><div class="core-author-link"><a href="/authored-by/Sexton/Patrick+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au36" aria-controls="axel_author_au36"><span property="givenName">Julie</span> <span property="familyName">Warneck</span></a><div id="au36" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Julie</span> <span property="familyName">Warneck</span> <a class="orcid-id" href="https://orcid.org/0000-0002-8846-4445" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-8846-4445</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Protogenia Consulting Ltd, PO-Box 289, Ely, CB79DR, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Warneck/Julie" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">14</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au37" aria-controls="axel_author_au37"><span property="givenName">Mary</span> <span property="familyName">Vinson</span></a><div id="au37" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Mary</span> <span property="familyName">Vinson</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">20</div><div id="fn6"><div id="ntpara0035" role="paragraph">Present address: Autolus Therapeutics PLC, V Mediaworks, 191 Wood Lane, White City, London W12 7FP, UK</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Vinson/Mary" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">20</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au38" aria-controls="axel_author_au38"><span property="givenName">Tim</span> <span property="familyName">Tasker</span></a><div id="au38" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Tim</span> <span property="familyName">Tasker</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Tasker/Tim" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au39" aria-controls="axel_author_au39"><span property="givenName">Benjamin G.</span> <span property="familyName">Tehan</span></a><div id="au39" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Benjamin G.</span> <span property="familyName">Tehan</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">Present address: Merck Research Laboratories, Rahway, NJ 07065, USA</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Tehan/Benjamin+G" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">15</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au40" aria-controls="axel_author_au40"><span property="givenName">Barry</span> <span property="familyName">Teobald</span></a><div id="au40" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Barry</span> <span property="familyName">Teobald</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">21</div><div id="fn7"><div id="ntpara0040" role="paragraph">Present address: Sitryx Therapeutics Limited, Oxford Science Park, Oxford, OX4 4GA, UK</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Teobald/Barry" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">21</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au41" aria-controls="axel_author_au41"><span property="givenName">Arthur</span> <span property="familyName">Christopoulos</span></a><div id="au41" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Arthur</span> <span property="familyName">Christopoulos</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia</span></div></div><div class="core-author-link"><a href="/authored-by/Christopoulos/Arthur" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au42" aria-controls="axel_author_au42"><span property="givenName">Christopher J.</span> <span property="familyName">Langmead</span></a><div id="au42" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christopher J.</span> <span property="familyName">Langmead</span> <a class="orcid-id" href="https://orcid.org/0000-0003-3483-1120" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-3483-1120</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia</span></div></div><div class="core-author-link"><a href="/authored-by/Langmead/Christopher+J" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au43" aria-controls="axel_author_au43"><span property="givenName">Ali</span> <span property="familyName">Jazayeri</span></a><div id="au43" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ali</span> <span property="familyName">Jazayeri</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">16</div><div id="fn2"><div id="ntpara0015" role="paragraph">Present address: OMass Therapeutics, The Schrödinger Building, Heatley Road, The Oxford Science Park, Oxford OX4 4GE, UK</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Jazayeri/Ali" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">16</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au44" aria-controls="axel_author_au44"><span property="givenName">Robert M.</span> <span property="familyName">Cooke</span></a><div id="au44" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Robert M.</span> <span property="familyName">Cooke</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Cooke/Robert+M" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au45" aria-controls="axel_author_au45"><span property="givenName">Prakash</span> <span property="familyName">Rucktooa</span></a><div id="au45" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Prakash</span> <span property="familyName">Rucktooa</span> <a class="orcid-id" href="https://orcid.org/0000-0003-2050-7389" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-2050-7389</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Rucktooa/Prakash" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au46" aria-controls="axel_author_au46"><span property="givenName">Miles S.</span> <span property="familyName">Congreve</span></a><div id="au46" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Miles S.</span> <span property="familyName">Congreve</span> <a class="orcid-id" href="https://orcid.org/0000-0003-1913-0318" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0003-1913-0318</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Congreve/Miles+S" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au47" aria-controls="axel_author_au47"><span property="givenName">Malcolm</span> <span property="familyName">Weir</span></a><div id="au47" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Malcolm</span> <span property="familyName">Weir</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:malcolm.weir@soseiheptares.com" property="email" title="Send email to Malcolm Weir">malcolm.weir@soseiheptares.com</a></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Weir/Malcolm" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup> <a id="eadd0010" href="mailto:malcolm.weir@soseiheptares.com" property="email" title="Send email to Malcolm Weir">malcolm.weir@soseiheptares.com</a></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au48" aria-controls="axel_author_au48"><span property="givenName">Andrew B.</span> <span property="familyName">Tobin</span></a><div id="au48" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Andrew B.</span> <span property="familyName">Tobin</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:andrew.tobin@glasgow.ac.uk" property="email" title="Send email to Andrew B. Tobin">andrew.tobin@glasgow.ac.uk</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">23</div><div id="fn9"><div id="ntpara0050" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Tobin/Andrew+B" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a role="doc-noteref">23</a></sup> <a id="eadd0015" href="mailto:andrew.tobin@glasgow.ac.uk" property="email" title="Send email to Andrew B. Tobin">andrew.tobin@glasgow.ac.uk</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Sosei-Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">The Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G12 8QQ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Cross Pharma Consulting Ltd, 20-22 Wenlock Road, London, N17GU, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Brain Mapping Unit, University of Cambridge, Department of Psychiatry, Herchel Smith Building, Cambridge, CB20SZ, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Eli Lilly &amp; Co, Neuroscience Discovery, Erl Wood Manor, Windlesham, Surrey, GU20 6PH, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">H. Lundbeck A/S, Neuroscience Research, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">Center for Neuroscience, Biosciences Division, SRI International, 333 Ravenswood Avenue, Menlo Park, CA 94025, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">University Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, OX12JD, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">P1vital, Manor house, Howbery Buisness Park, Wallingford, OX108BA, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Centre for Cognitive Neuroscience - Duke-NUS Medical School, 8 College Road, 169857, Singapore</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Neuroscience and Psychiatry Unit, University of Manchester, Manchester, M139PT UK</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville 3052, Victoria, Australia</span></div><div property="affiliation" typeof="Organization"><span class="label">13</span><span id="aff13" property="name">ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville 3052, Victoria, Australia</span></div><div property="affiliation" typeof="Organization"><span class="label">14</span><span id="aff14" property="name">Protogenia Consulting Ltd, PO-Box 289, Ely, CB79DR, UK</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">15</div><div id="fn1"><div id="ntpara0010" role="paragraph">Present address: Merck Research Laboratories, Rahway, NJ 07065, USA</div></div></div><div role="doc-footnote" data-has="label"><div class="label">16</div><div id="fn2"><div id="ntpara0015" role="paragraph">Present address: OMass Therapeutics, The Schrödinger Building, Heatley Road, The Oxford Science Park, Oxford OX4 4GE, UK</div></div></div><div role="doc-footnote" data-has="label"><div class="label">17</div><div id="fn3"><div id="ntpara0020" role="paragraph">Present address: Pfizer, Structural Biology and Biophysics, East 42<sup>nd</sup> Street, New York City, NY 10017, USA</div></div></div><div role="doc-footnote" data-has="label"><div class="label">18</div><div id="fn4"><div id="ntpara0025" role="paragraph">Present address: Evotec (UK) Ltd., 114 Innovation Dr, Milton Park, Milton, Abingdon OX14 4RZ, UK</div></div></div><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn5"><div id="ntpara0030" role="paragraph">Present address: OXGENE Biotechnology, Medawar Centre, Robert Robinson Ave, Littlemore, Oxford, OX44HG, UK</div></div></div><div role="doc-footnote" data-has="label"><div class="label">20</div><div id="fn6"><div id="ntpara0035" role="paragraph">Present address: Autolus Therapeutics PLC, V Mediaworks, 191 Wood Lane, White City, London W12 7FP, UK</div></div></div><div role="doc-footnote" data-has="label"><div class="label">21</div><div id="fn7"><div id="ntpara0040" role="paragraph">Present address: Sitryx Therapeutics Limited, Oxford Science Park, Oxford, OX4 4GA, UK</div></div></div><div role="doc-footnote" data-has="label"><div class="label">22</div><div id="fn8"><div id="ntpara0045" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">23</div><div id="fn9"><div id="ntpara0050" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received June 19, 2020</span>; <span>Revised April 29, 2021</span>; <span>Accepted November 1, 2021</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.11.001" property="sameAs" target="_blank">10.1016/j.cell.2021.11.001 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867421013167" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 Published by Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.11.001" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(20)X0025-0"><img src="/cms/asset/b8554f90-8088-47a3-8406-493259c94f1d/cov200h.gif" alt="Cover Image - Cell, Volume 184, Issue 24"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2901316-7" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (3)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901316-7" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.11.001">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2901316-7" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.11.001&amp;pii=S0092-8674%2821%2901316-7" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901316-7" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.11.001">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.11.001" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867421013167&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867421013167&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=184&amp;issue=24&amp;pii=S0092-8674%2820%29X0025-0" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(21)01232-0" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(21)01223-X" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental information (3)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">Agonist:receptor co-structures inform synthesis of a M1-receptor partial agonist</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">M1-receptor agonist shows pro-cognitive activity in preclinical models</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">M1-receptor agonist shows low cholinergic adverse effects in human studies</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">M1-receptor agonist activates centers of learning and memory in elderly volunteers</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Current therapies for Alzheimer’s disease seek to correct for defective cholinergic transmission by preventing the breakdown of acetylcholine through inhibition of acetylcholinesterase, these however have limited clinical efficacy. An alternative approach is to directly activate cholinergic receptors responsible for learning and memory. The M1-muscarinic acetylcholine (M1) receptor is the target of choice but has been hampered by adverse effects. Here we aimed to design the drug properties needed for a well-tolerated M1-agonist with the potential to alleviate cognitive loss by taking a stepwise translational approach from atomic structure, cell/tissue-based assays, evaluation in preclinical species, clinical safety testing, and finally establishing activity in memory centers in humans. Through this approach, we rationally designed the <b>optimal properties, including selectivity and partial agonism</b>, into HTL9936—a potential candidate for the treatment of memory loss in Alzheimer’s disease. More broadly, this demonstrates a strategy for targeting difficult GPCR targets from structure to clinic.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/7a6cb915-e043-4374-a8f7-57869308fc5e/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.11.001/asset/20c9bcef-348b-4743-96da-ee52fb88f4ae/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/7a6cb915-e043-4374-a8f7-57869308fc5e/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;Alzheimer%27s+disease&quot;" alt="Search on this keyword" rel="nofollow">Alzheimer's disease</a></li><li><a href="/action/doSearch?AllField=&quot;G+protein+coupled+receptors&quot;" alt="Search on this keyword" rel="nofollow">G protein coupled receptors</a></li><li><a href="/action/doSearch?AllField=&quot;muscarinic+receptor&quot;" alt="Search on this keyword" rel="nofollow">muscarinic receptor</a></li><li><a href="/action/doSearch?AllField=&quot;M1+muscarinic+acetylcholine+receptor&quot;" alt="Search on this keyword" rel="nofollow">M1 muscarinic acetylcholine receptor</a></li><li><a href="/action/doSearch?AllField=&quot;structural+based+drug+design&quot;" alt="Search on this keyword" rel="nofollow">structural based drug design</a></li><li><a href="/action/doSearch?AllField=&quot;neurodegeneration&quot;" alt="Search on this keyword" rel="nofollow">neurodegeneration</a></li><li><a href="/action/doSearch?AllField=&quot;prion+disease&quot;" alt="Search on this keyword" rel="nofollow">prion disease</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0045" role="paragraph">Alzheimer’s disease (AD), the most common cause of age-related dementia, represents one of the most urgent healthcare challenges facing us today with numbers affected projected to increase ∼50 million worldwide to 75 million by 2030 in line with an aging global population. The “<i>cholinergic hypothesis of AD</i>” postulates that learning and memory deficits result from the loss of cholinergic innervation to the entorhinal cortex and hippocampus from nuclei in the basal forebrain, which may be partially recovered by elevating acetylcholine (ACh) levels, through the inhibition of the ACh catabolising cholinesterases (<span class="dropBlock reference-citations"><a id="body-ref-sref6-1" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6-1" aria-controls="sref6-1">Bartus et&nbsp;al., 1982</a><div class="dropBlock__holder" data-db-target-of="sref6-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bartus, R.T. ∙ Dean, 3rd, R.L. ∙ Beer, B. ...</div><div><strong>The cholinergic hypothesis of geriatric memory dysfunction</strong></div><div><em>Science.</em> 1982; <strong>217</strong>:408-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.7046051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0019972810" target="_blank" aria-label="Open Scopus in new tab">Scopus (4969)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7046051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.7046051&amp;pmid=7046051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37-1" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-1" aria-controls="sref37-1">Francis et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref37-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Francis, P.T. ∙ Palmer, A.M. ∙ Snape, M. ...</div><div><strong>The cholinergic hypothesis of Alzheimer’s disease: a review of progress</strong></div><div><em>J.&nbsp;Neurol. Neurosurg. Psychiatry.</em> 1999; <strong>66</strong>:137-147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jnnp.66.2.137" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0032910197" target="_blank" aria-label="Open Scopus in new tab">Scopus (1838)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10071091/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fjnnp.66.2.137&amp;pmid=10071091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Restoration of defective cholinergic transmission via inhibition of the cholinesterases is the primary symptomatic treatment for cognitive deficits associated with AD (<span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Douchamps and Mathis, 2017</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Douchamps, V. ∙ Mathis, C.</div><div><strong>A second wind for the cholinergic system in Alzheimer’s therapy</strong></div><div><em>Behav. Pharmacol.</em> 2017; <strong>28</strong>:112-123</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/FBP.0000000000000300" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014038934" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28240674/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FFBP.0000000000000300&amp;pmid=28240674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Despite showing some efficacy, principally in the early stages of disease, cholinesterase therapies show significant dose-related adverse responses, particularly gastrointestinal, that limit clinical use (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Courtney et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Courtney, C. ∙ Farrell, D. ∙ Gray, R. ..., AD2000 Collaborative Group</div><div><strong>Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial</strong></div><div><em>Lancet.</em> 2004; <strong>363</strong>:2105-2115</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2FS0140-6736%2804%2916499-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2FS0140-6736%2804%2916499-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-3042567016" target="_blank" aria-label="Open Scopus in new tab">Scopus (868)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15220031/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2804%2916499-4&amp;pmid=15220031" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Inglis, 2002</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Inglis, F.</div><div><strong>The tolerability and safety of cholinesterase inhibitors in the treatment of dementia</strong></div><div><em>Int. J. Clin. Pract. Suppl.</em> 2002; 45-63</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12139367/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=12139367" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref75" href="#" role="doc-biblioref" data-xml-rid="bib75" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref75" aria-controls="sref75">Thompson et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref75"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">75.</div><div>Thompson, S. ∙ Lanctôt, K.L. ∙ Herrmann, N.</div><div><strong>The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease</strong></div><div><em>Expert Opin. Drug Saf.</em> 2004; <strong>3</strong>:425-440</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1517/14740338.3.5.425" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-4544248755" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15335298/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1517%2F14740338.3.5.425&amp;pmid=15335298" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0050" role="paragraph">Based on its high expression in areas such as the hippocampus and cortex (<span class="dropBlock reference-citations"><a id="body-ref-sref12-1" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-1" aria-controls="sref12-1">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and the pro-cognitive effects in pre-clinical animal studies (<span class="dropBlock reference-citations"><a id="body-ref-sref12-2" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-2" aria-controls="sref12-2">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Digby et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Digby, G.J. ∙ Noetzel, M.J. ∙ Bubser, M. ...</div><div><strong>Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</strong></div><div><em>J.&nbsp;Neurosci.</em> 2012; <strong>32</strong>:8532-8544</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1523/JNEUROSCI.0337-12.2012" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84862864622" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22723693/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.0337-12.2012&amp;pmid=22723693" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Ghoshal et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Ghoshal, A. ∙ Rook, J.M. ∙ Dickerson, J.W. ...</div><div><strong>Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model</strong></div><div><em>Neuropsychopharmacology.</em> 2016; <strong>41</strong>:598-610</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/npp.2015.189" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84949575416" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26108886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnpp.2015.189&amp;pmid=26108886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-1" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-1" aria-controls="sref59-1">Moran et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref59-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Moran, S.P. ∙ Dickerson, J.W. ∙ Cho, H.P. ...</div><div><strong>M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition</strong></div><div><em>Neuropsychopharmacology.</em> 2018; <strong>43</strong>:1763-1771</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41386-018-0033-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85044465425" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29581537/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41386-018-0033-9&amp;pmid=29581537" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Shirey et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Shirey, J.K. ∙ Brady, A.E. ∙ Jones, P.J. ...</div><div><strong>A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</strong></div><div><em>J.&nbsp;Neurosci.</em> 2009; <strong>29</strong>:14271-14286</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1523/JNEUROSCI.3930-09.2009" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-70449640543" target="_blank" aria-label="Open Scopus in new tab">Scopus (206)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19906975/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.3930-09.2009&amp;pmid=19906975" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), the M1 muscarinic acetylcholine receptor&nbsp;(M1-receptor), one of five muscarinic receptor subtypes (M1–M5), is widely considered to be a key or mediator of cognitive function and thereby a target for the treatment in AD (<span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Conn et&nbsp;al., 2009a</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Conn, P.J. ∙ Christopoulos, A. ∙ Lindsley, C.W.</div><div><strong>Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2009; <strong>8</strong>:41-54</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd2760" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-58149193205" target="_blank" aria-label="Open Scopus in new tab">Scopus (864)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19116626/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd2760&amp;pmid=19116626" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref23-1" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-1" aria-controls="sref23-1">Conn et&nbsp;al., 2009b</a><div class="dropBlock__holder" data-db-target-of="sref23-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Conn, P.J. ∙ Jones, C.K. ∙ Lindsley, C.W.</div><div><strong>Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</strong></div><div><em>Trends Pharmacol. Sci.</em> 2009; <strong>30</strong>:148-155</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-61349093537" target="_blank" aria-label="Open Scopus in new tab">Scopus (255)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19201489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2008.12.002&amp;pmid=19201489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref35-1" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-1" aria-controls="sref35-1">Felder et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref35-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Felder, C.C. ∙ Goldsmith, P.J. ∙ Jackson, K. ...</div><div><strong>Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases</strong></div><div><em>Neuropharmacology.</em> 2018; <strong>136</strong>:449-458</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2018.01.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85046631768" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29374561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2018.01.028&amp;pmid=29374561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This has led many pharmaceutical companies to pursue drug discovery programs targeting the M1-receptor (<span class="dropBlock reference-citations"><a id="body-ref-sref35-2" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-2" aria-controls="sref35-2">Felder et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref35-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Felder, C.C. ∙ Goldsmith, P.J. ∙ Jackson, K. ...</div><div><strong>Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases</strong></div><div><em>Neuropharmacology.</em> 2018; <strong>136</strong>:449-458</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2018.01.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85046631768" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29374561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2018.01.028&amp;pmid=29374561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0055" role="paragraph">A number of orthosteric muscarinic agonists that utilize the binding site of the natural ligand acetylcholine have advanced to the clinic (<span class="dropBlock reference-citations"><a id="body-ref-sref35-3" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-3" aria-controls="sref35-3">Felder et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref35-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Felder, C.C. ∙ Goldsmith, P.J. ∙ Jackson, K. ...</div><div><strong>Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases</strong></div><div><em>Neuropharmacology.</em> 2018; <strong>136</strong>:449-458</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2018.01.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85046631768" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29374561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2018.01.028&amp;pmid=29374561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and showed tantalising evidence of efficacy. These include the M1/M4 preferring agonist xanomeline that improved both cognitive and behavioral disturbances in AD patients (<span class="dropBlock reference-citations"><a id="body-ref-sref10" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10" aria-controls="sref10">Bodick et&nbsp;al., 1997a</a><div class="dropBlock__holder" data-db-target-of="sref10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Bodick, N.C. ∙ Offen, W.W. ∙ Levey, A.I. ...</div><div><strong>Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</strong></div><div><em>Arch. Neurol.</em> 1997; <strong>54</strong>:465-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/archneur.1997.00550160091022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0030902127" target="_blank" aria-label="Open Scopus in new tab">Scopus (600)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9109749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Farchneur.1997.00550160091022&amp;pmid=9109749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">1997b</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Bodick, N.C. ∙ Offen, W.W. ∙ Shannon, H.E. ...</div><div><strong>The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease</strong></div><div><em>Alzheimer Dis. Assoc. Disord.</em> 1997; <strong>11</strong>:S16-S22</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9339268/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=9339268" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and improved symptoms in schizophrenia patients (<span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Shekhar et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Shekhar, A. ∙ Potter, W.Z. ∙ Lightfoot, J. ...</div><div><strong>Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</strong></div><div><em>Am. J. Psychiatry.</em> 2008; <strong>165</strong>:1033-1039</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1176/appi.ajp.2008.06091591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-48949095543" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18593778/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1176%2Fappi.ajp.2008.06091591&amp;pmid=18593778" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and the bitopic M1-ligand GSK1034702 (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Bradley et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Bradley, S.J. ∙ Molloy, C. ∙ Bundgaard, C. ...</div><div><strong>Bitopic Binding Mode of an M<sub>1</sub> Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes</strong></div><div><em>Mol. Pharmacol.</em> 2018; <strong>93</strong>:645-656</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.118.111872" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85052534454" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29695609/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.118.111872&amp;pmid=29695609" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref16-1" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-1" aria-controls="sref16-1">Budzik et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref16-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Budzik, B. ∙ Garzya, V. ∙ Shi, D. ...</div><div><strong>Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists</strong></div><div><em>ACS Med. Chem. Lett.</em> 2010; <strong>1</strong>:244-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ml100105x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77956510685" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24900202/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fml100105x&amp;pmid=24900202" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62-1" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-1" aria-controls="sref62-1">Nathan et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref62-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Nathan, P.J. ∙ Watson, J. ∙ Lund, J. ...</div><div><strong>The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction</strong></div><div><em>Int J Neuropsychopharmacol.</em> 2013; <strong>16</strong>:721-731</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1017/S1461145712000752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84875697137" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22932339/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1017%2FS1461145712000752&amp;pmid=22932339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), which improved immediate and delayed recall in a nicotine abstinence study. Both programs were subsequently terminated based on cholinergic-adverse responses, predominantly within gastrointestinal and cardiovascular systems.</div><div id="p0060" role="paragraph">The challenge then was to design muscarinic agonists with a pharmacological profile that would activate receptors in the CNS in areas such as the cortex and hippocampus involved in learning and memory while avoiding side effects, particularly gastrointestinal and cardiovascular, that would be unacceptable in a drug for elderly patients. Attempts to map compound pharmacology to physiological activity has proved exceedingly difficult. This is hampered by the lack of selectivity across muscarinic subtypes. An obvious approach therefore would be to design an M1-agonist with high selectivity particularly over M2- and M3-receptors since these are considered to be the primary receptor subtypes mediating peripheral adverse responses. However, in the case of muscarinic receptors, this is very difficult due to the high sequence similarity of the orthosteric binding site across all five receptor subtypes (<span class="dropBlock reference-citations"><a id="body-ref-sref79" href="#" role="doc-biblioref" data-xml-rid="bib79" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref79" aria-controls="sref79">Vuckovic et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref79"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">79.</div><div>Vuckovic, Z. ∙ Gentry, P.R. ∙ Berizzi, A.E. ...</div><div><strong>Crystal structure of the M<sub>5</sub> muscarinic acetylcholine receptor</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2019; <strong>116</strong>:26001-26007</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1914446116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85076692249" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31772027/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1914446116&amp;pmid=31772027" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, it was possible that some of the observed side effects might be mediated through the M1-receptor itself (<span class="dropBlock reference-citations"><a id="body-ref-sref1-1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-1" aria-controls="sref1-1">Alt et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref1-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Alt, A. ∙ Pendri, A. ∙ Bertekap, Jr., R.L. ...</div><div><strong>Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 2016; <strong>356</strong>:293-304</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/jpet.115.226910" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84959420309" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26582730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fjpet.115.226910&amp;pmid=26582730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref14-1" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-1" aria-controls="sref14-1">Bradley et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref14-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Bradley, S.J. ∙ Molloy, C. ∙ Valuskova, P. ...</div><div><strong>Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:240-249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-019-0453-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85079780292" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32080630/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-019-0453-9&amp;pmid=32080630" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref25-1" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-1" aria-controls="sref25-1">Davoren et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref25-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Davoren, J.E. ∙ Lee, C.W. ∙ Garnsey, M. ...</div><div><strong>Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2016; <strong>59</strong>:6313-6328</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.6b00544" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84978634494" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27275946/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.6b00544&amp;pmid=27275946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We hypothesized these challenges could potentially be overcome by a partial agonist that might activate highly expressed central receptors while showing reduced activity at peripheral M1-receptors where expression is lower.</div><div id="p0065" role="paragraph">Here we describe the strategy taken to use structure-based drug design (SBDD) (<span class="dropBlock reference-citations"><a id="body-ref-sref21" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21" aria-controls="sref21">Congreve et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Congreve, M. ∙ Oswald, C. ∙ Marshall, F.H.</div><div><strong>Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs</strong></div><div><em>Trends Pharmacol. Sci.</em> 2017; <strong>38</strong>:837-847</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2017.05.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2017.05.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85021129087" target="_blank" aria-label="Open Scopus in new tab">Scopus (97)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28648526/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2017.05.010&amp;pmid=28648526" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Jazayeri et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Jazayeri, A. ∙ Andrews, S.P. ∙ Marshall, F.H.</div><div><strong>Structurally Enabled Discovery of Adenosine A<sub>2A</sub> Receptor Antagonists</strong></div><div><em>Chem. Rev.</em> 2017; <strong>117</strong>:21-37</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.chemrev.6b00119" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85020139339" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27333206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.chemrev.6b00119&amp;pmid=27333206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to identify a selective M1-receptor orthosteric partial agonist (HTL9936) and to carefully profile the pharmacology of this molecule in a step-wise translational approach <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i> to confirm whether this resulted in the desired profile devoid of the dose-limiting side effects associated with previous M1-receptor agonists. As a final translational step prior to progressing to evaluation in patients with AD, the pharmacology was evaluated in early clinical studies designed to establish the safety profile at doses that produce evidence of functional target engagement in the CNS of healthy volunteers.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Screening fragment-like compounds as starting points for drug design</h3><div id="p0070" role="paragraph">To initiate hit finding, homology models of the human M1-receptor bound to the agonist 77-LH-28-1 were derived based on the crystal structure of the avian β<sub>1</sub>-adrenergic receptor:cyanopindolol (PDB: <a id="intref0030" href="http://firstglance.jmol.org/fg.htm?mol2VT4" target="_blank">2VT4</a>) complex (<span class="dropBlock reference-citations"><a id="body-ref-sref80-1" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-1" aria-controls="sref80-1">Warne et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref80-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Warne, T. ∙ Serrano-Vega, M.J. ∙ Baker, J.G. ...</div><div><strong>Structure of a beta1-adrenergic G-protein-coupled receptor</strong></div><div><em>Nature.</em> 2008; <strong>454</strong>:486-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature07101" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-47949129742" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18594507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature07101&amp;pmid=18594507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); the best available template at the time. In this model (<a id="crosref0510" href="#fig1">Figure&nbsp;1</a>A), residues Y82<sup>2.61</sup>, L102<sup>3.29</sup>, D105<sup>3.32</sup>, and Y408<sup>7.43</sup> (Ballosteros and Weinstein GPCR residue numbering scheme) lined the orthosteric pocket consistent with mutagenesis data (<span class="dropBlock reference-citations"><a id="body-ref-sref53-1" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-1" aria-controls="sref53-1">Lebon et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref53-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Lebon, G. ∙ Langmead, C.J. ∙ Tehan, B.G. ...</div><div><strong>Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors</strong></div><div><em>Mol. Pharmacol.</em> 2009; <strong>75</strong>:331-341</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.108.050963" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-59449090754" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19001633/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.108.050963&amp;pmid=19001633" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To support hit identification, a careful consideration of predicted binding modes of known agonists were made in the homology model, and a targeted library of fragment-like compounds was subsequently assembled <i>in silico</i>. The aim was to enrich for known chemotypes incorporating novel exemplars of privileged ring systems and functional groups that were observed across different classes of muscarinic agonist ligands (<span class="dropBlock reference-citations"><a id="body-ref-sref5" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5" aria-controls="sref5">Avlani et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Avlani, V.A. ∙ Langmead, C.J. ∙ Guida, E. ...</div><div><strong>Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor</strong></div><div><em>Mol. Pharmacol.</em> 2010; <strong>78</strong>:94-104</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.110.064345" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77953777461" target="_blank" aria-label="Open Scopus in new tab">Scopus (59)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20413650/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.110.064345&amp;pmid=20413650" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref16-2" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-2" aria-controls="sref16-2">Budzik et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref16-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Budzik, B. ∙ Garzya, V. ∙ Shi, D. ...</div><div><strong>Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists</strong></div><div><em>ACS Med. Chem. Lett.</em> 2010; <strong>1</strong>:244-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ml100105x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77956510685" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24900202/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fml100105x&amp;pmid=24900202" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref39" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39" aria-controls="sref39">Goodwin et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Goodwin, J.A. ∙ Hulme, E.C. ∙ Langmead, C.J. ...</div><div><strong>Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands</strong></div><div><em>Mol. Pharmacol.</em> 2007; <strong>72</strong>:1484-1496</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.107.038265" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36349016730" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17848601/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.107.038265&amp;pmid=17848601" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref53-2" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-2" aria-controls="sref53-2">Lebon et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref53-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Lebon, G. ∙ Langmead, C.J. ∙ Tehan, B.G. ...</div><div><strong>Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors</strong></div><div><em>Mol. Pharmacol.</em> 2009; <strong>75</strong>:331-341</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.108.050963" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-59449090754" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19001633/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.108.050963&amp;pmid=19001633" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A set of 322 commercially available fragment-like molecules were ultimately purchased following prioritisation by docking molecule selections into the M1 homology model and then tested in an <i>in&nbsp;vitro</i> functional extracellular regulated protein kinase-1/2 phosphorylation (pERK1/2) and calcium mobilisation assays (<a id="crosref0540" href="#fig1">Figure&nbsp;1</a>B). Sixteen compounds exhibited activity, the top four of which were prioritised for further pharmacological characterization and medicinal chemistry optimization (<a id="crosref0545" href="#fig1">Figure&nbsp;1</a>C; <a id="crosref0550" href="#mmc1">Table S1</a>). Of these four hits the bis-piperidine primary amide, Compound 4, demonstrated an EC<sub>50</sub> of 3.5&nbsp;μM at the M1-receptor and was considered an attractive starting point for further optimization.</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/92a7cebb-21ee-4707-8df8-2a9aaced4d21/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.11.001/asset/3100697d-2571-4f5f-b5e1-1f302dfcdc6c/main.assets/gr1.jpg" height="258" width="656" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/92a7cebb-21ee-4707-8df8-2a9aaced4d21/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Initial M1-receptor homology model and hit-finding campaign</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Original homology model of the human M1-receptor with the muscarinic agonist 77-LH-28-1 docked into the orthosteric site used to support identification of a fragment library for hit identification. Ballesteros-Weinstein residue numbering is shown in superscript.</div><div id="fspara0020" role="paragraph">(B and C) (B) Schematic of the fragment screening campaign to identify 16 hit compounds possessing M1-receptor activity, from which (C) 4 fragment-like hits (Compounds 1–4) were identified.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>High-resolution structures of the agonist-bound M1-receptor</h3><div id="p0075" role="paragraph">To accelerate SBDD we sought to generate a high-resolution crystal structure of the M1-receptor in an agonist-bound conformation. To facilitate structure determination, a thermostabilized receptor construct (termed M1-StaR) (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Doré et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Doré, A.S. ∙ Robertson, N. ∙ Errey, J.C. ...</div><div><strong>Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine</strong></div><div><em>Structure.</em> 2011; <strong>19</strong>:1283-1293</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.str.2011.06.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.str.2011.06.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79960181417" target="_blank" aria-label="Open Scopus in new tab">Scopus (465)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21885291/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.str.2011.06.014&amp;pmid=21885291" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66-1" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-1" aria-controls="sref66-1">Robertson et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref66-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Robertson, N. ∙ Jazayeri, A. ∙ Errey, J. ...</div><div><strong>The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery</strong></div><div><em>Neuropharmacology.</em> 2011; <strong>60</strong>:36-44</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2010.07.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-78149501282" target="_blank" aria-label="Open Scopus in new tab">Scopus (132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20624408/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2010.07.001&amp;pmid=20624408" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) was generated in the presence of the agonist 77-LH-28-1 (<span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">Langmead et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Langmead, C.J. ∙ Austin, N.E. ∙ Branch, C.L. ...</div><div><strong>Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</strong></div><div><em>Br. J. Pharmacol.</em> 2008; <strong>154</strong>:1104-1115</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/bjp.2008.152" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-46249084634" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18454168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fbjp.2008.152&amp;pmid=18454168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The M1-StaR contained twelve amino acid substitutions (<a id="crosref0570" href="#figs1">Figures S1</a>A and S1B) including a tryptophan to alanine substitution at position 101 (W101A<sup>3.28</sup>) that was predicted to enable direct access of small molecule agonists, including 77-LH-28-1, to the orthosteric binding site of the M1-receptor (<span class="dropBlock reference-citations"><a id="body-ref-sref53-3" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-3" aria-controls="sref53-3">Lebon et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref53-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Lebon, G. ∙ Langmead, C.J. ∙ Tehan, B.G. ...</div><div><strong>Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors</strong></div><div><em>Mol. Pharmacol.</em> 2009; <strong>75</strong>:331-341</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.108.050963" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-59449090754" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19001633/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.108.050963&amp;pmid=19001633" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). With the exception of W101A<sup>3.28</sup>, none of the other eleven amino acid substitutions were predicted to directly influence the acetylcholine binding site (<a id="crosref0580" href="#figs1">Figures S1</a>A and S1B). To aid expression, the first 87 amino acids of the M1-receptor were replaced by residues 1–95 of the human M4-receptor. To promote crystalisation, the last 22 residues of C-termini were removed and residues R220–F355 in the third intracellular loop were replaced with T4-lysozyme (T4L) (<a id="crosref0585" href="#figs1">Figures S1</a>A and S1B). Consistent with an agonist-like conformation, the M1-StaR-T4L had high agonist (77-LH-28-1) binding affinity while showing a significant reduction in antagonist (NMS) affinity compared to wild-type receptor (<a id="crosref0590" href="#mmc1">Table S2</a>).</div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/565674cd-c813-425c-9037-27565ff1d8af/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.11.001/asset/b64422de-18c8-4d22-b891-aa7d55dfbe38/main.assets/figs1.jpg" height="582" width="750" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/565674cd-c813-425c-9037-27565ff1d8af/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Crystallisation construct design and pharmacological characterization, related to <a id="crosref1320" href="#fig2">Figures 2</a>A–2C</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0215" role="paragraph">(A) Sequence alignment across the human M1 and M4-receptors and the final M1-StaR. The ClustalX colouring scheme (as implemented in JALVIEW) was used in the alignment. (B) M1-StaR-T4L crystallisation construct in schematic snake-plot representation. Thermostabilising mutations (F27A1.34, T32A1.39, V46L1.53, L64A2.43, T95A, W101A3.28, S112A3.39, A143L4.43, A196T5.46, K362A6.32, A364L6.34, S411A7.46) are represented in green, whereas the C435A mutation to remove a post-translational modification is in red. The disulfide bond between C98 and Cys178 is shown as a yellow line.</div></div></div></div></figcaption></figure></div><div id="p0080" role="paragraph">The M1-StaR-T4L was subsequently crystallized bound to 77-LH-28-1 in lipidic cubic phase (LCP) and the structure determined to 2.17&nbsp;Å resolution (<a id="crosref0595" href="#fig2">Figure&nbsp;2</a>A; <a id="crosref0600" href="#mmc1">Table S3</a>). In this structure, 77-LH-28-1 is very well defined in the electron density map and is primarily held in place via the charge-charge interaction from the protonated nitrogen within the piperidine fragment at the center of the ligand to the negatively charged aspartate (D105<sup>3.32</sup>) side chain (<a id="crosref0605" href="#fig2">Figures 2</a>B and 2C; <a id="crosref0610" href="#figs2">Figures S2</a>A and S2B). This piperidine ring system breaks apart the “tyrosine cage” seen in subsequently published muscarinic antagonist structures (<span class="dropBlock reference-citations"><a id="body-ref-sref74-1" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-1" aria-controls="sref74-1">Thal et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref74-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Thal, D.M. ∙ Sun, B. ∙ Feng, D. ...</div><div><strong>Crystal structures of the M1 and M4 muscarinic acetylcholine receptors</strong></div><div><em>Nature.</em> 2016; <strong>531</strong>:335-340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature17188" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84982308386" target="_blank" aria-label="Open Scopus in new tab">Scopus (261)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26958838/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature17188&amp;pmid=26958838" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Toward the apical side of the receptor, the tetrahydroquinoline-2-one moiety of the ligand makes hydrophobic contacts with W91<sup>23.50</sup>, L102<sup>3.29</sup>, Y85<sup>2.64</sup>, and Y82<sup>2.61</sup> as well as with the disulphide bridge between cysteine residues C98<sup>3.25</sup> - C178<sup>45.50</sup>, thereby linking transmembrane domain 3 (TM3) extracellular loop 2 (ECL2). The tetrahydroquinoline-2-one oxygen further makes a water-mediated hydrogen bond with the hydroxyl group of Y82<sup>2.61</sup>. The lower part of the 77-LH-28-1, encompassing the piperidine ring and the aliphatic tail, is sheathed within an elongated cavity, delineated by water molecules which are stabilized by an intricate hydrogen-bonding network, and by Y106<sup>3.33</sup>, Y408<sup>7.43</sup>, W157<sup>4.57</sup>, and Y404<sup>7.39</sup>, all of which make van der Waals contacts with the ligand. This structure thus provided important initial co-ordinates to support M1-receptor SBDD.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/fe3651c1-3632-4e73-b132-fdfc8be987eb/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.11.001/asset/de4ff4ed-cc1f-43b7-bfee-ee70c39a4a6c/main.assets/gr2.jpg" height="531" width="656" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/fe3651c1-3632-4e73-b132-fdfc8be987eb/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">Structure of 77-LH-28-1 bound to the M1-receptor and design of HTL9936</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0030" role="paragraph">(A) Crystal structure of M1-StaR-T4L shown as ribbons colored blue (N terminus) to red (C terminus), with 77-LH-28 bound in the orthosteric site represented as a space-filled model.</div><div id="fspara0035" role="paragraph">(B) Zoomed-in view of the M1-StaR-T4L orthosteric site with 77-LH-28-1 as well as side chains of binding site residues within 5&nbsp;Å of the ligand, shown as sticks. Water molecules are represented as blue spheres, and hydrogen bonding networks are shown as dashed lines. The 1σ contoured 2mFo-dFc electron density map corresponding to 77-LH-28-1 (represented as sticks) is shown as a blue mesh in the right-hand side inset.</div><div id="fspara0040" role="paragraph">(C) Superposition of binding site residues of the M1-receptor homology model (pink) onto the crystal structure of the M1-StaR-T4L bound to 77-LH-28-1 (yellow). Ligands for each of these structures are represented as sticks in pink and yellow respectively for the homology model and for the crystal structure and provide a visual summary of the accuracy of the initial homology model.</div><div id="fspara0045" role="paragraph">(D) Medicinal chemistry iterations leading to the design of (S)-Compound 7 (HTL9936) from the original hit molecule Compound 4.</div><div id="fspara0050" role="paragraph">See also <a id="crosref1275" href="#figs1">Figures S1</a> and <a id="crosref1280" href="#figs2">S2</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/634b3d83-fda6-459c-98c3-a02dcb2b1a9b/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.11.001/asset/37cf4902-8b9a-41f9-8063-38a1fafed5e3/main.assets/figs2.jpg" height="576" width="506" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/634b3d83-fda6-459c-98c3-a02dcb2b1a9b/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">Molecular details of the M1-receptor extended orthosteric agonist binding site, related to <a id="crosref1325" href="#fig2">Figures 2</a>A–2C and <a id="crosref1330" href="#fig3">3</a>A–3E</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0225" role="paragraph">Surface representation of the M1-receptor as viewed parallel to the membrane plane to reveal the occupied binding sites and ligand interaction diagrams depicting the key molecular interactions made by (A,B) 77-LH-28-1, (B.C) HTL9936 and (C,D) GSK1034702.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>Structure-based drug design of a lead M1-receptor agonist—HTL9936</h3><div id="p0085" role="paragraph">The key challenge we initially sought to address within the hit series was early evidence for M1-receptor selectivity against the highly homologous M2- and M3-receptors. To address this challenge, a series of molecules were synthesized to investigate the structural activity relationship (SAR) among which were a series of small amides including the iso-butyl amide Compound 5 (<a id="crosref0620" href="#fig2">Figure&nbsp;2</a>D), which showed improved M1-receptor agonist activity (EC<sub>50</sub> 316&nbsp;nM), but still contained weak M2- and M4-receptor activity (<a id="crosref0625" href="#mmc1">Table S4</a>). Analysis of the docked structure of Compound 5 predicted that the shape of the ring system attached to the ethyl carbamate and subsequent structural re-arrangements of the “tyrosine cage” would confer improved selectivity over M2- and M3-receptor subtypes. This was confirmed by the introduction of an azepine ring that filled a sub-pocket of the orthosteric site defined between Tyr106<sup>3.33</sup>, Trp378<sup>6.48</sup>, Tyr381<sup>6.51</sup>, and Cys407<sup>7.42</sup> in a more efficient manner to give racemic Compound 6 (<a id="crosref0630" href="#fig2">Figure&nbsp;2</a>D), which showed sub-micromolar potency at the M1-receptor in calcium assays (EC<sub>50</sub> 79&nbsp;nM) with no detectable agonist activity at M2- and M3-receptors and a ten-fold lower potency at M4-receptors (EC<sub>50</sub> 794&nbsp;nM) (<a id="crosref0635" href="#mmc1">Table S4</a>). This formed a critical breakthrough in the development of selective M1-receptor agonists.</div><div id="p0090" role="paragraph">Further investigation of the structural activity relationships of the amide group determined that lipophilic secondary amides were preferred (e.g., Compounds 14–18; <a id="crosref0640" href="#mmc1">Table S4</a>) while alkyl tertiary amides (e.g., Compounds 19 and 20; <a id="crosref0645" href="#mmc1">Table S4</a>) and alkyl amides with polar substituents (e.g., Compounds 21, 22, and 26; <a id="crosref0650" href="#mmc1">Table S4</a>) were not. An example of a preferred secondary amide is racemic Compound 7 (<a id="crosref0655" href="#fig2">Figure&nbsp;2</a>D), which contains a cyclobutylmethyl secondary amide. Separation of racemic Compound 7 gave the enantiomers (S)-Compound 7 (HTL9936) [M1 EC<sub>50</sub> 32&nbsp;nM, M2&nbsp;&gt; 20&nbsp;μM, M3&nbsp;&gt; 20&nbsp;μM, M4 398&nbsp;nM] and (R)-Compound 7 [M1 EC<sub>50</sub> 398&nbsp;nM, M2&nbsp;&gt; 20&nbsp;μM, M3&nbsp;&gt; 20 uM, M4 2.5&nbsp;μM] (<a id="crosref0660" href="#mmc1">Table S4</a>). The (S)-enantiomer is the preferred chiral center on azepine ring, and (S)-Compound 7 (HTL9936) was progressed to further structural studies and preclinical assessment (Patent:WO2013/072705).</div></section><section id="sec-2-4"><h3>Structure of the M1-receptor:HTL9936 complex in comparison to other agonists</h3><div id="p0095" role="paragraph">To refine our understanding of ligand binding modes driving selectivity at the M1-receptor, we obtained structures of the M1-StaR-T4L with HTL9936 and the M1-agonist GSK1034702 (<span class="dropBlock reference-citations"><a id="body-ref-sref16-3" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16-3" aria-controls="sref16-3">Budzik et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref16-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Budzik, B. ∙ Garzya, V. ∙ Shi, D. ...</div><div><strong>Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists</strong></div><div><em>ACS Med. Chem. Lett.</em> 2010; <strong>1</strong>:244-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ml100105x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77956510685" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24900202/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fml100105x&amp;pmid=24900202" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); the latter reached early clinical development but was subsequently withdrawn due to dose-limiting cardiovascular and gastrointestinal side effects (<span class="dropBlock reference-citations"><a id="body-ref-sref35-4" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35-4" aria-controls="sref35-4">Felder et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref35-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Felder, C.C. ∙ Goldsmith, P.J. ∙ Jackson, K. ...</div><div><strong>Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases</strong></div><div><em>Neuropharmacology.</em> 2018; <strong>136</strong>:449-458</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2018.01.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85046631768" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29374561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2018.01.028&amp;pmid=29374561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). When it was tested alongside other compounds, we observed significant M2-receptor agonist activity for GSK1034702 (<a id="crosref0675" href="#mmc1">Table S4</a>) that may underlie some of the dose-limiting clinical effects and provides a rationale for a direct structural comparison. In our comparative analysis of different M1-receptor-ligand binding modes, we used previously defined aminergic GPCR ligand binding site regions (<span class="dropBlock reference-citations"><a id="body-ref-sref77-1" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77-1" aria-controls="sref77-1">Vass et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref77-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Vass, M. ∙ Podlewska, S. ∙ de Esch, I.J.P. ...</div><div><strong>Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2019; <strong>62</strong>:3784-3839</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.8b00836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85058134004" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30351004/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.8b00836&amp;pmid=30351004" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) including the centrally located amine pocket (D103<sup>3.32</sup>, S109<sup>3.36</sup>, W378<sup>6.48</sup>, Y381<sup>6.51</sup>, Y404<sup>7.39</sup>, C407<sup>7.42</sup>, Y408<sup>7.43</sup>), connecting the major pocket (Y106<sup>3.33</sup>, N110<sup>3.37</sup>, W157<sup>4.56</sup>, A<sup>5.43</sup>, T196<sup>5.46</sup>, N382<sup>6.52</sup>) and minor pocket (F77<sup>2.56</sup>, L81<sup>2.60</sup>, Y282<sup>2.61</sup>, A/W101<sup>3.28</sup>, L102<sup>3.29</sup>), extending toward the extracellular vestibule (Y85<sup>2.64</sup>, W91<sup>23.50</sup>, C178<sup>45.50</sup>, I180<sup>45.52</sup>). We found that like 77-LH-28-1, HTL9936 was primarily held in place via the charge-charge interaction from the protonated nitrogen to the negatively charged aspartate, D105<sup>3.32</sup> in the amine pocket (<a id="crosref0685" href="#fig3">Figures 3</a>A–3C; <a id="crosref0690" href="#figs2">Figure&nbsp;S2</a>C and S2D). HTL9936 demonstrates a similar re-arrangement of the tyrosine cage to 77-LH-28-1 with nitrogen of the piperidine ring making contact with Y404<sup>7.39</sup> causing a rotation that confers a unique conformation of another tyrosine within the cage, Y381<sup>6.51</sup> (<a id="crosref0695" href="#fig3">Figures 3</a>A–3C). The base of the amine pocket is formed by C407<sup>7.42</sup>, making hydrophobic contacts to the homopiperidine ring, and W378<sup>6.48</sup>, which is forming an edge-to-face π-stacking arrangement with the delocalized π electrons of the carbamate system.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/bb2e56ce-f388-4179-92de-872bc60464ce/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.11.001/asset/831ec24b-d6b3-4614-95db-24509ad8c96f/main.assets/gr3.jpg" height="665" width="752" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/bb2e56ce-f388-4179-92de-872bc60464ce/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">Structural comparison of the active state of the agonist-bound human M1-receptor</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0060" role="paragraph">(A) Crystal structure of the M1-StaR-T4L bound to HTL9936.</div><div id="fspara0065" role="paragraph">(B) Ligand binding site of M1-StaR-T4L bound to HTL9936.</div><div id="fspara0070" role="paragraph">(C) Superposition of ligand binding site of M1-StaR-T4L bound to HTL9936, GSK1034702 and 77-LH-28-1. In the M1-StaR-T4L-GSK1034702 complex, Y106<sup>3.33</sup> and W157<sup>4.57</sup> adopt clearly distinctly rotameric states from similar residues in the other two structures, as indicated by the curved arrows.</div><div id="fspara0075" role="paragraph">(D) Crystal structure of the M1-StaR-T4L bound to GSK1034702.</div><div id="fspara0080" role="paragraph">(E) Ligand binding site of M1-StaR-T4L bound to GSK1034702.</div><div id="fspara0085" role="paragraph">(F) Comparative analysis of structural protein-ligand interactions and ligand binding site volumes of crystal structures and Molecular Dynamics (MD) simulations of M1-StaR-T4L bound to HTL9936, 77-LH-28-1 and GSK1034702. Apolar and polar protein-ligand interactions in crystal structures (yellow crosses) and MD simulation ensembles (red and blue triangles) are defined per amino acid residue as described in the <a id="crosref1285" href="#sec-4-1">STAR Methods</a> section, including the consideration of water-mediated polar interactions. Major pocket, amine pocket, minor pocket, and extracellular vestibule (ECV) residues are color coded as defined for aminergic GPCR ligand binding site regions (<span class="dropBlock reference-citations"><a id="body-ref-sref77-2" href="#" role="doc-biblioref" data-xml-rid="bib77" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref77-2" aria-controls="sref77-2">Vass et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref77-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">77.</div><div>Vass, M. ∙ Podlewska, S. ∙ de Esch, I.J.P. ...</div><div><strong>Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2019; <strong>62</strong>:3784-3839</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.8b00836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85058134004" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30351004/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.8b00836&amp;pmid=30351004" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Binding site volumes of crystal structures (yellow arrows) and MD simulation trajectories (violin plots), for HTL9936 (blue), 77-LH-28-1 (orange) and GSK1034702 (gray) are shown on the right.</div><div id="fspara0090" role="paragraph">See also <a id="crosref1295" href="#figs2">Figures S2</a> and <a id="crosref1300" href="#figs3">S3</a>.</div></div></div></div></figcaption></figure></div><div id="p0100" role="paragraph">GSK1034702 is primarily held in place via a similar interaction with the negatively charged aspartate D105<sup>3.32</sup> (<a id="crosref0700" href="#fig3">Figures 3</a>C–3E; <a id="crosref0705" href="#figs2">Figures S2</a>E and S2F). However, a number of notable differences were observed in the binding mode of GSK1034702 compared to 77-LH-28-1 and HTL9936, which despite the identical amino acid sequences between the muscarinic subtypes in the orthosteric site can rationalise the reduced selectivity versus M2-receptor agonism. Most notably, the reduced size of the tetrahydropyran fragment at the base of the ligand enables direct contact with Y106<sup>3.33</sup> that in turn is associated with displacement of W157<sup>4.57</sup>, W378<sup>6.48</sup>, and Y404<sup>7.39</sup>, thereby forcing a distinct orientation in this region of the binding pocket from that seen in the structures with 77-LH-28-1 and HTL9936. In addition, at the top of the minor binding pocket the larger 7-fluoro-5-methyl-benzimidazol-2-one portion of GSK1034702 occupies the whole of the region vacated by the W101<sup>3.28</sup>A (W101A) mutation in the M1-StaR.</div><div id="p0105" role="paragraph">Comparative MD simulations were performed in the M1-StaR background to provide complementary insights into the flexibility of M1-ligand binding mode conformations and the stability of water-mediated polar interaction networks identified from the structural analysis (<a id="crosref0710" href="#fig3">Figure&nbsp;3</a>F). HTL9936 forms stable water-mediated polar interaction networks in the major pocket with Y106<sup>3.33</sup>, T196<sup>5.46</sup>, Y381<sup>6.51</sup>, and N382<sup>6.52</sup> via its carbamate moiety and in the minor pocket and extracellular vestibule with C178<sup>45.50</sup> and Y404<sup>7.39</sup> via its amide group. Similarly, GSK1034702 forms stable water-mediated polar interaction networks with its tetrahydro-<i>2H</i>-puran moiety and Y106<sup>3.33</sup> and T196<sup>5.46</sup> and between its benzimidazol-2-one group and Y82<sup>2.61</sup>, I180<sup>45.52</sup> and Y381<sup>6.51</sup>. In contrast, the water-mediated polar interaction between 77-LH-28-1 and Y82<sup>2.61</sup> observed in the crystal structure is not stable in MD simulations. The pentyl moiety of 77-LH-28-1 is flexible, adopting alternative binding modes between Y106<sup>3.33</sup>/W157<sup>4.57</sup> or between A193<sup>5.43</sup>/Y381<sup>6.51</sup> in the major pocket. The broad range of binding site volumes sampled in MD simulations (<a id="crosref0715" href="#fig3">Figure&nbsp;3</a>F) is consistent with the relative flexibility of the M1-receptor:77-LH-28-1 complex compared to GSK1034702 and HTL9936. Analysis of the binding site volumes for the partial agonist HTL9936 and agonists 77-LH-28-1 and GSK1034702 highlight a closer alignment to the binding site volumes of the antagonist tiotropium than the larger binding site volumes sampled for the small agonist iperoxo (<a id="crosref0720" href="#figs3">Figure&nbsp;S3</a>). Altogether, the comparative analysis of M1-receptor ligand interaction fingerprints (<span class="dropBlock reference-citations"><a id="body-ref-sref49" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49" aria-controls="sref49">Kooistra et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref49"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Kooistra, A.J. ∙ Leurs, R. ∙ de Esch, I.J. ...</div><div><strong>Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study</strong></div><div><em>J.&nbsp;Chem. Inf. Model.</em> 2015; <strong>55</strong>:1045-1061</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jcim.5b00066" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84930227130" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25848966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jcim.5b00066&amp;pmid=25848966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref50" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50" aria-controls="sref50">Kooistra et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref50"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Kooistra, A.J. ∙ Vischer, H.F. ∙ McNaught-Flores, D. ...</div><div><strong>Function-specific virtual screening for GPCR ligands using a combined scoring method</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:28288</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/srep28288" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84975721733" target="_blank" aria-label="Open Scopus in new tab">Scopus (77)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27339552/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsrep28288&amp;pmid=27339552" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and structurally resolved ligand binding sites in the M1-StaR indicate that the partial agonist HTL9936 has several unique M1-receptor binding mode features compared to agonists 77-LH-28-1 and GSK1034702 (<a id="crosref0735" href="#fig3">Figure&nbsp;3</a>). HTL9936 has a more extended, stable binding mode targeting a larger M1-receptor binding site connecting major and minor pockets, stabilized by the novel, optimized piperidine-azepine ring system of HTL9936. In addition, the carbamate moiety of HTL9936 stabilizes a unique, extended water mediated polar receptor-ligand interaction network in the major pocket between TM3, TM5, and TM6. While keeping in mind that the MD simulations were performed in the M1-StaR background and not the WT receptor, the combined structural features of HTL9936 described here potentially provide a basis for the partial agonism of this novel M1-receptor modulator.</div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/f01124a0-b2c2-4f91-9ace-d33a0a3094ea/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.11.001/asset/847de518-76a3-47c0-85fd-24cf4b7dc48b/main.assets/figs3.jpg" height="242" width="497" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/f01124a0-b2c2-4f91-9ace-d33a0a3094ea/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Molecular dynamic simulations of ligand binding to the M1-receptor, related to <a id="crosref1335" href="#fig3">Figure&nbsp;3</a>F</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0235" role="paragraph">Comparative analysis of ligand binding site volumes of crystal structures (yellow cross) and Molecular Dynamics (MD) simulations (violin plots) of M1-StaR-T4L bound to antagonist tiotropium (PDB:<a id="intref0150" href="http://firstglance.jmol.org/fg.htm?mol5XCV" target="_blank">5XCV</a>), partial agonist HTL9936, and agonists GSK1034702, 77-LH-28-1 and iperoxo (PDB:<a id="intref0155" href="http://firstglance.jmol.org/fg.htm?mol6OIJ" target="_blank">6OIJ</a>).</div></div></div></div></figcaption></figure></div></section><section id="sec-2-5"><h3><i>In&nbsp;vitro</i> pharmacological and signaling characterization of HTL9936</h3><div id="p0110" role="paragraph"><i>In&nbsp;vitro</i> profiling in CHO cells overexpressing human M1-receptor confirmed the agonist activity of HTL9936 in pERK1/2 (EC<sub>50</sub> 32&nbsp;nM), label-free dynamic mass redistribution (EC<sub>50</sub> 79&nbsp;nM) and inositol phosphate (IP1) assay formats (EC<sub>50</sub> 631&nbsp;nM; <a id="crosref0740" href="#fig4">Figures 4</a>A and 4B; Table S5). Importantly, HTL9936 demonstrated no detectable agonism at human M2-, M3-, or M5-receptors, although partial agonist activity was observed at the human M4-receptor (Table S5). HTL9936 was further confirmed to demonstrate similar pharmacological activity across human, dog, rat, and monkey M1-receptors (Table S5). Equilibrium radioligand binding studies using the antagonist [<sup>3</sup>H]-NMS demonstrated that like acetylcholine, HTL9936 had weak affinity for the human M1 (pKi&nbsp;= 4.7 ± 0.03, n&nbsp;= 4), M2 (pKi&nbsp;= 5.5 ± 0.3, n&nbsp;= 6), and M4 (pKi&nbsp;= 5.4, n&nbsp;= 1) receptors while there was no detectable binding to the M3-receptor.</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/f4028846-06cc-4e19-9165-8ee66bf82386/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.11.001/asset/f9748c3b-eeb5-4992-a28f-33351b9e3218/main.assets/gr4.jpg" height="513" width="750" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/f4028846-06cc-4e19-9165-8ee66bf82386/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text"><i>In&nbsp;vitro</i> pharmacological characterization of HTL9936</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0100" role="paragraph">(A) Inositol phosphate accumulation elicited by ACh or HTL9936 via the human M1-receptor expressed in CHO Flp-In cells. Data are expressed as means ± SEM of 3–4 independent experiments performed in duplicate.</div><div id="fspara0105" role="paragraph">(B) ERK1/2 phosphorylation elicited by HTL9936 at the M1-, M2-, M3-, or M4-receptors expressed in CHO cells. Data are expressed as a percentage of the maximum response stimulated by ACh and are means ± SEM of 2-13 experiments performed in duplicate.</div><div id="fspara0110" role="paragraph">(C) Stimulation of [<sup>35</sup>S]-GTPyS binding to cortical membranes prepared from wild-type (WT) or M1-knockout mice (M1-KO). Data shown are means ± SEM of 3 experiments (pEC<sub>50</sub>&nbsp;= 5.6 ± 0.1 at the WT).</div><div id="fspara0115" role="paragraph">(D) HTL9936 dose-dependently increases CA1 neurons spontaneous firing. Data are expressed as mean firing rates (normalized to carbachol effect) over the 10 last min of each compound exposure period ± SEM.</div><div id="fspara0120" role="paragraph">(E) Summary statistics of firing rate of CA1 neurons recorded <i>in&nbsp;vivo</i> in isoflurane anaesthetised rats compared to vehicle-treated animals calculated as the 5&nbsp;min average after vehicle, 1&nbsp;mg/kg or 10&nbsp;mg/kg HTL9936 treatment.</div><div id="fspara0125" role="paragraph">(F) 10&nbsp;mg/kg i.v. administered HTL9936 (open circles) produced a significant increase in the <i>in&nbsp;vivo</i> firing rate of CA1 neurons compared to vehicle treated animals (squares). The muscarinic antagonist scopolamine (dose 1&nbsp;mg/kg) administered i.v. after 10&nbsp;min reversed the increase in firing back to baseline activity but had no effect on vehicle-treated animals. Data shown are mean of 3 rats expressed as percent of pre-drug baseline.</div><div id="fspara0130" role="paragraph">(G) HTL9936 antagonism of ACh-stimulated inositol phosphate accumulation in CHO Flp-In cells expressing the human M1-receptor. Cells were incubated with 3&nbsp;μM phenoxybenzamine prior to addition of HTL9936 at escalating concentrations. Data are means ± SEM of 3–4 independent experiments performed in duplicate.</div><div id="fspara0135" role="paragraph">See also <a id="crosref1305" href="#figs4">Figures S4</a> and <a id="crosref1310" href="#figs5">S5</a>.</div></div></div></div></figcaption></figure></div><div id="p0115" role="paragraph">The recombinant overexpressed cells provide a sensitive assay for muscarinic agonism—however, demonstrating agonist activity in native systems increases confidence in achieving the desired pharmacological profile. This is particularly important in the case of partial agonists. In membranes prepared from the cortex of wild-type mice, HTL9936 stimulated a robust increase in G<sub>q/11</sub> protein-coupling (EC<sub>50</sub>&nbsp;= 2.5μM, E<sub>max</sub> 76% of the oxotremorine-M response [n&nbsp;= 3]), which was absent in membranes prepared from M1-receptor KO animals (<a id="crosref0745" href="#fig4">Figure&nbsp;4</a>C). Electrophysiological recordings in rat hippocampal slices established that HTL9936 increased the intrinsic excitability and spontaneous firing rates of CA1 pyramidal cells with a EC<sub>50</sub>&nbsp;= 1.6μM (<a id="crosref0750" href="#fig4">Figure&nbsp;4</a>D). These findings were corroborated using <i>in&nbsp;vivo</i> electrophysiological recordings in adult rats where HTL9936 caused a concentration-dependent increase in neuronal firing rate (<a id="crosref0755" href="#fig4">Figure&nbsp;4</a>E) that was reversed with the muscarinic antagonist scopolamine (i.v.) (<a id="crosref0760" href="#fig4">Figure&nbsp;4</a>F).</div><div id="p0120" role="paragraph">While HTL9936 was observed to behave as a full agonist at the human M1-receptor in both pERK1/2 and DMR recombinant assay formats (Table S5), it appeared as a partial agonist at the rat receptor (Table S5) and in native mouse cortical membranes in GTPγS assays (<a id="crosref0765" href="#fig4">Figure&nbsp;4</a>C). To resolve this apparent contradiction, we determined the degree of intrinsic efficacy of HTL9936 relative to acetylcholine by using the receptor-alkylating agent phenoxybenzamine (PBZ) to irreversibly reduce M1-receptor levels in the cell line recombinantly overexpressing the human M1-receptor. Inactivation of M1-receptors with PBZ resulted in a reduction of both potency and maximal responses with HTL9936 more sensitive than acetylcholine to these effects (<a id="crosref0770" href="#figs4">Figure&nbsp;S4</a>). Moreover, under equivalent conditions of receptor depletion, HTL9936 behaved as a partial agonist in interaction assays with acetylcholine, eliciting a rightward shift in the IP<sub>1</sub> acetylcholine concentration-response curve with increasing concentrations of HTL9936 (<a id="crosref0775" href="#fig4">Figure&nbsp;4</a>G). Analysis of the data yielded Schild slopes approximating to unity (0.95 ± 0.08) and a pA<sub>2</sub> value of 5.2 ± 0.11; that correlated with the pKi for HTL9936 described in radio-ligand binding studies above.</div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/46bee298-2dfe-4183-bbd7-cb338790d570/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.11.001/asset/0d3b1ea4-82b0-47df-837f-289f57f9adf7/main.assets/figs4.jpg" height="217" width="497" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/46bee298-2dfe-4183-bbd7-cb338790d570/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Partial agonist activity of HTL9936, related to <a id="crosref1340" href="#fig4">Figure&nbsp;4</a>G</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0245" role="paragraph">Inositol phosphate accumulation elicited by ACh or HTL9936 under control conditions or following pre-incubation (30&nbsp;min) with 3&nbsp;μM phenoxybenzamine to irreversibly reduce receptor expression in CHO Flp-In cells expressing the human M<sub>1</sub>-receptor. Data are means ± S.E.M. of 3-4 independent experiments performed in duplicate.</div></div></div></div></figcaption></figure></div><div id="p0125" role="paragraph">We next assessed the potential of HTL9936 to act as a biased ligand directing M1-receptor signaling toward one signaling pathway in preference to another (<span class="dropBlock reference-citations"><a id="body-ref-sref72" href="#" role="doc-biblioref" data-xml-rid="bib72" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref72" aria-controls="sref72">Smith et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref72"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">72.</div><div>Smith, J.S. ∙ Lefkowitz, R.J. ∙ Rajagopal, S.</div><div><strong>Biased signalling: from simple switches to allosteric microprocessors</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2018; <strong>17</strong>:243-260</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd.2017.229" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85044178621" target="_blank" aria-label="Open Scopus in new tab">Scopus (501)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29302067/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd.2017.229&amp;pmid=29302067" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). We determined the transduction co-efficient (τ) for acetylcholine (the reference ligand) and HTL9936 coupling the M1-receptor to G<sub>q</sub>, G<sub>11</sub>, G<sub>15</sub>, the inositol phosphate (IP) pathway, pERK, and arrestin recruitment to the plasma membrane and receptor-internalisation (<a id="crosref0785" href="#figs5">Figures S5</a>A–S5H). By determining the ratios of the transduction coefficients (ΔΔlog(τ/K<sub>A</sub>)) (<span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Kenakin and Christopoulos, 2013</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Kenakin, T. ∙ Christopoulos, A.</div><div><strong>Measurements of ligand bias and functional affinity</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2013; <strong>12</strong>:483</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd3954-c2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84880675341" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23681003/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd3954-c2&amp;pmid=23681003" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), we observe very little if any bias activity of HTL9936 (all ΔΔlog(τ/K<sub>A</sub>) values are between 1 and −1, indicating that HTL936 performed as a relatively unbiased agonist of the M1-receptor (<a id="crosref0795" href="#figs5">Figure&nbsp;S5</a>H)). These experiments also showed the partial agonism of HTL9936 (<a id="crosref0800" href="#figs5">Figures S5</a>A–S5G).</div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/c78cccca-b77f-4020-9fcc-86f95c354789/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.11.001/asset/32e5d1d3-1631-42f3-918a-6c2d28071f5e/main.assets/figs5.jpg" height="763" width="506" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/c78cccca-b77f-4020-9fcc-86f95c354789/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">HTL9936 is an unbiased partial agonist of the M1-receptor, related to <a id="crosref1345" href="#fig4">Figure&nbsp;4</a>G</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0255" role="paragraph">A-G. Concentration responses are shown for ACh and HTL9936 using assays assessing a variety of M1-receptor signalling pathways and/or activation readouts. All data are shown as mean ± SEM and presented as percentages of the maximal ACh response from the same assay. A-C. Responses in BRET biosensor assays measuring activation of Gq, G11 or G15&nbsp;G proteins. N=5, performed in triplicate. D. Accumulation of IP1 in response to 1&nbsp;h treatment, N=5 in quadruplicate. E. Levels of phosphoERK induced in response to 5&nbsp;min treatment. N=3 performed in duplicate. F. Recruitment of arrestin to the cell membrane as assessed using a bystander BRET assay, N=6 in quadruplicate. G. Internalisation of the M1-receptor, assessed through a bystander BRET assay measuring translocation of M1 receptors to early endosomes. N=4, in quadruplicate. H. Summary of ΔΔlog(τ/KA) calculated based on the data presented in A-G. All ΔΔlog(τ/KA) values are between 1 and -1, indicating that HTL9936 performed as a relatively unbiased agonist of the M1 receptor.</div></div></div></div></figcaption></figure></div><div id="p0130" role="paragraph">HTL9936 was also found to be highly selective against a broad panel of 62 GPCRs (DiscoverX neurological and psychiatric panel) where at 10&nbsp;μM, HTL9936 exhibited &lt;25% agonism at other receptors.</div></section><section id="sec-2-6"><h3>Evaluation of HTL9936 in pre-clinical efficacy models</h3><div id="p0135" role="paragraph">The <i>in&nbsp;vivo</i> pharmacology of HTL9936 was examined across a range of efficacy models in mice, rats, dogs, and non-human primates as described in the following sections.</div><div id="p0140" role="paragraph">Prior to testing in behavioral models, HTL9936 brain:plasma and brain:CSF ratios were measured in rats after intravenous (1&nbsp;mg/kg) and oral (10&nbsp;mg/kg) dosing and revealed significant distribution into the CNS (measured by total brain concentration and calculated unbound drug; Table S6). The CNS distribution profile was confirmed in dogs where assessment of the distribution into the CSF after subcutaneous dosing demonstrated CSF:plasma ratios of 0.66, 0.6, and 0.65 at the 0.3, 1, and 2&nbsp;mg/kg doses (Table S6). A Kp,uu of ∼0.2 was calculated in mice. The calculated, or measured, plasma and brain exposures achieved in these studies and the approximate unbound drug levels as a ratio of the <i>in&nbsp;vitro</i> potency values determined for HTL9936 are provided in Table S6.</div><div id="p0145" role="paragraph">Initial assessments of HTL9936 in cognitive tasks focused on reversal of learning and memory deficits induced by the non-specific muscarinic antagonist scopolamine. In a mouse model of fear conditioning involving associative learning and activation of hippocampal CA1, medial PFC, and basolateral amygdala (<span class="dropBlock reference-citations"><a id="body-ref-sref55" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55" aria-controls="sref55">Maksymetz et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref55"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Maksymetz, J. ∙ Joffe, M.E. ∙ Moran, S.P. ...</div><div><strong>M<sub>1</sub> Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder</strong></div><div><em>Biol. Psychiatry.</em> 2019; <strong>85</strong>:989-1000</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.biopsych.2019.02.020&amp;cf=fulltext&amp;site=bps-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.biopsych.2019.02.020&amp;cf=pdf&amp;site=bps-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85064313667" target="_blank" aria-label="Open Scopus in new tab">Scopus (23)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31003787/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.biopsych.2019.02.020&amp;pmid=31003787" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), administration of scopolamine (i.p, 1.5&nbsp;mg/kg) 30&nbsp;min prior to fear conditioning training resulted in a significant reduction in contextual-dependent fear learning and memory (<a id="crosref0810" href="#fig5">Figure&nbsp;5</a>A). Co-administration of HTL9936 with scopolamine resulted in a dose-dependent restoration of learning and memory responses (<a id="crosref0815" href="#fig5">Figure&nbsp;5</a>A). Next, the effects of HTL9936 were examined in a rat passive avoidance test, a spatial memory consolidation task dependent on intact entorhinal-hippocampal interactions (<span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Myhrer, 2003</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Myhrer, T.</div><div><strong>Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks</strong></div><div><em>Brain Res. Brain Res. Rev.</em> 2003; <strong>41</strong>:268-287</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0165-0173(02)00268-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0037343932" target="_blank" aria-label="Open Scopus in new tab">Scopus (408)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12663083/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0165-0173%2802%2900268-0&amp;pmid=12663083" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) where animals learn to avoid making a choice that results in receiving a mild aversive stimulus. Treatment with scopolamine (1&nbsp;mg/kg i.p. 6&nbsp;h post-training) induced a statistically significant amnesic effect that was reversed in a dose-dependent manner by HTL9936 (<a id="crosref0825" href="#fig5">Figure&nbsp;5</a>B; estimated concentration of unbound drug in the brain [Cu,br]&nbsp;= 262 and 786&nbsp;nM at 10 and 30&nbsp;mg/kg doses p.o, respectively). The maximal response observed with HTL9936 was equivalent to that obtained using the clinically approved acetylcholinesterase inhibitor donepezil (0.1&nbsp;mg/kg; p.o) (<a id="crosref0830" href="#fig5">Figure&nbsp;5</a>B). In control experiments, HTL9936 demonstrated no difference in effect in open-field exploratory behavior consistent with unaltered locomotor, anxiolytic, and general behavior of the animals (<a id="crosref0835" href="#figs6">Figure&nbsp;S6</a>).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/1f7006e1-d443-4167-95fe-ff36d5fa9a89/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.11.001/asset/3526bf25-7474-4d0e-97f7-e7abd985a6a2/main.assets/gr5.jpg" height="360" width="750" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/1f7006e1-d443-4167-95fe-ff36d5fa9a89/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text"><i>In&nbsp;vivo</i> pharmacological characterization of HTL9936 in rodents</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0145" role="paragraph">(A) Effects of HTL9936 (10, 30, or 100&nbsp;mg/kg; i.p.) on scopolamine (1.5&nbsp;mg/kg; i.p.)-induced impairments in contextual fear conditioning in male C57BL/6J mice. Data are expressed as means ± SEM of 6–12 mice. Data were analyzed using one-way ANOVA with Bonferroni’s multiple comparison test, where <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 versus vehicle alone and <sup>#</sup>p&nbsp;&lt; 0.05 versus 1.5&nbsp;mg/kg scopolamine-treated.</div><div id="fspara0150" role="paragraph">(B and C) Effects of HTL9936 (3, 10, or 30&nbsp;mg/kg; p.o.) alone (B) or in combination with donepezil (C) on scopolamine (1&nbsp;mg/kg; i.p.)-induced amnesia in a passive avoidance paradigm in adult Wistar rats. HTL9936 or donepezil (0.1 or 0.01&nbsp;mg/kg) were administered 90&nbsp;min prior to the training period. Data shown are means ± SEM of 6 rats. Data were analyzed using a one-way ANOVA where <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 versus vehicle alone and <sup>#</sup>p&nbsp;&lt; 0.05, <sup>##</sup>p&nbsp;&lt; 0.01, <sup>###</sup>p&nbsp;&lt; 0.001 versus 1&nbsp;mg/kg scopolamine-treated.</div><div id="fspara0155" role="paragraph">(D) Effects of acute HTL9936 (p.o.) administration on improvement of memory performance in a rodent novel object recognition paradigm. Adult male Wistar rats were treated with vehicle (saline) or HTL9936 (3, 10, or 30&nbsp;mg/kg) 90&nbsp;min prior to training. Galanthamine (3&nbsp;mg/kg) or donepezil (0.1&nbsp;mg/kg) administered 60&nbsp;min prior to training were used as positive controls. Time (s) spent exploring the novel object during the testing phase is shown. Data shown are means ± SEM of 8 rats (one animal highlighted with an (+) did not respond in the vehicle group and was removed from the analysis). Data were analyzed using one-way ANOVA with Dunnett’s multiple comparison test, where <sup>∗</sup>p&nbsp;&lt; 0.01 comparing treatment versus vehicle.</div><div id="fspara0160" role="paragraph">See also <a id="crosref1315" href="#figs6">Figure&nbsp;S6</a> and Tables S5 and S6.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/2dfe8e00-ce11-4b9a-a8f3-5117eb6b132f/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.11.001/asset/3a770916-f493-4ac4-af41-346a9e402d56/main.assets/figs6.jpg" height="214" width="506" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/2dfe8e00-ce11-4b9a-a8f3-5117eb6b132f/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Effects of acute administration of HTL9936 and the cholinesterase inhibitor donepezil on open field exploratory behaviour, related to <a id="crosref1350" href="#fig5">Figure&nbsp;5</a>B</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0265" role="paragraph">Data are means ± S.E.M. of 6 rats and show distance travelled (cm) over a 5&nbsp;minute period.</div></div></div></div></figcaption></figure></div><div id="p0150" role="paragraph">Learning and memory deficits in AD have been attributed to a loss of cholinergic transmission that are treated clinically with acetylcholinesterase inhibitors (e.g., donepezil) (<span class="dropBlock reference-citations"><a id="body-ref-sref6-2" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6-2" aria-controls="sref6-2">Bartus et&nbsp;al., 1982</a><div class="dropBlock__holder" data-db-target-of="sref6-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Bartus, R.T. ∙ Dean, 3rd, R.L. ∙ Beer, B. ...</div><div><strong>The cholinergic hypothesis of geriatric memory dysfunction</strong></div><div><em>Science.</em> 1982; <strong>217</strong>:408-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.7046051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0019972810" target="_blank" aria-label="Open Scopus in new tab">Scopus (4969)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7046051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.7046051&amp;pmid=7046051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37-2" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37-2" aria-controls="sref37-2">Francis et&nbsp;al., 1999</a><div class="dropBlock__holder" data-db-target-of="sref37-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Francis, P.T. ∙ Palmer, A.M. ∙ Snape, M. ...</div><div><strong>The cholinergic hypothesis of Alzheimer’s disease: a review of progress</strong></div><div><em>J.&nbsp;Neurol. Neurosurg. Psychiatry.</em> 1999; <strong>66</strong>:137-147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jnnp.66.2.137" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0032910197" target="_blank" aria-label="Open Scopus in new tab">Scopus (1838)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10071091/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fjnnp.66.2.137&amp;pmid=10071091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, it was important to assess the potential effects of combining HTL9936 with the current clinical standard of care, donepezil. For these studies, we employed a dose of donepezil (0.01&nbsp;mg/kg) that was inactive in the rat passive avoidance model combined with a dose of HTL9936 of 3mg/kg (estimated Cu,br&nbsp;= 79&nbsp;nM) that similarly gave no response alone (<a id="crosref0850" href="#fig5">Figure&nbsp;5</a>C). When combined, HTL9936/donepezil resulted in a significant partial reversal of scopolamine-induced deficits consistent with an additive-like effect between these compounds (<a id="crosref0855" href="#fig5">Figure&nbsp;5</a>C).</div><div id="p0155" role="paragraph">In experiments not involving scopolamine, treatment with HTL9936 improved working memory in the rat novel object recognition paradigm that reflects improved functioning of fronto-hippocampal and entorhinal circuits (<span class="dropBlock reference-citations"><a id="body-ref-sref20" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20" aria-controls="sref20">Cohen and Stackman, 2015</a><div class="dropBlock__holder" data-db-target-of="sref20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Cohen, S.J. ∙ Stackman, Jr., R.W.</div><div><strong>Assessing rodent hippocampal involvement in the novel object recognition task. A review</strong></div><div><em>Behav. Brain Res.</em> 2015; <strong>285</strong>:105-117</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbr.2014.08.002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84925439504" target="_blank" aria-label="Open Scopus in new tab">Scopus (405)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25169255/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbr.2014.08.002&amp;pmid=25169255" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The effective dose of HTL9936 was 10&nbsp;mg/kg (estimated Cu,br&nbsp;= 262&nbsp;nM) (<a id="crosref0865" href="#fig5">Figure&nbsp;5</a>D), which showed an effect that was significantly better than the positive controls donepezil and another acetylcholinesterase inhibitor, galantamine (<a id="crosref0870" href="#fig5">Figure&nbsp;5</a>D).</div><div id="p0160" role="paragraph">Finally, compounds which stimulate CNS activity in particular dopaminergic function are associated with increases in locomotor activity. Such activity can compromise interpretation of cognitive measure. HTL9936 at doses up to 100&nbsp;mg/kg showed no adverse responses nor had any effect on locomotor activity when administered alone or in combination with amphetamine. The amphetamine-induced hyper-location model is also known to be sensitive to the effects of M4-receptor agonists and therefore, despite the evidence of M4 activity in the recombinant assays HTL9936, at least in this model, did not appear to demonstrate evidence of M4-receptor agonist-like activity.</div></section><section id="sec-2-7"><h3>HTL9936 reversed cognitive deficits in a mouse model of neurodegeneration</h3><div id="p0165" role="paragraph">We next wanted to test the effects of HTL9936 in the context of neurodegenerative disease. Our previous studies have determined that murine prion disease is associated with disrupted hippocampal cholinergic innervation that results in learning and memory deficits that could be restored by donepezil and muscarinic ligands (<span class="dropBlock reference-citations"><a id="body-ref-sref12-3" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-3" aria-controls="sref12-3">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Consistent with the notion that HTL9936 can restore cholinergic tone in a manner that might be relevant in the treatment of cognitive dysfunction in AD, we found that HTL9936 significantly improved fear conditioning learning and memory in murine prion disease (<a id="crosref0880" href="#fig6">Figure&nbsp;6</a>A). In these studies, Tg37 hemizygous mice at 9&nbsp;weeks post inoculation (w.p.i.) with Rocky Mountain Laboratory (RML) prions were treated with HTL9936 (30&nbsp;mg/kg; i.p.) 30&nbsp;min prior to the training phase. On re-exposure to the training environment 24&nbsp;h later, mice treated with HTL9936 showed significantly higher immobility levels (∼34%) than mice receiving vehicle (∼13%), indicating that hippocampal-dependent contextual learning and memory processes in neurodegenerative mice were improved by acute administration of HTL9936 in this disease model (<a id="crosref0885" href="#fig6">Figure&nbsp;6</a>A).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/9507409c-2885-4baf-84f2-2879ce892be3/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.11.001/asset/7d5e49d5-5e32-4dae-98be-c4eaba5b1a1f/main.assets/gr6.jpg" height="443" width="497" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/9507409c-2885-4baf-84f2-2879ce892be3/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text"><i>In&nbsp;vivo</i> effects of HTL9936 in neurodegenerative backgrounds</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0170" role="paragraph">(A) Effects of HTL9936 on improvement of fear conditioning learning and memory deficits in prion-diseased mice. Data shown represent immobility levels during the context retrieval phase in prion-infected mice treated with vehicle (5% glucose) or HTL9936 (30&nbsp;mg/kg; i.p.) 30&nbsp;min prior to fear conditioning training. Data represent means ± SEM of 6–7 mice and were analyzed using a Student’s t test where <sup>∗</sup>p&nbsp;&lt; 0.05.</div><div id="fspara0175" role="paragraph">(B) Effects of HTL9936 administration on cognitive function of aged beagle dogs in the DNMP test. Data shown are DNMP performances at the 55&nbsp;s delay in the lowest performing subjects at baseline and following 10–11&nbsp;days treatment with vehicle (0.9% saline), HTL9936 (0.3, 1 and 3&nbsp;mg/kg; s.c.), or 1.5&nbsp;mg/kg donepezil (p.o.). Mean DNMP performance was calculated for the 5 baseline DNMP sessions and the last 5 treatment DNMP session. Data shown are means ± SEM and data were analyzed using a two-way ANOVA with Dunnett’s multiple comparison test where <sup>∗</sup>p&nbsp;&lt; 0.05 versus vehicle.</div><div id="fspara0180" role="paragraph">See also Tables S5 and S6.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-8"><h3>HTL9936 demonstrates cognitive benefits in aged beagles</h3><div id="p0170" role="paragraph">Similar to clinical AD pathology, beagle dogs exhibit age-dependent cognitive decline, Aβ pathology, and evidence of cholinergic hypofunction, suggesting that this may represent a valuable pre-clinical species with translational relevance for muscarinic agonists targeting cognitive decline (<span class="dropBlock reference-citations"><a id="body-ref-sref4" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4" aria-controls="sref4">Araujo et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Araujo, J.A. ∙ Greig, N.H. ∙ Ingram, D.K. ...</div><div><strong>Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs</strong></div><div><em>J.&nbsp;Alzheimers Dis.</em> 2011; <strong>26</strong>:143-155</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3233/JAD-2011-110005" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-80052845637" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21593569/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3233%2FJAD-2011-110005&amp;pmid=21593569" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). A delayed non-matching to position (DNMP) cognitive model was used to assess the effects of HTL9936 on a visual-spatial working memory task in aged beagle dogs. HTL9936 was administered subcutaneously at 0.3, 1, and 2&nbsp;mg/kg. Bioanalysis of plasma and CSF at 4&nbsp;h post-dose confirmed plasma:CSF ratios were consistent with pre-clinical rodent assessment (measured C<sub>csf</sub> concentrations&nbsp;= 13, 48, and 128&nbsp;nM, respectively; see Table S6). Baseline DNMP performance was assessed daily for 5&nbsp;days followed by daily dosing of HTL9936 or vehicle for 10&nbsp;days with DNMP assessment on 5 consecutive occasions. Significant improvements in visual-spatial memory were seen after treatment with HTL9936 at 0.3&nbsp;mg/kg and 1&nbsp;mg/kg. The effects at the 1&nbsp;mg/kg dose of HTL9936 were equivalent to that of donepezil (<a id="crosref0895" href="#fig6">Figure&nbsp;6</a>B).</div></section><section id="sec-2-9"><h3>Translation of muscarinic receptor agonism to non-human primates</h3><div id="p0175" role="paragraph">Rodent models are the mainstay of our attempts to understand mammalian brain function and as a tool for target validation and drug discovery. However, their ability to accurately predict human behavior depends on translational understanding of target function in the context of the behavior to be studied. Non-human primates offer an intermediate species in which to explore pharmacology between rodents and human. As a next step, we therefore examined the CNS exposure and preliminary evidence for CNS target engagement in non-human primates. We employed a basic quantitative EEG (qEEG) protocol to assess the effect of HTL9936 on resting state network firing in non-human primates. HTL9936 was dosed subcutaneously to avoid complications associated with the low oral bioavailability in primates (predicted brain exposures of Cu,br&nbsp;= 20 and 198&nbsp;nM for 0.3 and 3&nbsp;mg/kg, respectively) and resulted in increased delta power (<a id="crosref0900" href="#fig7">Figures 7</a>A–7F; Table S6). Delta oscillations have been linked with cognitive tasks (<span class="dropBlock reference-citations"><a id="body-ref-sref7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7" aria-controls="sref7">Başar et&nbsp;al., 2001</a><div class="dropBlock__holder" data-db-target-of="sref7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Başar, E. ∙ Başar-Eroglu, C. ∙ Karakaş, S. ...</div><div><strong>Gamma, alpha, delta, and theta oscillations govern cognitive processes</strong></div><div><em>Int. J. Psychophysiol.</em> 2001; <strong>39</strong>:241-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0167-8760(00)00145-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0034518840" target="_blank" aria-label="Open Scopus in new tab">Scopus (933)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11163901/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0167-8760%2800%2900145-8&amp;pmid=11163901" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) where they are considered to suppress “non-relevant” neuronal activity necessary to allow for the execution of tasks such as working memory (<span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">Harmony, 2013</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Harmony, T.</div><div><strong>The functional significance of delta oscillations in cognitive processing</strong></div><div><em>Front. Integr. Nuerosci.</em> 2013; <strong>7</strong>:83</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fnint.2013.00083" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84889655088" target="_blank" aria-label="Open Scopus in new tab">Scopus (433)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24367301/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffnint.2013.00083&amp;pmid=24367301" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/530a955e-7fea-490e-a74f-2fcb3fcebc8c/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2021.11.001/asset/004bd7c7-00b9-4edd-ab43-15c9906fbd03/main.assets/gr7.jpg" height="439" width="750" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/530a955e-7fea-490e-a74f-2fcb3fcebc8c/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">HTL9936 elicits robust changes in qEEG power spectra in cynomolgus monkeys and fMRI indicates target engagement in human volunteers</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0190" role="paragraph">(A and B) Dose-related changes in normalized power (to vehicle) across the Fp2-Oz (A) and Cz-Oz (B) electrode derivations. Results represent mean ± SEM of the AUC between 30 and 120&nbsp;min after subcutaneous treatment with 0.3 and 1.0&nbsp;mg/kg HTL9936 for 5 monkeys. <sup>∗</sup>p&nbsp;&lt; 0.05 versus vehicle-treated group by paired t test.</div><div id="fspara0195" role="paragraph">(C–F) Time-frequency power spectrum showing resting state total power of the EEG at each frequency and time point, under HTL9936 normalized to time-by-time to vehicle treatment (t-values; frequency resolution—2&nbsp;Hz; temporal resolution—1&nbsp;min) for Fp2-Oz (C and E) and Cz-Oz (D and F) electrode derivations post-dose 30–120&nbsp;min (90&nbsp;min sampling window) for 0.3- (C and D) and 3.0&nbsp;mg/kg (E and F) HTL9936 (N&nbsp;= 5).</div><div id="fspara0200" role="paragraph">(G) Histogram illustrating fMRI in elderly human volunteers of the effects of HTL9936 on BOLD activation (expressed as a percentage signal change compared to rest) within regions associated with the Arena task (for the contrasts encoding versus rest and retrieval versus rest), (H) drug-induced signal change extracted from the left hippocampal activation during encoding (x&nbsp;= −30, y&nbsp;= −52, z&nbsp;= −7; Z<sub>max</sub> &gt; 3.8; p<sub>svn</sub>&nbsp;= 0.018) plotted for each dose. Error bars represent the standard error of the mean. BOLD (Brain-oxygen-level-dependent); <i><sup>∗</sup></i>p&nbsp;&lt; 0.05 relative to placebo.</div><div id="fspara0205" role="paragraph">See also Tables S5 and S6.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-10"><h3>Evaluating the safety pharmacology of HTL9936—did the increased selectivity lead to an improved therapeutic margin in preclinical species?</h3><div id="p0180" role="paragraph">Historically, the presence of classic cholinergic side effects, including salivation, sweating, convulsion/seizures, and gastrointestinal distress has resulted in dose-limiting toxicology and clinical adverse events thought to be mediated in part by the non-selective activation of M2- and M3-receptors (<span class="dropBlock reference-citations"><a id="body-ref-sref23-2" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-2" aria-controls="sref23-2">Conn et&nbsp;al., 2009b</a><div class="dropBlock__holder" data-db-target-of="sref23-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Conn, P.J. ∙ Jones, C.K. ∙ Lindsley, C.W.</div><div><strong>Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</strong></div><div><em>Trends Pharmacol. Sci.</em> 2009; <strong>30</strong>:148-155</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-61349093537" target="_blank" aria-label="Open Scopus in new tab">Scopus (255)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19201489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2008.12.002&amp;pmid=19201489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). As part of the safety evaluation necessary to support clinical development, HTL9936 was evaluated across a battery of CNS and cardiovascular (CV) safety studies.</div><div id="p0185" role="paragraph">Substantial literature highlights a potential role for the M1-receptor in proconvulsive/seizure-like behaviors (<span class="dropBlock reference-citations"><a id="body-ref-sref14-2" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-2" aria-controls="sref14-2">Bradley et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref14-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Bradley, S.J. ∙ Molloy, C. ∙ Valuskova, P. ...</div><div><strong>Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:240-249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-019-0453-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85079780292" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32080630/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-019-0453-9&amp;pmid=32080630" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref26-1" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-1" aria-controls="sref26-1">Davoren et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref26-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Davoren, J.E. ∙ Garnsey, M. ∙ Pettersen, B. ...</div><div><strong>Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist Activity</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2017; <strong>60</strong>:6649-6663</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.7b00597" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85027287269" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28598634/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.7b00597&amp;pmid=28598634" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Hamilton et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Hamilton, S.E. ∙ Loose, M.D. ∙ Qi, M. ...</div><div><strong>Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1997; <strong>94</strong>:13311-13316</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.94.24.13311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0030708762" target="_blank" aria-label="Open Scopus in new tab">Scopus (319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9371842/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.94.24.13311&amp;pmid=9371842" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Rook et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Rook, J.M. ∙ Abe, M. ∙ Cho, H.P. ...</div><div><strong>Diverse Effects on M<sub>1</sub> Signaling and Adverse Effect Liability within a Series of M<sub>1</sub> Ago-PAMs</strong></div><div><em>ACS Chem. Neurosci.</em> 2017; <strong>8</strong>:866-883</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acschemneuro.6b00429" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85018529314" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28001356/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facschemneuro.6b00429&amp;pmid=28001356" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In a modified Irwin Functional Observation Battery test used to assess potential behavioral adverse effects in rats, there were no observations of significance adverse responses, including a complete absence of seizure-like effects on oral dosing up to 100&nbsp;mg/kg (Cmax&nbsp;= 6,400&nbsp;ng/mL; Cu,pl&nbsp;= 11,994&nbsp;nM). In total across the entire HTL9936 program, there was only one convulsive-like episode recorded following treatment with HTL9936 in a 4-day repeat dose tolerability assessment in dogs. In this animal, the plasma Cmax was &gt;32,000&nbsp;ng/mL (Cu,pl&nbsp;= 59,971&nbsp;nM), significantly above the exposures predicted to be required for cognitive improvements.</div><div id="p0190" role="paragraph">The cardiovascular effects of HTL9936 were initially tested in both telemetered rats and dogs. In rats, oral dosing of HTL9936 at 3, 10, 30, and 100&nbsp;mg/kg resulted in a dose-dependent increase in heart rate and mean arterial blood pressure averaged over the 5&nbsp;h post-dose period. No significant effects were evident at the 3&nbsp;mg/kg dose. The effects of HTL9936 at all doses were transient in nature returning to baseline as the predicted exposure of HTL9936 declined. A similar dose-dependent profile of HTL9936 effects on blood pressure, but not heart rate, was seen in the dog GLP-compliant cardiovascular safety pharmacology telemetry study. All hemodynamic changes returned to control levels within 30&nbsp;min of the end of the i.v. infusion (Table S6).</div><div id="p0195" role="paragraph">Consistent with other recently published studies on M1-receptor ligands (<span class="dropBlock reference-citations"><a id="body-ref-sref1-2" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-2" aria-controls="sref1-2">Alt et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref1-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Alt, A. ∙ Pendri, A. ∙ Bertekap, Jr., R.L. ...</div><div><strong>Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 2016; <strong>356</strong>:293-304</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/jpet.115.226910" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84959420309" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26582730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fjpet.115.226910&amp;pmid=26582730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref25-2" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25-2" aria-controls="sref25-2">Davoren et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref25-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Davoren, J.E. ∙ Lee, C.W. ∙ Garnsey, M. ...</div><div><strong>Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2016; <strong>59</strong>:6313-6328</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.6b00544" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84978634494" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27275946/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.6b00544&amp;pmid=27275946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), HTL9936 was generally poorly tolerated in dogs compared with similar plasma exposures achieved in rats. Clinical signs attributable to M1-receptor agonism such as excessive salivation, vomiting, and lacrimation were observed in safety pharmacology and toxicology studies where the plasma exposure exceeded 157&nbsp;ng/mL (Cu,pl&nbsp;= 283&nbsp;nM). These observations were not evident in either rats or non-human primates with plasma exposure up to 732 and 557&nbsp;ng/mL, respectively (Cu,pl&nbsp;= 1,372 and 991&nbsp;nM, respectively), suggesting potential differences in species sensitivity to cholinergic adverse events.</div><div id="p0200" role="paragraph">In summary, HTL9936 demonstrated significant benefits across a range of established and novel models used to assess cognition with limited evidence for cholinergic AEs that have been associated with some historical programs. In order to help contextualise the safety, pharmacology, and efficacy data, the apparent therapeutic index (TI) was calculated by comparing the total plasma exposures between efficacy studies and the safety pharmacology/toxicology studies. These data are summarized in Table S6 and provide evidence of a therapeutic window that may be explored further in human studies.</div></section><section id="sec-2-11"><h3>The profile of HTL9936 in healthy human volunteers</h3><div id="p0205" role="paragraph">HTL9936 was progressed into a randomized, double-blind, placebo-controlled, first-time-in-human (FTIH) ascending single and multiple oral dose study in healthy young and elderly volunteers (<a id="intref0035" href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> Identifier: NCT02291783). The single ascending dose (SAD) pharmacokinetics are summarized in Table S6.</div><div id="p0210" role="paragraph">The concentration of CNS drugs in the CSF have been widely used as a surrogate for the unbound drug concentrations in the brain in order to assess the potential for drugs to access their pharmacological targets. CSF drug levels were measured in 6 healthy male subjects after a single 54&nbsp;mg oral dose of HTL9936. The maximum HTL9936 concentration in CSF was reached between 2–3 h, which was delayed relative to the plasma t<sub>max</sub> (approximately 0.5 h). The mean ng/mL (±SD) ratio of CSF/plasma was 0.11 ± 0.04, 0.30 ± 0.05, and 0.39 ± 0.08 at 1, 2, and 3&nbsp;h post-dose, respectively, with the rising ratio over time due to the relative persistence of HTL9936 in CSF compared with plasma. Based on the AUC<sub>0-3h</sub>, the mean (±SD) CSF/plasma ratio was 21 ± 3.4%. These data are consistent with pre-clinical CNS distribution data where CSF levels were measured.</div><div id="p0215" role="paragraph">In the SAD study, HTL9936 between 1–100mg showed no serious adverse events that led to withdrawal (Table S6). Mild responses consistent with cholinergic mechanisms (salivation, sweating, and changes in blood pressure and/or heart rate) were recorded only in the 175&nbsp;mg cohort (3/5 subjects)(Table S6). Only subjects with a Cmax of 242&nbsp;ng/mL recorded evidence of cholinergic side effects, which increased in duration and severity with increasing exposure (Table S6), In the context of therapeutic margins, the plasma drug concentrations of 242&nbsp;ng/mL is about 5× higher than the plasma minimal effective concentration in the aged beagle DNMP efficacy study (0.3&nbsp;mg/kg dosed subcutaneously, Cmax plasma exposure 58&nbsp;ng/mL). Based on the measured CSF to plasma ratios of HTL9936 from 1 to 3&nbsp;h post-dose (11, 30, and 39, respectively), the plasma Cmax of 242&nbsp;ng/mL can be estimated to represent unbound brain exposures in the range of 72 to 259&nbsp;nM.</div></section><section id="sec-2-12"><h3>CNS signal finding studies in human subjects</h3><div id="p0220" role="paragraph">To understand whether HTL9936 would have sufficient safety margins between peripheral adverse cholinergic effects and CNS activity associated with cognition, it was helpful to identify a biomarker of CNS activity. Quantitative electroencephalogram (EEG) and Event Related Potentials (ERP) were included in the multiple dosing part of the study on day 1, day 4, and day 9 when HTL9936 would be predicted to have reached steady state. In a P300 active auditory oddball EEG paradigm, effects were found along frontal-parietal regions involved in generating attentional response and processing of stimuli. The high exposure group showed significant within- and between-group effects for deviant amplitude for electrodes Fz and Cz on day 9, with consistent but smaller effects on day 4. The deviant-standard results were consistent with the amplitude effects (Table S6).</div><div id="p0225" role="paragraph">The pharmacodynamic effects of HTL9936 on hippocampal dependent spatial learning and memory and hippocampal activity were examined in a separate study in elderly subjects (aged 65–80 years; <a id="intref0040" href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> Identifier: NCT02546310). The study was a single-dose, double-blind, placebo-controlled functional magnetic resonance imaging (fMRI) study in which 54 healthy elderly subjects were randomly allocated to either placebo (0.9% sodium chloride aq. i.v.; n&nbsp;= 18) or HTL9936 (i.v.; n&nbsp;= 36) treatment. HTL9936 was administered via i.v. infusion in order to ensure control of HTL9936 exposure at steady-state within closely defined limits during the fMRI assessment. Two doses of HTL9936 were employed in this study with the aim of safely exploring preliminary evidence that the drug was active within CNS regions relevant to cognition. A low dose of 10.1&nbsp;mg i.v. (n&nbsp;= 18) predicted to achieve steady-state plasma concentrations of 25&nbsp;ng/mL and a high dose of 40.3&nbsp;mg i.v. predicted to achieve steady-state plasma concentration of 100&nbsp;ng/mL. Based on the measured human CSF to plasma ratios of HTL9936 these plasma exposures were predicted to range from approximately 7–30&nbsp;nM and 30–110&nbsp;nM for the low and high doses respectively (0.2- to 3.4-fold the human M1-receptor <i>in&nbsp;vitro</i> potency). Learning- and memory-related hippocampal activity was assessed using the Arena task, which is extensively described elsewhere (<span class="dropBlock reference-citations"><a id="body-ref-sref2-1" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-1" aria-controls="sref2-1">Antonova et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref2-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Age-related neural activity during allocentric spatial memory</strong></div><div><em>Memory.</em> 2009; <strong>17</strong>:125-143</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/09658210802077348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-60549116899" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18608980/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F09658210802077348&amp;pmid=18608980" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref3-1" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" aria-label="Reference 2011" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-1" aria-controls="sref3-1">2011</a><div class="dropBlock__holder" data-db-target-of="sref3-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze</strong></div><div><em>J.&nbsp;Psychopharmacol.</em> 2011; <strong>25</strong>:1256-1265</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/0269881110379285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-80054041085" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20823079/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F0269881110379285&amp;pmid=20823079" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Not unexpectedly, HTL9936 did not significantly improve task performance in this small number of healthy elderly subjects but did result in a significant drug by activation interaction effect in the left hippocampus during encoding of spatial cues, driven by increased activation under the 10.1&nbsp;mg/kg dose, with the 40.3&nbsp;mg/kg dose showing a smaller effect (F(1,30)&nbsp;= 6.44, p&nbsp;= 0.017 small volume corrected; <a id="crosref0960" href="#fig7">Figures 7</a>G and 7H). The 10.1&nbsp;mg/kg dose consistently showed increased bilateral activation across the a-priori defined regions of interest during both encoding and retrieval phases of the task (<a id="crosref0965" href="#fig7">Figures 7</a>G and 7H). Taken together, these studies provide evidence of CNS target engagement for HTL9936 at concentrations with a safety profile suitable for further evaluation.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0230" role="paragraph">The publication of the first non-opsin GPCR crystal structures (<span class="dropBlock reference-citations"><a id="body-ref-sref19" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19" aria-controls="sref19">Cherezov et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Cherezov, V. ∙ Rosenbaum, D.M. ∙ Hanson, M.A. ...</div><div><strong>High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</strong></div><div><em>Science.</em> 2007; <strong>318</strong>:1258-1265</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1150577" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36448995359" target="_blank" aria-label="Open Scopus in new tab">Scopus (2873)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17962520/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1150577&amp;pmid=17962520" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Rasmussen et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Rasmussen, S.G. ∙ Choi, H.J. ∙ Rosenbaum, D.M. ...</div><div><strong>Crystal structure of the human beta2 adrenergic G-protein-coupled receptor</strong></div><div><em>Nature.</em> 2007; <strong>450</strong>:383-387</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature06325" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36248970132" target="_blank" aria-label="Open Scopus in new tab">Scopus (1712)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17952055/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature06325&amp;pmid=17952055" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Rosenbaum et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Rosenbaum, D.M. ∙ Cherezov, V. ∙ Hanson, M.A. ...</div><div><strong>GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function</strong></div><div><em>Science.</em> 2007; <strong>318</strong>:1266-1273</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1150609" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36448978229" target="_blank" aria-label="Open Scopus in new tab">Scopus (1224)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17962519/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1150609&amp;pmid=17962519" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) heralded the prospect that SBDD would unlock the full therapeutic potential of “hard-to-target” GPCRs such as the M1-receptor. Here we present the rational SBDD of a selective GPCR ligand with the expected <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i> pharmacology that delivers preclinical efficacy in animal models and desirable animal and human toxicity that when tested in humans gave clinically relevant effects. In this way, we present a general road-map for the application of SBDD in GPCR-drug discovery. Specifically, our study demonstrates that it is possible to design a M1-receptor agonist (HTL9936) with positive effects on memory centers in humans at doses that show a significant reduction in the adverse effects that have thwarted previous attempts to target this receptor in AD.</div><div id="p0235" role="paragraph">To understand M1-receptor pharmacology at the atomic level, we generated multiple agonist-bound structures of the M1-receptor. Comparison of the binding of the extended orthosteric agonists 77-LH-28-1, GSK1034702, and HTL9936 provided support for a common proximal trigger of activation, involving disruption of the “tyrosine cage” seen previously in muscarinic-receptor antagonist structures (<span class="dropBlock reference-citations"><a id="body-ref-sref74-2" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-2" aria-controls="sref74-2">Thal et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref74-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Thal, D.M. ∙ Sun, B. ∙ Feng, D. ...</div><div><strong>Crystal structures of the M1 and M4 muscarinic acetylcholine receptors</strong></div><div><em>Nature.</em> 2016; <strong>531</strong>:335-340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature17188" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84982308386" target="_blank" aria-label="Open Scopus in new tab">Scopus (261)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26958838/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature17188&amp;pmid=26958838" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). An appreciation of this allowed for the design of the size and orientation of the compound in this key activation region that acted to prevent the inward movement of Y104<sup>3.33</sup>, Y403<sup>6.51</sup>, and Y426<sup>7.39</sup> seen in the M2-receptor iperoxo agonist structure (<span class="dropBlock reference-citations"><a id="body-ref-sref36" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36" aria-controls="sref36">Fish et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Fish, I. ∙ Stößel, A. ∙ Eitel, K. ...</div><div><strong>Structure-Based Design and Discovery of New M<sub>2</sub> Receptor Agonists</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2017; <strong>60</strong>:9239-9250</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.7b01113" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85035068873" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29094937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.7b01113&amp;pmid=29094937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Appreciation of this resulted in the generation of compounds including HTL9936 with greatly reduced M2- and M3-receptor agonist activity but maintained nM activity at the M1-receptor.</div><div id="p0240" role="paragraph">Eliminating M2- and M3-receptor activity provided a clear rationale for the favorable safety profile of HTL9936 relative to orthosteric agonists such as xanomeline (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Bender et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Bender, A.M. ∙ Jones, C.K. ∙ Lindsley, C.W.</div><div><strong>Classics in Chemical Neuroscience: Xanomeline</strong></div><div><em>ACS Chem. Neurosci.</em> 2017; <strong>8</strong>:435-443</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acschemneuro.7b00001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85015182374" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28141924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facschemneuro.7b00001&amp;pmid=28141924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and GSK1034702 (<span class="dropBlock reference-citations"><a id="body-ref-sref62-2" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-2" aria-controls="sref62-2">Nathan et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref62-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Nathan, P.J. ∙ Watson, J. ∙ Lund, J. ...</div><div><strong>The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction</strong></div><div><em>Int J Neuropsychopharmacol.</em> 2013; <strong>16</strong>:721-731</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1017/S1461145712000752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84875697137" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22932339/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1017%2FS1461145712000752&amp;pmid=22932339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) that both show M2- and M3-receptor activity as well as clear cholinergic adverse responses in the clinic. There may, however, be other factors in play that contribute to the safety profile of HTL9936. Our data, and that of others, have established that both peripheral adverse responses and centrally mediated seizure and convulsions can be mediated by previously unappreciated on-target activity at M1-receptors (<span class="dropBlock reference-citations"><a id="body-ref-sref14-3" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-3" aria-controls="sref14-3">Bradley et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref14-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Bradley, S.J. ∙ Molloy, C. ∙ Valuskova, P. ...</div><div><strong>Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:240-249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-019-0453-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85079780292" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32080630/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-019-0453-9&amp;pmid=32080630" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref26-2" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-2" aria-controls="sref26-2">Davoren et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref26-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Davoren, J.E. ∙ Garnsey, M. ∙ Pettersen, B. ...</div><div><strong>Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist Activity</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2017; <strong>60</strong>:6649-6663</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.7b00597" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85027287269" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28598634/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.7b00597&amp;pmid=28598634" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Engers et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Engers, J.L. ∙ Childress, E.S. ∙ Long, M.F. ...</div><div><strong>VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events</strong></div><div><em>ACS Med. Chem. Lett.</em> 2018; <strong>9</strong>:917-922</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acsmedchemlett.8b00261" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85053240025" target="_blank" aria-label="Open Scopus in new tab">Scopus (11)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258541/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facsmedchemlett.8b00261&amp;pmid=30258541" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Here, our <i>in&nbsp;vitro</i> pharmacological characterization of HTL9936 revealed an un-biased signaling profile that, based on our previous studies (<span class="dropBlock reference-citations"><a id="body-ref-sref14-4" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14-4" aria-controls="sref14-4">Bradley et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref14-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Bradley, S.J. ∙ Molloy, C. ∙ Valuskova, P. ...</div><div><strong>Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:240-249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-019-0453-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85079780292" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32080630/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-019-0453-9&amp;pmid=32080630" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), would be predictive of a ligand with cognitive efficacy and minimal central and peripheral M1-related adverse effects.</div><div id="p0245" role="paragraph">Furthermore, an important feature of HTL9936 pharmacology is the partial agonist profile that likely contributes to low adverse events at clinically relevant concentrations. Previous pre-clinical studies have highlighted that centrally expressed M1-receptors exhibit a high level of receptor reserve (<span class="dropBlock reference-citations"><a id="body-ref-sref64" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64" aria-controls="sref64">Porter et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref64"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Porter, A.C. ∙ Bymaster, F.P. ∙ DeLapp, N.W. ...</div><div><strong>M1 muscarinic receptor signaling in mouse hippocampus and cortex</strong></div><div><em>Brain Res.</em> 2002; <strong>944</strong>:82-89</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0006-8993(02)02721-X" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0037135123" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12106668/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0006-8993%2802%2902721-X&amp;pmid=12106668" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This suggests that M1-partial agonists such as HTL9936 can show sufficient efficacy to stimulate the well-coupled post-synaptic M1-receptors in the CNS while the partial nature of agonism means that peripheral M1-receptors expressed at lower levels are poorly activated. Importantly, the comparative analysis of M1-receptor crystal structures bound to HTL9936, and the full agonists 77-LH-28-1 and GSK1034702 provided a hypothesis for the molecular nature of partial agonism of HTL9936 that will aid future SBDD.</div><div id="p0250" role="paragraph">It should be noted that alternative approaches to those described here are currently being pursued to overcome the challenge of cholinergic-adverse that include xanomeline administered in combination with a peripheral non-selective muscarinic antagonist trospium (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Brannan et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Brannan, S.K. ∙ Sawchak, S. ∙ Miller, A.C. ...</div><div><strong>Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2021; <strong>384</strong>:717-726</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa2017015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85101606520" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33626254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa2017015&amp;pmid=33626254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and M1-receptor specific positive allosteric modulators that potentiate the action of endogenous acetylcholine (<span class="dropBlock reference-citations"><a id="body-ref-sref23-3" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23-3" aria-controls="sref23-3">Conn et&nbsp;al., 2009b</a><div class="dropBlock__holder" data-db-target-of="sref23-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Conn, P.J. ∙ Jones, C.K. ∙ Lindsley, C.W.</div><div><strong>Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</strong></div><div><em>Trends Pharmacol. Sci.</em> 2009; <strong>30</strong>:148-155</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-61349093537" target="_blank" aria-label="Open Scopus in new tab">Scopus (255)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19201489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2008.12.002&amp;pmid=19201489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref78" href="#" role="doc-biblioref" data-xml-rid="bib78" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref78" aria-controls="sref78">Voss et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref78"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">78.</div><div>Voss, T. ∙ Li, J. ∙ Cummings, J. ...</div><div><strong>Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer’s disease</strong></div><div><em>Alzheimers Dement (N Y).</em> 2018; <strong>4</strong>:173-181</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.trci.2018.03.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85047000461" target="_blank" aria-label="Open Scopus in new tab">Scopus (42)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29955661/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.trci.2018.03.004&amp;pmid=29955661" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Moran et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Moran, S.P. ∙ Dickerson, J.W. ∙ Cho, H.P. ...</div><div><strong>M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition</strong></div><div><em>Neuropsychopharmacology.</em> 2018; <strong>43</strong>:1763-1771</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41386-018-0033-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85044465425" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29581537/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41386-018-0033-9&amp;pmid=29581537" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0255" role="paragraph">Importantly for the design of future clinical trials using HTL9936, or related molecules, is the observation reported here that HTL9936 has efficacy both alone and in combination with donepezil indicating that combination trails with current standards of care should be feasible.</div><div id="p0260" role="paragraph">In conclusion, we describe the rational design of a partial M1-agonist, HTL9936, that delivers a therapeutic window between desirable pro-cognitive activity and peripheral cholinergic adverse effects. In this way, we not only provide the basis for the development of effective drugs for the treatment of AD but also describe a general road-map for the application of SBDD in GPCR-drug discovery that realizes the promise of rational ligand design made over a decade ago by the report of the first GPCR structures.</div></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0265" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>GF/B filters</td><td>Merck</td><td>WHA1821047</td></tr><tr><td>UltraGold Scintillation</td><td>Perkin Elmer</td><td>6013329</td></tr><tr><td>Complete protease inhibitor cocktail</td><td>Merck</td><td>11697498001</td></tr><tr><td>Superflow resin</td><td>QIAGEN</td><td>30410</td></tr><tr><td>Superdex 200</td><td>Sigma-Aldrich</td><td>GE28-9909-44</td></tr><tr><td>Atropine</td><td>Sigma-Aldrich</td><td>A0132-1G</td></tr><tr><td>GSK1034702</td><td>In house synthesis</td><td>N/A</td></tr><tr><td>Acetylcholine (chloride)</td><td>Sigma-Aldrich</td><td>A6625-10mgs</td></tr><tr><td>Donepezil</td><td>Tocris</td><td>4385</td></tr><tr><td>[3H]-77-LH-28-1</td><td>RC Tritec, Switzerland</td><td>Custom radionucleotide synthesis 48.01Ci/mmol</td></tr><tr><td>[3H]-NMS</td><td>PerkinElmer</td><td>NET636250UC</td></tr><tr><td>DMEM (high glucose w-out sodium pyruvate)</td><td>Invitrogen</td><td>41965-039</td></tr><tr><td>FBS (heat inactivated)</td><td>Invitrogen</td><td>10500064</td></tr><tr><td>GeneJuice</td><td>Sigma-Aldrich</td><td>70967</td></tr><tr><td>Poly-d-lysine coated plates</td><td>VWR</td><td>734-0120</td></tr><tr><td>Hanks Balanced salt solution (HBSS)</td><td>Merck</td><td>H4641</td></tr><tr><td>ESF 921 medium</td><td>Expression systems</td><td>96-001-01</td></tr><tr class="rowsep"><td>384 well white proxiplates</td><td>Cole Parmer (UK)</td><td>781358</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>Alphascreen Surefire pERK assay</td><td>Perkin Elmer</td><td>ALSU-PERK-A-HV</td></tr><tr><td>IP-One Tb assay kit</td><td>CisBio</td><td>621PAPEC</td></tr><tr class="rowsep"><td>Bac to Bac Expression System</td><td>ThermoFisher</td><td>10359016</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited data</b></td></tr><tr><td>M1-StaR-T4L in complex with 77-LH-28-1</td><td>This paper</td><td>6ZFZ</td></tr><tr><td>M1-StaR-T4L in complex with HTL9936</td><td>This paper</td><td>6ZG4</td></tr><tr><td>M1-StaR-T4L in complex with GSK1034702</td><td>This paper</td><td>6ZG9</td></tr><tr><td>β<sub>1</sub>-adrenergic receptor:cyanopindolol</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref80-2" href="#" role="doc-biblioref" data-xml-rid="bib80" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref80-2" aria-controls="sref80-2">Warne et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref80-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">80.</div><div>Warne, T. ∙ Serrano-Vega, M.J. ∙ Baker, J.G. ...</div><div><strong>Structure of a beta1-adrenergic G-protein-coupled receptor</strong></div><div><em>Nature.</em> 2008; <strong>454</strong>:486-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature07101" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-47949129742" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18594507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature07101&amp;pmid=18594507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td>2VT4</td></tr><tr><td>Phase1 Healthy Volunteer SAD/MAD</td><td>Clinicaltrials.gov</td><td>NCT02291783</td></tr><tr><td>Cognition and BOLD fMRI Healthy Elderly Subjects</td><td>Clinicaltrials.gov</td><td>NCT02546310</td></tr><tr><td>Phase1 Healthy Volunteer SAD/MAD</td><td>EUDRACT.ema.europa.eu</td><td>2013-002307-34</td></tr><tr class="rowsep"><td>Cognition and BOLD fMRI Healthy Elderly Subjects</td><td>EUDRACT.ema.europa.eu</td><td>2015-002490-38</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Cell lines</b></td></tr><tr><td>HEK293T</td><td>Sigma-Aldrich</td><td>12022001-Cdna-20ul</td></tr><tr class="rowsep"><td>CHO-FlpIn</td><td>ThermoFisher</td><td>R75807</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Organisms/strains</b></td></tr><tr><td>Mice C57BL/6 (male aged 8-12weeks)</td><td>Charles River</td><td>N/A</td></tr><tr><td>Rats (adult male Hans Wistar age 11weeks)</td><td>Harlan, UK</td><td>N/A</td></tr><tr><td>Beagle dogs (male and female 32to 48weeks)</td><td>Harlan, UK</td><td>N/A</td></tr><tr><td>Cynomolgus macaques (Mascara fasicularis) male</td><td>SRI, US</td><td>N/A</td></tr><tr><td>Mice C57BL/6 (male aged 8-12weeks)</td><td>Charles River</td><td>N/A</td></tr><tr class="rowsep"><td>Mice Tg37 (male homozygous mice)</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref56-1" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-1" aria-controls="sref56-1">Mallucci et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref56-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Mallucci, G. ∙ Dickinson, A. ∙ Linehan, J. ...</div><div><strong>Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis</strong></div><div><em>Science.</em> 2003; <strong>302</strong>:871-874</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1090187" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0242363656" target="_blank" aria-label="Open Scopus in new tab">Scopus (621)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14593181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1090187&amp;pmid=14593181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; 5646 pp871</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>Schrodinger Glide softwear</td><td>Schrodinger LLC</td><td><a id="intref0045" href="https://www.schrodinger.com" target="_blank">https://www.schrodinger.com</a></td></tr><tr><td>Ethivision XT,</td><td>Noldus UK</td><td><a id="intref0050" href="https://www.noldus.com/" target="_blank">https://www.noldus.com/</a></td></tr><tr><td>DataQuest ART</td><td>DSI, St Paul, MN</td><td>Dataquest ART <a id="intref0055" href="https://www.datasci.com/products/software/dataquest-art" target="_blank">https://www.datasci.com/products/software/dataquest-art</a></td></tr><tr><td>Phaser</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref57-1" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-1" aria-controls="sref57-1">McCoy et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref57-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>McCoy, A.J. ∙ Grosse-Kunstleve, R.W. ∙ Adams, P.D. ...</div><div><strong>Phaser crystallographic software</strong></div><div><em>J.&nbsp;Appl. Cryst.</em> 2007; <strong>40</strong>:658-674</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0021889807021206" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-34447508216" target="_blank" aria-label="Open Scopus in new tab">Scopus (16093)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19461840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0021889807021206&amp;pmid=19461840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0060" href="https://www.phaser.cimr.cam.ac.uk/index.php/Downloads" target="_blank">https://www.phaser.cimr.cam.ac.uk/index.php/Downloads</a></td></tr><tr><td>MolProbity</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref17-1" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-1" aria-controls="sref17-1">Chen et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chen, V.B. ∙ Arendall, 3rd, W.B. ∙ Headd, J.J. ...</div><div><strong>MolProbity: all-atom structure validation for macromolecular crystallography</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:12-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909042073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-74549178560" target="_blank" aria-label="Open Scopus in new tab">Scopus (11100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20057044/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909042073&amp;pmid=20057044" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0065" href="http://molprobity.biochem.duke.edu/" target="_blank">http://molprobity.biochem.duke.edu/</a></td></tr><tr><td>POINTLESS</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref82-1" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-1" aria-controls="sref82-1">Winn et. al. 2011</a><div class="dropBlock__holder" data-db-target-of="sref82-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Winn, M.D. ∙ Ballard, C.C. ∙ Cowtan, K.D. ...</div><div><strong>Overview of the CCP4 suite and current developments</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2011; <strong>67</strong>:235-242</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910045749" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79953737180" target="_blank" aria-label="Open Scopus in new tab">Scopus (10209)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21460441/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910045749&amp;pmid=21460441" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0070" href="https://www.ccp4.ac.uk/" target="_blank">https://www.ccp4.ac.uk/</a></td></tr><tr><td>AIMLESS</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref34-1" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-1" aria-controls="sref34-1">Evans and Murshudov 2013</a><div class="dropBlock__holder" data-db-target-of="sref34-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Evans, P.R. ∙ Murshudov, G.N.</div><div><strong>How good are my data and what is the resolution?</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2013; <strong>69</strong>:1204-1214</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444913000061" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84879367781" target="_blank" aria-label="Open Scopus in new tab">Scopus (3299)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23793146/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444913000061&amp;pmid=23793146" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0075" href="https://www.ccp4.ac.uk/" target="_blank">https://www.ccp4.ac.uk/</a></td></tr><tr><td>MOSFLM</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref8-1" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-1" aria-controls="sref8-1">Battye et&nbsp;al. 2011</a><div class="dropBlock__holder" data-db-target-of="sref8-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Battye, T.G. ∙ Kontogiannis, L. ∙ Johnson, O. ...</div><div><strong>iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2011; <strong>67</strong>:271-281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910048675" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79953759821" target="_blank" aria-label="Open Scopus in new tab">Scopus (2515)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21460445/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910048675&amp;pmid=21460445" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0080" href="https://www.mrc-lmb.cam.ac.uk/mosflm/mosflm/" target="_blank">https://www.mrc-lmb.cam.ac.uk/mosflm/mosflm/</a></td></tr><tr><td>XDS</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref47-1" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-1" aria-controls="sref47-1">Kabsch, 2010</a><div class="dropBlock__holder" data-db-target-of="sref47-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Kabsch, W.</div><div><strong>Xds</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909047337" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-76449099287" target="_blank" aria-label="Open Scopus in new tab">Scopus (12940)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124692/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909047337&amp;pmid=20124692" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0085" href="https://xds.mr.mpg.de/" target="_blank">https://xds.mr.mpg.de/</a></td></tr><tr><td>COOT</td><td><span class="dropBlock reference-citations"><a id="body-ref-sref31-1" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-1" aria-controls="sref31-1">Emsley et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref31-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span></td><td><a id="intref0090" href="https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/" target="_blank">https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/</a></td></tr><tr><td>MATLAB</td><td>The MathWorks, Inc., USA</td><td><a id="intref0095" href="https://www.mathworks.com" target="_blank">https://www.mathworks.com</a></td></tr><tr><td>Brainvision Analyzer software</td><td>Brain Products Gilching, Germany</td><td><a id="intref0100" href="https://brainvision.com" target="_blank">https://brainvision.com</a></td></tr><tr><td>ImageJ</td><td>Noldus UK</td><td><a id="intref0105" href="https://imagej.nih.gov" target="_blank">https://imagej.nih.gov</a></td></tr><tr><td>BUSTER</td><td>Globalphasing Ltd</td><td><a id="intref0110" href="https://www.globalphasing.com" target="_blank">https://www.globalphasing.com</a></td></tr><tr><td>PyMOL</td><td>Schrodinger LLC</td><td><a id="intref0115" href="https://pymol.org/2/" target="_blank">https://pymol.org/2/</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2901316-7" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0270" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact,. Andrew Tobin (<a id="intref0120" href="mailto:andrew.tobin@glasgow.ac.uk">andrew.tobin@glasgow.ac.uk</a>)</div></section><section id="sec-4-2-2"><h4>Materials availability</h4><div id="p0275" role="paragraph">Materials described in this manuscript may be made available to qualified, academic, non-commercial researchers through a materials transfer agreement upon request the lead contact Andrew Tobin (andrew.tobin@glasgow.ac.uk).</div></section></section><section id="sec-4-3"><h3>Experimental model and subject details</h3><section id="sec-4-3-1"><h4>Cell Culture</h4><div id="p0280" role="paragraph">HEK293T and Chinese hamster ovary (CHO-K1) cells stably expressing recombinant M1-receptors were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 0.292 g.l<sup>-1</sup> L-glutamine, penicillin/streptomycin mixture and 10% (v/v) fetal bovine serum (FBS) at 37°C in a 5% CO<sub>2</sub> humidified atmosphere. For experiments using transiently transfected HEK293T cells, transfections were carried out using 1&nbsp;mg/mL polyethyleneimine (PEI) (MW-25000) and experiments conducted 48&nbsp;h post transfection. FlpInCHO cells (Thermo Fisher Scientific) transfected to stably express recombinant human M1-receptor were&nbsp;grown in T75cm<sup>2</sup> flasks in Ham’s F-12 media containing 10% fetal bovine serum and 1% penicillin/streptomycin and under&nbsp;hygromycin B selection (400&nbsp;μg/mL) were induced to express the M1-receptor by treatment with 100&nbsp;ng.ml<sup>-1</sup> doxycycline for 24 h.</div></section><section id="sec-4-3-2"><h4>Use of pre-clinical animal species</h4><div id="p0285" role="paragraph">Mouse work reported here was conducted on male and female C57/B6 mice or female Tg37 transgenic line overexpressing mouse prion protein (<span class="dropBlock reference-citations"><a id="body-ref-sref56-2" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-2" aria-controls="sref56-2">Mallucci et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref56-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Mallucci, G. ∙ Dickinson, A. ∙ Linehan, J. ...</div><div><strong>Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis</strong></div><div><em>Science.</em> 2003; <strong>302</strong>:871-874</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1090187" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0242363656" target="_blank" aria-label="Open Scopus in new tab">Scopus (621)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14593181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1090187&amp;pmid=14593181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) under the UK Home Office Project license PPL7008473, PP7704105 and PP7704105. Experimentally naive male Wistar rats were purpose bred at Harlan, UK. Animals were introduced to the experimental holding rooms 5&nbsp;days prior to the commencement of the study, housed in groups of 4 during this period, and maintained at 22-24°C on a standard 12 hour-light/dark cycle, with food and water available <i>ad libitum</i>. All animals were examined and weighed daily. Rat <i>in&nbsp;vivo</i> studies were approved by University College Dublin ethics committee and carried out by individuals licensed by the Irish Department of Health according to current European legislation (Directive 86/609EEC).</div></section><section id="sec-4-3-3"><h4>Rat intravenous infusion in non-GLP cardiovascular study</h4><div id="p0290" role="paragraph">The study was performed using 7 male Wistar rats (JANVIER LABS, C.S. 4105, Saint Berthevin F-53941 France), weighing 220-300&nbsp;g on the day of surgical implantation. Animals were housed in groups of 2-4 in polysulfone cages (floor area&nbsp;= 1500&nbsp;cm<sup>2</sup>) under standard conditions: room temperature (22 ± 2°C), light/dark cycle (12h/12h), air replacement (15-20 volumes/hour), water and food (SDS, RM1) <i>ad libitum</i>. Animals were allowed to habituate for at least 5&nbsp;days prior to surgery.Following surgical procedures animals were individually housed. The study was conducted under EU and French animal welfare regulation for animal use in experimentation (European Directive 2010/63/EEC and French decree and orders of February 1st 2013). HTL9936 or vehicle were administered by gavage (4mL/kg) at time&nbsp;= 0. Summary profiles representing the mean of HTL9936 across 4-6 animals at 3, 10, 30 and 100&nbsp;mg/kg on heart rate and mean arterial blood pressure are depicted below. Arterial blood pressure and heart rate (determined from the pulsed blood pressure signal) were continuously measured 60&nbsp;min before administration of HTL9936 or vehicle. At each time point the results were averaged over the preceding 5&nbsp;min period <b>(Figure&nbsp;S7A,B).</b></div><div id="p0295" role="paragraph">The rat GLP cardiovascular study was conducted under EU and French animal welfare regulation for animal use in experimentation (European Directive 2010/63/EEC and French decree and orders of February 1<sup>st</sup> 2013).</div></section><section id="sec-4-3-4"><h4>Dog intravenous infusion in GLP cardiovascular study</h4><div id="p0300" role="paragraph">Six male pure-bred beagle dogs were obtained from Harlan, UK. The animals were housed in an air-conditioned room to provide a minimum of 15 to 20 air</div><div id="p0305" role="paragraph">changes/hour. Routinely, the temperature was maintained within acceptable limits (nominally 15 to 21°C). On one occasion the temperature exceeded the protocol specification and was recorded at 26°C. Fluorescent lighting was controlled automatically to give a cycle of 12 hours light and 12 hours dark. Each animal was offered approximately 300&nbsp;g of 5L66 Certified High Density Canine Diet (IPS Product Supplies Ltd., London) each morning. The study was designed to meet the requirements of ICH Guideline (Topic S7A;CPMP/ICH/539/00) on Safety Pharmacology Studies for Human Pharmaceuticals (November 2000). Animals were implanted with calibrated sensors (DSI D70 Series) for arterial blood pressure (ABP). The signals were processed by the Open Art/ PoNeMah data acquisition/analysis software. Vehicle and test article were administered by intravenous infusion over 2 hours, using a constant dose volume of 10&nbsp;mL/kg (5&nbsp;mL/kg/hr) and data was continuously recorded at logging rates of 1&nbsp;min. Two pre-dose readings of the heart rate, blood pressure (Diastolic, systolic and mean arterial pressure) and ECG intervals (PR-, QRS-, QT- and QTCF) were taken 15&nbsp;min apart before administration of each dose. Following the start of the infusion, of vehicle or test article, readings were taken from the line averages at 15, 30, 45, 60, 75, 90, 105 and 120&nbsp;min (i.e during the infusion), 150 and 180&nbsp;min (i.e., 0.5 and 1 hour post infusion in sling) (additional recordings were continued to 12hours post-dose). For each variable, the mean of the pre-dose values recorded for each animal on each dose were taken as the baseline for that dose and that animal. Each time point was analyzed using ANOVA, fitting DOSE and ANIMAL as fixed effects with the baseline value as a covariate. Pairwise comparisons of each dose with control (Dose 1) were made using Dunnett’s test (<a id="crosref1100" href="#figs7">Figures S7</a>C and S7D).</div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/998dae1d-f366-4eb0-af3e-7fc86e9c12b7/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.11.001/asset/e68836ca-d1cc-4511-b1d4-258b21899ef7/main.assets/figs7.jpg" height="429" width="750" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/998dae1d-f366-4eb0-af3e-7fc86e9c12b7/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Effects on heart rate and blood pressure of intravenous administration of HT9936 in rats and dogs, related to <a id="crosref1355" href="#mmc1">STAR Methods</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0275" role="paragraph"><b>A.</b> Averaged baseline subtracted mean arterial blood pressure effects in rats across over −60 to 300&nbsp;minute time period. HTL9936 was administered at time&nbsp;= 0. Data are expressed as mean ± S.E.M. analysed by repeated measurement ANOVA and pairwise comparisons of each compound to vehicle by post-hoc Dunnett’s test. Significant values are relative to the vehicle treatment only. Differences were considered to be significant by <i>P</i>&nbsp;&lt; 0.05 for 10&nbsp;mg/kg <sup>$</sup>, 30&nbsp;mg/kg <sup>∗</sup> and 100&nbsp;mg/kg <sup>+</sup> respectively. <b>B.</b> Averaged baseline subtracted heart rate effects in rats across over −60 to 300&nbsp;minute time period. HTL9936 was administered at time&nbsp;= 0. Data are expressed as mean ± S.E.M. analysed by repeated measurement ANOVA and pairwise comparisons of each compound to vehicle by post-hoc Dunnett’s test. Significant values are relative to the vehicle treatment only. Differences were considered to be significant by <i>P</i>&nbsp;&lt; 0.05 for 10&nbsp;mg/kg <sup>$</sup>, 30&nbsp;mg/kg <sup>∗</sup> and 100&nbsp;mg/kg <sup>+</sup> respectively. <b>C.</b> Group mean effects on mean atrial blood pressure in dogs. Data presented as mean ± S.E.M. (n=6 except ghoup 1 n=5 at 240&nbsp;mins, group 2 n=0 at 20 hours, n=3 at 22hours and 24 hours, group 4 n=3 at 240&nbsp;mins, n=4 at 5 hours and n=5 at 16 hours. <b>D.</b> Group mean effects on heart rate in dogs. Data presented as mean ± S.E.M. (n=6 except ghoup 1 n=5 at 240&nbsp;mins, group 2 n=0 at 20 hours, n=3 at 22hours and 24 hours, group 4 n=3 at 240&nbsp;mins, n=4 at 5 hours and n=5 at 16 hours.</div></div></div></div></figcaption></figure></div></section><section id="sec-4-3-5"><h4>Beagle aged studies</h4><div id="p0310" role="paragraph">Adult male and female Beagle dogs were housed individually. A combination of commercially available artificial light and natural light was provided to the animals. Heating and cooling was electronically maintained and set to maintain the temperature in a range from 15°C to 28°C with the room ventilation designed to provide 18 filtered air changes per hour. All animal facilities were cleaned daily. The animals were fed Purine Pro Plan to maintain bodyweight at the end of each day with access to ffod after the study protocol on test occasions. Water was provided <i>ad lib</i>. Protocols for the aged beagle dog studies were approved by Vivocore Internal Animal Care and Use Committee (IACUC) in accordance with the Canadian Council on Animal Care (CCAC).</div></section><section id="sec-4-3-6"><h4>Non-human primate studies</h4><div id="p0315" role="paragraph">Adult male Cynomolgus macaques (Macaca fasicularis) were used for these studies. Subjects were house in a temperature controlled recording room maintained on a 12-hour light/dark cycle. They had access to water <i>ad libitum</i> and are fed a full daily regimen of food. In addition to their food,the animals are provided with fresh fruits and vegetables daily and their welfare supported with additional environmental enrichment strategies (access to toys, ambient sounds and visual stimulation).</div><div id="p0320" role="paragraph">All studies were conducted in compliance with USDA and SRI International IACUC guidelines. SRI International is an AAALAC accredited institution.</div></section><section id="sec-4-3-7"><h4>Toxicology studies on HTL9936</h4><div id="p0325" role="paragraph">The rat and dog were appropriate species in which to conduct nonclinical safety evaluation and HTL9936. Male and female rates of the RccHan: WIST strain were obtained from Harlan, Bicester, UK. and the animals were approximately seven to eight&nbsp;weeks old at the start of dosing. Throughout the study the animals had access <i>ad libitum</i> to SQC Rat and Mouse Maintenance Diet No 1, Expanded, (Special Diets Services Ltd, Witham, UK). Rooms were air-conditioned to provide 15 to 20 air changes/hour. The temperature and relative humidity ranges were maintained in the specified ranges of 20 to 24°C and 45 to 65%, respectively. Fluorescent lighting was controlled automatically to give a cycle of 12 hours light and 12 hours dark. The animals were given wooden Aspen chew blocks and rodent retreats that did not require analyses as forms of environmental enrichment.</div><div id="p0330" role="paragraph">Beagle dogs were aged between 32 to 40&nbsp;weeks old at the start of dosing. Animals were offered 5L66 Certified High Density Canine Diet (IPS Product Supplies Ltd, London) each day and water was provided <i>ad libitum</i> via an automatic watering system. Rooms were air-conditioned to provide 15 to 20 air changes/hour and the temperature range was maintained in the specified range of 15 to 21°C. Fluorescent lighting was controlled automatically to give a cycle of 12 hours light and 12 hours dark. Environment enrichment included the provision of toys (such as balls, inert nylon chews), raised platforms and exercise/socialisation periods. Details were maintained in the study record</div><div id="p0335" role="paragraph">Toxicology studies were conducted males and female of both species under the UK Home Office Project License PPL60/3774 and where appropriate in accordance with the OECD Principle on Good Laboratory Practice ENV/MC/CHEM (98)17.</div></section><section id="sec-4-3-8"><h4>Human experimental subjects</h4><div id="p0340" role="paragraph">HTL9936 was progressed into a randomized, double blind, placebo controlled, first time-in-human (FTIH) ascending single and multiple oral dose study in healthy young adult male volunteers and healthy elderly male and female volunteers. (<a id="intref0125" href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> Identifier: NCT02291783).</div><div id="p0345" role="paragraph">The pharmacodynamic effects of HTL9936 on hippocampal dependent spatial learning and memory and hippocampal activity were examined in a separate study in heqalthy elderly male and female subjects (aged 65-80 years; <a id="intref0130" href="http://ClinicalTrials.gov" target="_blank">ClinicalTrials.gov</a> Identifier: NCT02546310).</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>GPCR residue numbering</h4><div id="p0350" role="paragraph">The generic GPCR residue numbering system (<span class="dropBlock reference-citations"><a id="body-ref-sref45" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45" aria-controls="sref45">Isberg et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Isberg, V. ∙ de Graaf, C. ∙ Bortolato, A. ...</div><div><strong>Generic GPCR residue numbers - aligning topology maps while minding the gaps</strong></div><div><em>Trends Pharmacol. Sci.</em> 2015; <strong>36</strong>:22-31</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2014.11.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2014.11.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84920166693" target="_blank" aria-label="Open Scopus in new tab">Scopus (345)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25541108/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2014.11.001&amp;pmid=25541108" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) used throughout this paper is based on the based on the Ballesteros-Weinstein residue numbering system includes two numbers (X.N), the first (1-7) denotes the transmembrane helix (TM), and the following number indicates the residue position relative to the most conserved amino-acid in the helix (which is assigned the number 50). Conserved residue positions in Extracellular Loop 1 (EL1, between TM2 and TM3) and Extracellular Loop 2 (EL2, between TM4 and TM5) are defined as W23.50 and C45.50, respectively. For example, 3.33 indicates the residue 17 positions before the most conserved amino-acid in Class A GPCR TM3 (R3.50). If an amino acid is followed by its residue number, the generic GPCR residue numbering is included as superscript.</div></section><section id="sec-4-4-2"><h4>Primary neuronal culture preparations</h4><div id="p0355" role="paragraph">Tissue culture plates were coated using 4&nbsp;μg.ml<sup>-1</sup> poly-D-lysine and 6&nbsp;μg.ml<sup>-1</sup> Laminin Mouse Protein in DEPC treated H<sub>2</sub>O and incubated overnight at 37°C. Plates were then washed three times using DEPC treated H<sub>2</sub>O and dried for 2h at room temperature.</div><div id="p0360" role="paragraph">The hippocampal and cortical areas of the brain were isolated from E16 embryos. The tissues were chopped into smaller pieces, washed three times in Hanks’ balanced salt solution (HBSS), transferred to a 15&nbsp;mL tube containing 4ml of TrypLE Select 10X and incubated at 37°C for 10&nbsp;min. TrypLE Select 10X was then inactivated by adding 8&nbsp;mL of neurobasal complete media (Neurobasal Plus medium supplemented with 20&nbsp;ml.L<sup>-1</sup> B-27 plus, 0.292 g.L<sup>-1</sup> L-glutamine, 100 U.ml<sup>−1</sup> penicillin, 0.1 mg.ml<sup>−1</sup> streptomycin) to the tubes followed by centrifugation at 200 x g for 5&nbsp;min. The pellet was resuspended in neurobasal complete media to a final density of 5x10<sup>5</sup> cells/mL<sup>-1</sup>. Cells were then seeded onto pre-coated plates and maintained at 37°C in a 5% CO<sub>2</sub> humidified atmosphere.</div></section><section id="sec-4-4-3"><h4>Drug discovery screening strategy</h4><div id="p0365" role="paragraph">The protein preparation and docking experiments were done within the Schrödinger Maestro package. The grid generation necessary for docking was done within Glide. The residues highlighted in SDM experiments (in-house and external) were used to further define the cavity of the grid. However, no constraints were added in the grid generation to ensure that subsequent dockings were not biased in any way. As standard, up to 3 poses per molecular structure were stored for analysis.</div><div id="p0370" role="paragraph">1.6 million fragment-like compounds were prepared for screening, and all or a subset from more stringent prefiltering and clustering were docked into each of the models using the SP algorithm within the Schrödinger Glide software, running on a 28 CPU Linux cluster. The resultant hits from the virtual screen were then reduced further by applying distance and volume constraints to ensure that the bound poses were within the area highlighted by SDM to be important for agonism of the structure.</div><div id="p0375" role="paragraph">The more stringent subset was generated from a ligand-based scaffold hopping approach whereby common motifs within the known agonists, highlighted above, were used as a preselection filtering criterion to enrich the compound set for subsequent docking.</div></section><section id="sec-4-4-4"><h4>Generation of the M1-receptor StaR variant</h4><div id="p0380" role="paragraph">To alleviate toxicity associated with DNA propagation of WT M1-receptor, a hybrid construct comprising residues 1-95 of M4 fused to residues 88-438 of M1-receptor was used as the template for StaR generation which was found to minimize toxicity commonly associated with high expression levels while minimizing the number of amino acid substitutions. A single amino acid substitution Trp101<sup>3.28</sup> (W101A) was introduced to increase the affinity for the M1-receptor agonist 77-LH-28-1. Conformational thermostabilization was performed using a mutagenesis approach previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Magnani et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Magnani, F. ∙ Serrano-Vega, M.J. ∙ Shibata, Y. ...</div><div><strong>A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies</strong></div><div><em>Nat. Protoc.</em> 2016; <strong>11</strong>:1554-1571</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2016.088" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84979929935" target="_blank" aria-label="Open Scopus in new tab">Scopus (82)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27466713/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2016.088&amp;pmid=27466713" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66-2" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-2" aria-controls="sref66-2">Robertson et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref66-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Robertson, N. ∙ Jazayeri, A. ∙ Errey, J. ...</div><div><strong>The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery</strong></div><div><em>Neuropharmacology.</em> 2011; <strong>60</strong>:36-44</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2010.07.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-78149501282" target="_blank" aria-label="Open Scopus in new tab">Scopus (132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20624408/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2010.07.001&amp;pmid=20624408" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Mutants were analyzed for thermostability in the presence of the radioligand [<sup>3</sup>H] 77-LH-28-1. The final StaR contained 12 thermostabilizing mutations (F27A<sup>1.34</sup>, T32A<sup>1.39</sup>, V46L<sup>1.53</sup>, L64A<sup>2.43</sup>, T95A, W101A<sup>3.28</sup>, S112A<sup>3.39</sup>, A143L<sup>4.43</sup>, A196T<sup>5.46</sup>, K362A<sup>6.32</sup>, A364L<sup>6.34</sup>, S411A<sup>7.46</sup> – note these 12 mutations are referred to as γ12.1 in the constructs described below).</div></section><section id="sec-4-4-5"><h4>StaR radioligand binding assay</h4><div id="p0385" role="paragraph">Radioligand binding using [3H]-77-LH-28-1 was performed on HEK293T membranes following 48&nbsp;h transient transfection of M1/M4 W101A, M1/M4 W101A γ12.1 StaR or M1/M4 W101A γ12.1 T4L StaR. For confirmation of receptor expression to support functional characterization in the pERK assay, binding was also performed on CHO-K1 membranes stably expressing M1/M4 W101A γ12.1 StaR. All experiments were performed in 96 well format over 2&nbsp;h at room temperature using 5ug/well protein in a final volume of 400ul of assay buffer of the following composition: 20&nbsp;mM HEPES, 100&nbsp;mM NaCl and 10&nbsp;mM MgCl2, pH 7.4 Binding reactions were terminated by rapid filtration through GF/B filters (Perkin Elmer, Boston, MA, USA) pre-soaked with 0.5% w/v PEI for 1 h. Filters were then washed 3 times with 1&nbsp;mL ice-cold assay buffer. Dried filters were counted with UltimaGold scintillant (Perkin Elmer) using a Microbeta (Perkin Elmer, Boston, MA, USA). The specific bound counts (d.p.m.) were expressed as a percentage of the maximal binding observed in the absence of test compound (total) and non-specific binding determined in the presence of 10&nbsp;μM atropine.</div><div id="p0390" role="paragraph">Affinity (K<sub>D</sub>) for [<sup>3</sup>H] 77-LH-28-1 for each construct was determined in membranes by saturation binding assays, performed by incubating increasing concentrations of [<sup>3</sup>H] 77-LH-28-1 in the absence or presence of 10μM atropine. Radioligand inhibition binding assays were performed by co-incubating membranes with increasing concentrations of test compounds and an approximate 5x concentration of the equilibrium dissociation constant (K<sub>D</sub>) concentration of [<sup>3</sup>H] 77-LH-28-1 (K<sub>D</sub> for [<sup>3</sup>H] −77-LH-28-1 binding to HEK293T cell membranes expressing the M1/M4 W108A γ12.1 StaR was 0.06 ± 0.03&nbsp;nM; n&nbsp;= 3)</div></section><section id="sec-4-4-6"><h4>Thermostability measurement of M1-receptor variants</h4><div id="p0395" role="paragraph">Transiently transfected HEK293T cells were incubated in 50mM sodium citrate pH 6.4, 150mM NaCl, 200nM [<sup>3</sup>H] 77-LH-28-1 supplemented with Complete Protease Inhibitor Cocktail tablet (Roche) for 2&nbsp;h at room temperature. All subsequent steps were performed at 4°C. Cells were solubilised in 2% (w/v) <i>n</i>-nonyl-β-D-glucopyranoside (NG), for 1&nbsp;h and crude lysates clarified by centrifugation at 16,000&nbsp;g for 15&nbsp;min. Receptor thermostability was measured by incubation at varying temperatures for 30&nbsp;min followed by separation of unbound radioligand by gel filtration. Levels of ligand-bound receptor were determined using a liquid scintillation counter. Thermal stability (Tm) is defined as the temperature at which 50% ligand binding is retained.</div></section><section id="sec-4-4-7"><h4>Expression, membrane preparation and protein purification of M1-receptor variants</h4><div id="p0400" role="paragraph">To facilitate crystallization further modifications were made to the M1-StaR construct. The flexible domains were removed from the N terminus (residues 1-27) and C terminus (residues 439-460) and T4-lysozyme (T4L) was inserted into intracellular loop 3 (ICL3) between residues 219 and 354. These modifications did not alter the ligand binding properties of the receptor compared to wild-type M1-receptor. The construct further comprises an N-terminal GP64 signal sequence, and a C-terminal deca-histidine tag.</div><div id="p0405" role="paragraph">The receptor was expressed using the Bac to Bac Expression System (Invitrogen) in <i>Spodoptera frugiperda</i> Sf21 cells using ESF 921 medium (Expression Systems) supplemented with 10% (v/v) fetal bovine serum (Sigma-Aldrich) and 1% (v/v) Penicillin/Streptomycin (PAA Laboratories). Cells were infected at a density of 3.5&nbsp;× 10<sup>6</sup> cells/mL with virus at an approximate multiplicity of infection of 2. Cultures were grown at 27°C with constant shaking and harvested by centrifugation 48 hours post infection. All subsequent protein purification steps were carried out at 4°C unless otherwise stated.</div><div id="p0410" role="paragraph">For each protein preparation, cells from 5L cultures were resuspended in phosphate buffer saline (PBS) supplemented by 5&nbsp;mM EDTA and Complete EDTA-free protease inhibitor cocktail tablets (Roche). Cells were disrupted at ∼15 000 psi using a microfluidizer (Processor M-110L Pneumatic, Microfluidics). Membranes pelleted by ultra-centrifugation at 200 000&nbsp;g for 50&nbsp;min, were subjected to two successive high salt washes in a buffer containing PBS, 1&nbsp;M NaCl and Complete EDTA-free protease inhibitor cocktail tablets, before they were centrifuged at 200,000&nbsp;g for 50&nbsp;min. Washed membranes were resuspended in 125&nbsp;mL 40&nbsp;mM Tris pH 7.6 and 500&nbsp;mM NaCl supplemented with Complete EDTA-free protease inhibitor cocktail tablets and stored at −80°C until further use.</div><div id="p0415" role="paragraph">Membranes were thawed, resuspended in a total volume of 150&nbsp;mL with 40&nbsp;mM Tris–HCl pH 7.6, 500&nbsp;mM NaCl, Complete EDTA-free protease inhibitor cocktail tablets (Roche), 40&nbsp;μM HTL9936 (or 40&nbsp;μM GSK1034702) and incubated for 40&nbsp;min at room temperature. Membranes were then solubilized by addition of 1.5% (w/v) n-Dodecyl-β-D-maltopyranoside (DDM, Anatrace), and incubation for 1 hours at 4°C, followed by centrifugation at 145 000&nbsp;g for 60&nbsp;min to harvest solubilised material.</div><div id="p0420" role="paragraph">The solubilised material was batch bound for 3 hours to Ni-NTA (nickel-nitrilotriacetic acid) Superflow resin (QIAGEN) pre-equilibrated in 40&nbsp;mM Tris-HCl pH 7.6, 150&nbsp;mM NaCl, 10&nbsp;mM imidazole, 0.05% DDM, 20&nbsp;μM HTL9936 (or 20&nbsp;μM GSK1034702 or 77-LH-28-1). the resin was then packed in a cartridge, and the column was washed with a gradient of 10 to 60&nbsp;mM imidazole over 35 column volumes in a buffer containing 40&nbsp;mM Tris-HCl pH 7.6, 500&nbsp;mM NaCl, 0.05% (w/v) DDM, 70&nbsp;mM imidazole, 20&nbsp;μM HTL9936 (or 20&nbsp;μM GSK1034702 or 77-LH-28-1) and then the protein was eluted with 40&nbsp;mM Tris-HCl pH 7.6, 500&nbsp;mM NaCl, 0.05% DDM, 245&nbsp;mM imidazole, 20&nbsp;μM HTL9936 (or 20&nbsp;μM GSK1034702 or 77-LH-28-1). The receptor was further purified by size exclusion chromatography using a Superdex 200 column (GE Healthcare) pre-equilibrated with 40&nbsp;mM Tris-HCl pH 7.6, 150&nbsp;mM NaCl, 0.03% (w/v) DDM and 40&nbsp;μM HTL9936 (or 40&nbsp;μM GSK1034702 or 20&nbsp;μM HTL9936). Receptor purity was assayed using SDS-PAGE and LC-MS and receptor monodispersity was assayed using analytical SEC. The protein was typically concentrated to ∼60&nbsp;mg/mL using a 100 KDa cut off membrane prior to crystallization setups.</div></section><section id="sec-4-4-8"><h4>Procedures for synthesis of HTL9936</h4><div id="p0425" role="paragraph">Where no preparative routes are included, the relevant intermediate was commercially sourced. Commercial reagents were utilized without further purification. Room temperature (rt) refers to approximately 20-27°C. <sup>1</sup>H NMR spectra were recorded at 400 MHz on either a Bruker or Jeol instrument. Chemical shift values are expressed in parts per million (ppm), i.e., (5)-values. The following abbreviations are used for the multiplicity of the NMR signals: s&nbsp;= singlet, br&nbsp;= broad, d&nbsp;= doublet, t&nbsp;= triplet, q&nbsp;= quartet, quint&nbsp;= quintet, td&nbsp;= triplet of doublets, tt&nbsp;= triplet of triplets, qd&nbsp;= quartet of doublets, ddd&nbsp;= doublet of doublet of doublets, ddt&nbsp;= doublet of doublet of triplets, m&nbsp;= multiplet. Coupling constants are listed as J values, measured in Hz. NMR and mass spectroscopy results were corrected to account for background peaks. Chromatography refers to column chromatography performed using 60-120 mesh silica gel and executed under nitrogen pressure (flash chromatography) conditions. TLC for monitoring reactions refers to TLC run using the specified mobile phase and the silica gel F254 as a stationary phase from Merck. Microwave-mediated reactions were performed in Biotage Initiator or CEM Discover microwave reactors. Mass spectroscopy was carried out on Shimadzu LC-2010 EV, Waters ZQ-2000, UPLC-Mass SQD-3100 or Applied Biosystem API-2000 spectrometers using electrospray conditions as specified for each compound in the detailed experimental section. Preparative HPLC was typically carried out under the following conditions, (Waters HPLC): Column: XSelect CSH Prep C-18, 19&nbsp;× 50&nbsp;mm, 5&nbsp;μηι; Mobile phase: Gradients of water and MeCN (each containing 0.1% Formic Acid); gradient 5% MeCN in 0.1 HCOOH in water (30 s), 5% to 40% (over 7&nbsp;min) then 95% MeCN in 0.1 HCOOH in water (1&nbsp;min) then 5% MeCN in 0.1 HCOOH in water (1.5&nbsp;min) at 28&nbsp;mL / min.</div><div id="p0430" role="paragraph">LCMS experiments were typically carried out using electrospray conditions as specified for each compound under the following conditions;</div><div id="p0435" role="paragraph"><b><i>Method A and B:</i></b> Instruments: Waters Alliance 2795, Waters 2996 PDA detector, Micromass ZQ; Column: Waters X-Bridge C-18, 2.5 micron, 2.1&nbsp;× 20&nbsp;mm or Phenomenex Gemini-NX C-18, 3 micron, 2.0&nbsp;× 30&nbsp;mm; radient [time (min)/solvent D in C (%)]: <b>Method A</b>: 0.00/2, 0.10/2, 2.50/95, 3.50/95, 3.55/2, 4.00/2 or <b>Method B</b>: 0.00/2, 0.10/2, 8.40/95, 9.40/95, 9.50/2, 10.00/2; Solvents: solvent C&nbsp;= 2.5&nbsp;L H<sub>2</sub>0&nbsp;+ 2.5&nbsp;ml_ ammonia solution; solvent D&nbsp;= 2.5L MeCN&nbsp;+ 135&nbsp;mL H<sub>2</sub>0&nbsp;+ 2.5&nbsp;ml_ ammonia solution); Injection volume 3&nbsp;μl; UV detection 230 to 400nM; column temperature 45°C; Flow rate 1.5&nbsp;mL/min.</div><div id="p0440" role="paragraph"><b><i>Method C:</i></b> Instrument: LCMS (Agilent 1200-61 10) with UV and ELSD detector at 40°C using waters X-Bridge C18 (4.6&nbsp;mm<sup>∗</sup>50&nbsp;mm, 3.5&nbsp;μm) and using water (0.05% TFA) and acetonitrile (0.05% TFA) as the mobile phase. The eluent gradient program was MECN (0.05% TFA) from 5% to 100% for 1.6&nbsp;min and 100% MECN (0.05% TFA) for 1.4&nbsp;min. The flow rate was 2.0&nbsp;mL/min.</div><div id="p0445" role="paragraph"><b><i>Method D:</i></b> Instrument: LCMS (Agilent 1200-61 10) with UV and ELSD detector at 40°C using waters X-Bridge C18 (4.6&nbsp;mm<sup>∗</sup>50&nbsp;mm, 3.5&nbsp;μm) and using water (0.05% TFA) and acetonitrile (0.05% TFA) as the mobile phase. The eluent gradient program was MECN (0.05%TFA) from 5% to 100% for 5&nbsp;min and 100% MeCN (0.05% TFA) for 1.0&nbsp;min. The flow rate was 2.0&nbsp;mL/min.</div></section><section id="sec-4-4-9"><h4>Steps for the synthesis of HTL9936 are as follows</h4><div id="p0450" role="paragraph"><b>STEP 1.</b> A mixture of 4-oxoazepane-1-carboxylic acid <i>tert</i>-butyl ester (90 g, 422&nbsp;mmol) and (R)-1-phenylethanamine (56.4 g, 465&nbsp;mmol) in THF (1000&nbsp;ml) was stirred at rt for 15&nbsp;min and STAB (107.4 g, 510&nbsp;mmol) was added. The mixture was cooled to 0°C in an ice bath, then acetic acid (26.7 g, 450&nbsp;mmol) was added. The mixture was stirred overnight at rt then concentrated <i>in vacuo</i>, residue dissolved in DCM (800&nbsp;ml) and washed with sat. NaHCO<sub>3</sub> sol. (2&nbsp;× 300&nbsp;ml), dried (Na<sub>2</sub>SO<sub>4</sub>). The solvents were removed <i>in vacuo</i>, and the residue was purified by column chromatography (gradient 0% to 3% MeOH in DCM) to give tert-butyl 4-{[(1 R)-1-phenylethyl]amino}azepane-1-carboxylate (90 g, 67.0%) as a mixture of two diastereoisomers. 70&nbsp;g of this mixture was separated by chiral prep. HPLC [Instrument: Waters Thar-SFC 200 with UV detector GILSON UV-1 (−151/152/155/156) at 35°C using CHIRALPAK AY-H (2.0&nbsp;cm I.D. x 25&nbsp;cm L. 5&nbsp;μm) and using (Acetonitrile/iso-propanol)(0.2%DEA)/CO2&nbsp;= 1.2/4.8/94 (V/VV) as the mobile phase. Flow rate was 120&nbsp;mL/min (all solvents were HPLC grade). The system back pressure was 100bar. The SFC system was monitored at 214&nbsp;nm.] to afford <i>tert</i>-butyl (4S)-4-{[(1 R)-1-phenylethyl]amino}azepane-1-carboxylate (26 g, 24.9% yield) as a yellow oil 1H NMR: (400MHz, CDCI3) δ: 1.26 (d, J&nbsp;= 7.1, 3H), 1.33 (s, 9H), 1.34 - 1.43 (m, 3H), 1.72 - 1.97 (m, 3H), 2.34 - 2.39 (m, 1 H), 3.01 - 3.45 (m, 4H), 3.80 (q, J&nbsp;= 7.2, 1 H), 7.15 - 7.25 (m, 5H), NH proton not observed. [a]D<sup>20</sup>&nbsp;=&nbsp;+ 57.0 (c&nbsp;= 0.5 in MeOH) and <i>tert</i>-butyl (4R)-4-{[(1 R)-1-phenylethyl]amino}azepane-1-carboxylate (30 g, 28.6% yield) as a yellow oil. 1H NMR: (400MHz, CDCI3) δ: 1.27 (d, J&nbsp;= 7.0, 3H), 1.34 (s, 9H), 1.34 - 1.42 (m, 3H), 1.74 - 1.96 (m, 3H), 2.35 - 2.41 (m, 1 H), 3.02 - 3.45 (m, 4H), 3.81 (q, J&nbsp;= 7.1, 1 H), 7.16 - 7.26 (m, 5H), NH proton not observed. [a]D<sup>20</sup>&nbsp;= - 31.8 (c&nbsp;= 0.5 in MeOH)</div><div id="p0455" role="paragraph">The absolute configuration of <i>tert</i>-butyl (4S)-4-{[(1 R)-1-phenylethyl]amino}azepane-1-carboxylate was determined by X-ray analysis of the p-bromobenzoate salt of tert-butyl (4S)-4-{[(1 R)-1-phenylethyl]amino}azepane-1-carboxylate.</div><div id="p0460" role="paragraph"><b>STEP 2.</b> A suspension of Pd(OH)<sub>2</sub>/C (10%, 550&nbsp;mg), <i>tert</i>-butyl (4S)-4-{[(1 R)-1-phenylethyl]amino}azepane-1-carboxylate (5.5 g, 17.3&nbsp;mmol) and HCOONH<sub>4</sub> (3.3 g, 51.9&nbsp;mmol) in MeOH (80&nbsp;ml) was heated at reflux for 1.5 h. The reaction mixture was cooled to rt and filtered; the solvents of the filtrate were removed <i>in vacuo</i>. The residue was purified by column chromatography (gradient 0% to 10% MeOH in DCM) to give <i>tert</i>-butyl (4S)-4-aminoazepane-1-carboxylate (3.2 g, 87.3%). 1H NMR: (400MHz, CDCI3) δ: 1.34 - 1.42 (m, 3H), 1.39 (s, 9H), 1.45 - 1.53 (m, 2H), 1.60 - 1.86 (m, 3H), 2.80 - 2.90 (m, 1 H), 3.08 - 3.53 (m, 4H). LCMS (<b>Method D</b>): m/z 215 (M+H)<sup>+</sup> (ES+), at 1.53&nbsp;min, UV inactive. [a]D<sup>20</sup>&nbsp;=&nbsp;+ 21.3 (c&nbsp;= 1.0 in MeOH)</div><div id="p0465" role="paragraph"><b>STEP 3.</b> Methyl cyclopent-3-ene-1-carboxylate (4.42 g, 35&nbsp;mmol) was dissolved in DCM/MeOH (160&nbsp;ml, 3: 1) and cooled to −78°C. Ozone was passed through the solution until a blue color persisted. Excess ozone was purged from the reaction mixture with dry N<sub>2</sub>. Dimethylsulfide (10&nbsp;ml) was added and the reaction mixture was warmed to rt, the solvent was removed <i>in vacuo</i>. The residue was added to a solution of <i>tert</i>-butyl (4S)-4-aminoazepane-1-carboxylate (7.5 g, 35&nbsp;mmol), STAB (18.57 g, 87.6&nbsp;mmol), NEt<sub>3</sub> (4.26 g, 42.1&nbsp;mmol) and acetic acid (1.8&nbsp;ml_) in DCE (200&nbsp;ml). The mixture was stirred for 3 hours at rt and was then poured into aqueous Na<sub>2</sub>C0<sub>3</sub> solution. The mixture was extracted with EtOAc (3&nbsp;× 200&nbsp;ml), the organic phase was washed with water (100&nbsp;ml) and brine (100&nbsp;ml), dried over Na<sub>2</sub>S0<sub>4</sub>. The solvent was removed <i>in vacuo</i>, and the residue was purified by column chromatography (gradient 0% to 25% EtOAc in Petroleum ether) to give <i>tert</i>-butyl (4S)-4-[4-(methoxycarbonyl)piperidin-1-yl]azepane-1-carboxylate (7.7 g, 64.6% yield) as a yellow oil. LCMS (<b>Method C</b>): m/z 341 (M+H)<sup>+</sup> (ES+), at 1.49&nbsp;min, UV inactive.</div><div id="p0470" role="paragraph"><b>STEP 4.</b> <i>tert</i>-Butyl (4S)-4-[4-(methoxycarbonyl)piperidin-1-yl]azepane-1-carboxylate (7.7 g, 22.7&nbsp;mmol) was dissolved in THF and water (60&nbsp;ml, 1: 1) and cooled to 0°C. NaOH (1.0 g, 24.5&nbsp;mmol) was added and the reaction mixture was stirred at rt for 3 h. The organics solvents were removed <i>in vacuo</i>, and the aqueous phase was acidified with acetic acid to pH&nbsp;= 3∼4, then concentrated to dryness. The residue was suspended in CHCI3 (40&nbsp;ml) and filtered to remove inorganic salts. The filtrate was evaporated to dryness to afford 1-{(4S)-1-[(<i>tert</i>-butoxycarbonyl)carbonyl]azepan-4-yl}piperidine-4-carboxylic acid (6.2 g, 84% yield) as a yellow oil. 1H NMR: (400MHz, DMSO-d6) δ: 1.38 (s, 9H), 1.45 - 1.53 (m, 6H), 1.70 - 1.78 (m, 4H), 2.08 - 2.20 (m, 3H), 2.35 - 2.42 (m, 1 H), 2.65 - 2.69 (m, 2H), 3.12 - 3.19 (m, 2H), 3.30 - 3.41 (m, 2H), 8.32 (br. s, 1 H) LCMS (<b>Method C</b>): m/z 327 (M+H)<sup>+</sup> (ES+), at 1.35&nbsp;min, UV inactive [a]D<sup>20</sup>&nbsp;=&nbsp;+ 1 1.0 (c&nbsp;= 1.8 in MeOH)</div><div id="p0475" role="paragraph"><b>STEP 5.</b> 1-{(4S)-1-[(<i>tert</i>-butoxycarbonyl)carbonyl]azepan-4-yl}piperidine-4-carboxylic acid (2.0 g, 6.135&nbsp;mmol) was dissolved in DMF (25&nbsp;mL) and cooled to 0°C. (1-methylcyclobutyl)amine. HCl (1.49 g, 0.18&nbsp;mL, 12.27&nbsp;mmol), HATU (3.5 g, 9.202&nbsp;mmol) and DIPEA (3.67 g, 5.34&nbsp;mL, 30.67&nbsp;mmol) were added. The reaction mixture was stirred at rt for 16&nbsp;h and the solvents were removed <i>in vacuo</i>. The residue was partitioned between DCM and sat. NaHCO<sub>3</sub> sol., the organic layer was washed with sat. NaCI sol. and dried (MgSO<sub>4</sub>). The solvents were removed <i>in vacuo</i>, and the residue was purified by column chromatography (normal phase, [Biotage SNAP cartridge KP-sil 50 g, gradient 0% to 10% MeOH in DCM]) to give <i>tert</i>-butyl (S)-4-(4-((1-methylcyclobutyl)carbamoyl)piperidin-1-yl)azepane-1-carboxylate (0.459 g, 19%) as a pale yellow gum. LCMS (<b>Method A</b>): m/z 394 (M+H)<sup>+</sup> (ES<sup>+</sup>), at 1.81&nbsp;min, UV inactive</div><div id="p0480" role="paragraph"><b>STEP 6.</b> <i>tert</i>-Butyl (S)-4-(4-((1-methylcyclobutyl)carbamoyl)piperidin-1-yl)azepane-1-carboxylate (459mg, 1.14&nbsp;mmol) was dissolved in DCM (4&nbsp;mL) and TFA (2&nbsp;mL) was added. The reaction mixture was stirred at rt for 4h under nitrogen, then the solvents were removed <i>in vacuo</i>. The residue was dissolved in DCM (10&nbsp;mL) at rt. NEt<sub>3</sub> (0.49&nbsp;mL, 3.50&nbsp;mmol) and ethyl chloroformate (0.22&nbsp;mL, 2.33&nbsp;mmol) were added and the reaction mixture was stirred at rt overnight under nitrogen. The solvents were removed <i>in vacuo</i>, and the residue was partitioned between DCM and sat. NaHCO<sub>3</sub> sol.), organic layer washed with sat. NaCI sol. and dried over MgSO<sub>4</sub>. The residue was purified by column chromatography (normal phase, [Biotage SNAP cartridge KP-sil 25 g, gradient 3% to 10% MeOH in DCM]) to give ethyl (S)-4-(4-((1-methylcyclobutyl)carbamoyl)piperidin-1-yl)azepane-1-carboxylate (166&nbsp;mg, 39%) as a yellow gum. 1H NMR: (400MHz, DMSO-d6) d: 1.13 (td, J&nbsp;= 7.1, 2.3, 3H), 1.28 (s, 3H), 1.29 - 1.60 (m,7H), 1.60 - 1.87 (m, 7H), 1.90 – 1.99 (m, 1H), 2.02 – 2.24 (m, 4H), 2.32-2.40 (m, 1H), 2.65 – 2.73 (m, 2H), 3.06 – 3.22 (m, 2H), 3.35 – 3.48 (m, 2H), 3.98 (qd, J&nbsp;= 7.0, 2.7, 2H), 7.68 (br.s, 1H). LCMS (<b>Method B</b>): m/z 366 (M+H)<sup>+</sup> (ES<sup>+</sup>), at 3.28&nbsp;min, UV inactive.</div></section><section id="sec-4-4-10"><h4>Summary of synthesis of HTL9936</h4><div id="p0485" role="paragraph"><div class="figure-wrap"><figure id="undfig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.11.001/asset/043ac9b6-ef29-4c72-afc7-e5a778b2289b/main.assets/fx2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx2" alt="Figure undfig2" src="/cms/10.1016/j.cell.2021.11.001/asset/9145535a-f7b1-44ef-8293-c9a05e8742d2/main.assets/fx2.jpg" height="487" width="659" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/043ac9b6-ef29-4c72-afc7-e5a778b2289b/main.assets/fx2_lrg.jpg" loading="lazy"></a><div><button class="figure__open__ctrl">Figure viewer</button></div></figure></div></div></section><section id="sec-4-4-11"><h4>IP1 accumulation assay performed on CHO-FlpIn cells expressing the M1-receptor</h4><div id="p0490" role="paragraph">CHO-FlpIn cells stably expressing human M1-WT were grown to confluence in T75cm<sup>2</sup> flasks in Ham’s F-12 media containing 10% fetal bovine serum and 1% penicillin/streptomycin and under hygromycin B selection (400&nbsp;μg/mL). Cells were harvested and centrifuged at 1000 <i>x</i>g for 3&nbsp;min prior to resuspension in 1X stimulation buffer ((in mM): HEPEs, 10; CaCl<sub>2</sub>, 1; MgCl<sub>2</sub>, 0.5; KCl, 4.2; NaCl, 146; glucose, 5.5; LiCl, 50; pH7.4) at 1.43&nbsp;× 10<sup>6</sup> cells/mL. Test compounds (7&nbsp;μl/well) and cell suspension (7&nbsp;μl/well) were added to 384-well white proxiplates (PerkinElmer). Following a brief centrifugation, plates were incubated at 37°C for 45&nbsp;min. The IP1-d2 conjugate and the anti-IP1 cryptate Tb conjugate (IP-One Tb assay kit, CisBio) were diluted 1:30 in lysis buffer and 3&nbsp;μL of each were added to each well. The plate was incubated at 37°C for 1h and FRET between d2-conjugated IP1 (emission at 665&nbsp;nm) and Lumi4-Tb cryptate conjugated anti-IP1 antibody (emission at 620&nbsp;nm) was detected using an Envision plate reader (PerkinElmer). Results were calculated from the 665/620&nbsp;nm ratio and normalized to the maximum response stimulated by ACh.</div></section><section id="sec-4-4-12"><h4>IP1 accumulation assay performed on HEK293T cells expressing the M1-receptor</h4><div id="p0495" role="paragraph">HEK293T cells transiently transfected with a plasmid encoding the human M1 receptor were plated in poly-D-lysine coated 96-well plates at cell density of 40,000 cells/well. After 24h in culture, the plates were washed and incubated in Hank’s Balanced Salt Solution supplemented with 20mM HEPES (HBSS) for 30&nbsp;min. The HBSS was then replaced with assay buffer containing HBSS supplemented with 30mM LiCl and test compounds were added. Plates were then incubated at 37°C for one hour. The assay buffer was removed, and cells were lysed through the addition of 40&nbsp;μl/well of IP-One Assay Kit lysis buffer (CisBio) followed by a 10&nbsp;min shaking incubation at room temperature. The resulting lysates were assayed for IP-One using an HTRF IP-1 assay kit (CisBio) according to the manufacturer’s instructions. TRF emissions (665&nbsp;nm and 620&nbsp;nm) were measured using a Pherastar FS microplate reader (BMG Labtech).</div></section><section id="sec-4-4-13"><h4>[<sup>3</sup>H]-NMS binding to the M1-receptor</h4><div id="p0500" role="paragraph"><i>Competition binding:</i> Membranes (5&nbsp;μg/tube) prepared from CHO-FlpIn cells expressing the M1-receptor were incubated with an approximate K<sub>D</sub> concentration of [<sup>3</sup>H]-NMS (0.3&nbsp;nM) and increasing concentrations of HTL9936 (0.1&nbsp;nM to 300&nbsp;μM) for 1 hour at 37°C in binding buffer containing 100&nbsp;mM NaCl, 10&nbsp;mM MgCl<sub>2</sub>, and 20&nbsp;mM HEPES, pH 7.4. Non-specific binding (NSB) was determined in the presence of 1&nbsp;μM atropine). Reactions were terminated by rapid filtration onto GF/B filter paper (Whatman, Maidstone, UK) and three washes with 3&nbsp;mL ice-cold 0.9% NaCl using a Brandel harvester (M-24TI; Brandel, Fort Lauderdale, FL). Membrane bound radioactivity was determined by liquid scintillation (Ultima Gold; PerkinElmer) counting.</div><div id="p0505" role="paragraph"><i>Kinetic binding:</i> For determination of [<sup>3</sup>H]-NMS dissociation kinetics, membranes (5&nbsp;μg/tube) expressing the M1-receptor were pre-incubated with [<sup>3</sup>H]-NMS for 1 hour at 37°C in binding buffer containing 100&nbsp;mM NaCl, 10&nbsp;mM MgCl<sub>2</sub>, and 20&nbsp;mM HEPES, pH 7.4. Dissociation of the bound radioligand was initiated by the addition of atropine (10&nbsp;μM) alone or atropine (10&nbsp;μM) plus 100&nbsp;μM HTL-9936 added in a reverse time course protocol. Reactions were terminated by rapid filtration onto GF/B filter paper (Whatman, Maidstone, UK) and three washes with 3&nbsp;mL ice-cold 0.9% NaCl using a Brandel harvester (M-24TI; Brandel, Fort Lauderdale, FL). Membrane bound radioactivity was determined by liquid scintillation (UltimaGold; PerkinElmer) counting.</div></section><section id="sec-4-4-14"><h4>pERK1/2 assay on CHO-K1 cells expressing muscarinic receptors</h4><div id="p0510" role="paragraph">Functional assays were performed using the Alphascreen Surefire phopho-ERK1/2 assay. CHO-K1 cells stably expressing the human muscarinic M1, M2, M3, or M4 receptor or M1/M4 W101A γ12.1 StaR were plated (25K/well) onto 96-well tissue culture plates in MEM-alpha&nbsp;+ 10% dialysed FBS. Once adhered, cells were serum starved overnight. Agonist stimulation was performed by the addition of 5&nbsp;μl agonist to the cells for a pre-optimized 5&nbsp;min period (37°C). Media was removed and 50&nbsp;μl of lysis buffer added. After 15&nbsp;min a 4&nbsp;μl sample was transferred to a 384-well plate and 7&nbsp;μl of detection mixture added. Plates were incubated for 2&nbsp;h with gentle agitation in the dark and then read on a PHERAstar plate reader. pEC<sub>50</sub> and %E<sub>max</sub> values were estimated from the resulting data for each receptor subtype using GraphPad Prism.</div></section><section id="sec-4-4-15"><h4>pERK assay on CHO-K1 cells expressing muscarinic receptors</h4><div id="p0515" role="paragraph">HEK293T cells transiently transfected with a plasmid encoding the human M1 receptor were plated in poly-D lysine coated 96-well plates at a density of 40,000 cells/well. After 48&nbsp;h in culture, stimulation of ERK protein phosphorylation at Thr202/Tyr204 was assessed using a homogeneous time resolved FRET (HTRF) Phospho-ERK (Thr202/Tyr204) detection kit (Cisbio). Confluent monolayers of the cells were serum-starved for 7 hours before the experiment. The cells were washed in 200&nbsp;μL PBS and then incubated in serum-free DMEM medium at 37°C. Cells were stimulated with acetylcholine or HTL 936 for 5&nbsp;min at 37°C. The stimulations were terminated by aspiration of the test compounds and the addition of 50&nbsp;μL lysis buffer supplemented with blocking reagent. Lysates were gently agitated (600&nbsp;rpm) at room temperature for 10&nbsp;min. Subsequently, 16&nbsp;μL of lysate was transferred to a 384-well white ProxiPlate (PerkinElmer) and incubated with 4&nbsp;μL premixed antibody solution (anti-phospho-ERK1/2 Cryptate and anti-phospho-ERK1/2) for 2 hours at room temperature with agitation at 700&nbsp;rpm. Time resolved fluorescence emission (665&nbsp;nm and 620&nbsp;nm) was determined using a CLARIOstar microplate reader (BMG Labtech).</div></section><section id="sec-4-4-16"><h4>Arrestin interaction assay with the M1-receptor</h4><div id="p0520" role="paragraph">To assess arrestin recruitment to M1-receptor a bystander BRET assay was employed (<span class="dropBlock reference-citations"><a id="body-ref-sref61-1" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-1" aria-controls="sref61-1">Namkung et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref61-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Namkung, Y. ∙ Le Gouill, C. ∙ Lukashova, V. ...</div><div><strong>Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:12178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms12178" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84978431584" target="_blank" aria-label="Open Scopus in new tab">Scopus (200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27397672/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms12178&amp;pmid=27397672" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). HEK293T cells were co-transfected with plasmids encoding: 1. human β-Arrestin-2 fused at its N terminus to Nanoluciferase (Nluc); 2. the mNeonGreen (mNG) fluorescent protein fused at its C terminus with the prenylation CAAX sequence of KRas; and 3. a plasmid encoding human M1. For these transfections a DNA weight ratio of 1:25:5 was used for the Nluc-β-Arrestin-2: mNG-CAAX: M1-WT plasmids. After transfection, cells were cultured 24h before 20,000 cells/well were transferred to white poly-D-lysine coated 96-well plates and cultured a further 24h. For the assay, the white 96-well plates were washed twice with HBSS and incubated for 30&nbsp;min at 37°C. Nluc substrate, Coelenterazine 400a, was then added to a final concentration of 5&nbsp;μM and incubated for 15&nbsp;min. Dual 535 and 475&nbsp;nm luminescent emission measurements were then taken at 1.5&nbsp;min intervals using a PherStar FS plate reader (BMG labtech) for 6&nbsp;min prior to and 30&nbsp;min following the addition of the indicated test compounds. Net BRET responses were calculated as the 535/475 ratio after correcting for both the well baseline and test compound vehicle (0.1% DMSO) response. BRET data were then reported as the area under the Net BRET curve for the 30&nbsp;min following test compound addition, with responses for each experiment normalized to the maximal response to Ach in that experiment.</div></section><section id="sec-4-4-17"><h4>Determination of the internalisation of the M1-receptor</h4><div id="p0525" role="paragraph">Internalization of the M1-receptor was assessed using a bystander BRET assay designed to measure the translocation of M1 receptor to early endosomes (<span class="dropBlock reference-citations"><a id="body-ref-sref61-2" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-2" aria-controls="sref61-2">Namkung et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref61-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Namkung, Y. ∙ Le Gouill, C. ∙ Lukashova, V. ...</div><div><strong>Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:12178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms12178" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84978431584" target="_blank" aria-label="Open Scopus in new tab">Scopus (200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27397672/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms12178&amp;pmid=27397672" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). HEK293T cells were co-transfected with: 1. a plasmid encoding human M1 fused at its C-terminal to Nluc; and 2. a plasmid encoding mNG fused at its C-terminal to the FYVE domain of endofin. A DNA weight transfection ratio of 1:2 was used for Nluc tagged M1 receptor to mNG-FYVE. 24&nbsp;h after transfection, 50,000 cells/well were transferred to white 96-well plates and cultured a further 24&nbsp;h prior to the assay. Plates were then washed with HBSS, before incubating in HBSS for 30&nbsp;min at 37°C. Coelenterazine 400a was added to a final concentration of 5&nbsp;μM and plates incubated a further 15&nbsp;min. BRET measurements were taken using a PherStar FS plate reader, measuring luminescent emission at 535 and 475&nbsp;nm at 2&nbsp;min intervals for 6&nbsp;min prior to addition of test compounds, and a further 1&nbsp;h after addition of test compounds. Net BRET responses were calculated as the 535/475 ratio after correcting for both the well baseline and test compound vehicle response. BRET data were then measured as the area under the Net BRET curve for the 60&nbsp;min following test compound addition, which was then normalized to the maximal response to Ach in each assay.</div></section><section id="sec-4-4-18"><h4>Activation of G-proteins G<sub>q</sub>/G<sub>11</sub>/G<sub>15</sub></h4><div id="p0530" role="paragraph">Direct activation of members of the Gq/11 family by M1-receptor was assessed using the ‘TruPath’ BRET G protein biosensors (<span class="dropBlock reference-citations"><a id="body-ref-sref63-1" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-1" aria-controls="sref63-1">Olsen et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref63-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Olsen, R.H.J. ∙ DiBerto, J.F. ∙ English, J.G. ...</div><div><strong>TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:841-849</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-020-0535-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85085073530" target="_blank" aria-label="Open Scopus in new tab">Scopus (274)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32367019/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-020-0535-8&amp;pmid=32367019" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)Cells were transfected with a 1:1:1:1 ratio of plasmids encoding: 1. human M1, 2. Gq, G11, or G15 with an internal Rluc2 tag as described in (<span class="dropBlock reference-citations"><a id="body-ref-sref63-2" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63-2" aria-controls="sref63-2">Olsen et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref63-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Olsen, R.H.J. ∙ DiBerto, J.F. ∙ English, J.G. ...</div><div><strong>TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:841-849</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-020-0535-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85085073530" target="_blank" aria-label="Open Scopus in new tab">Scopus (274)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32367019/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-020-0535-8&amp;pmid=32367019" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). 3. Gγ9 (for Gq studies) or Gγ13 (for G11 and G15 studies), and 4. Gβ3. 24&nbsp;h after transfection cells were transferred to poly-D-lysine coated white 96 well plates and cultured a further 24h prior to the assay. Cells were then washed and incubated in HBSS for 30&nbsp;min. Coelenterazine 400a was added to a final concentration of 5&nbsp;μM and test compounds were added to the plate. Four minutes later bioluminescent emissions at 485-90nm and 525-90nm were measured using a CLARIOstar microplate reader (BMG Labtech). The BRET ratio of 525/485 emission was taken and responses were expressed as a percentages of the maximal BRET response obtained to Ach.</div></section><section id="sec-4-4-19"><h4>GTPγS assay to establish G protein activation by the M1-receptor</h4><div id="p0535" role="paragraph">Wild-type or M1-KO mice (<span class="dropBlock reference-citations"><a id="body-ref-sref12-4" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-4" aria-controls="sref12-4">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (8-12&nbsp;weeks) were humanely killed and cortical tissue was dissected on ice. Tissue was suspended in ice-cold buffer A (containing 0.9% (w/v) NaCl, 10&nbsp;mM HEPES, 0.2% (w/v) EDTA, pH 7.4) and homogenized (4&nbsp;× 5&nbsp;s bursts) using a Polytron homogenizer. The suspension was centrifuged at 200 xg for 5&nbsp;min at 4°C using an Eppendorf 5810R bench-top centrifuge. Supernatants were collected and re-homogenized as above. The suspension was subsequently centrifuged for 20&nbsp;min at 40,000 xg at 4°C using a Beckman Coulter Avanti JXN-26 centrifuge with a JA-25.25 rotor. Supernatant was discarded, and the pellet was re-suspended in 10&nbsp;mL ice-cold buffer B (10&nbsp;mM HEPES, 10&nbsp;mM EDTA, pH 7.4). The pellet was homogenized, GTP (1&nbsp;mM final) was added and the suspension was incubated at 37°C for 15&nbsp;min. The suspension was subsequently centrifuged for 20&nbsp;min at 40,000 xg at 4°C and the pellet was re- suspended in 15&nbsp;mL ice-cold buffer C (10&nbsp;mM HEPES, 0.1&nbsp;mM EDTA, pH 7.4) and re-homogenized as before. Suspension was centrifuged again for 20&nbsp;min at 40,000 xg at 4°C. The final pellet was re-suspended in buffer C and protein concentration was estimated using a Bradford assay and this resuspended homogenate further diluted in buffer C to produce a concentration of 2&nbsp;mg/mL. This preparation is the membrane preparation used in the [<sup>35</sup>S]-GTPγS binding assay described below.</div><div id="p0540" role="paragraph">[<sup>35</sup>S]-GTPγS binding and immunoprecipitation of Gα subunits was performed as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref12-5" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-5" aria-controls="sref12-5">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Specifically, wild-type or M1-KO membranes were diluted in assay buffer (in mM: HEPES, 10; NaCI, 100; MgCl2, 10; pH 7.4) containing a final concentration of 1&nbsp;μM GDP. Membranes (75&nbsp;μg in a total assay volume of 200&nbsp;mL) were added to [<sup>35</sup>S]-GTPγS (1&nbsp;nM final concentration) and agonists (CCh or CNO) and incubated at 30°C for 5&nbsp;min. Reactions were terminated by the addition of 1&nbsp;mL ice-cold assay buffer and immediate transfer to an ice bath. Samples were centrifuged (20,000 xg, 6&nbsp;min, 4°C) and membrane pellets solubilised by the addition of 50&nbsp;μL ice-cold solubilisation buffer (100&nbsp;mM Tris HCI, 200&nbsp;mM NaCI, 1&nbsp;mM EDTA, 1.25% Igepal and 0.2% SDS, pH 7.4) and incubation for 1&nbsp;h at 4°C on a shaking platform. Following complete protein re- solubilisation, 50&nbsp;μL of solubilisation buffer without SDS was added. Solubilised protein was pre-cleared using normal rabbit serum at a dilution of 1:100 and 3% (w/v) protein A-Sepharose beads in TE buffer (10&nbsp;mM Tris HCI, 10&nbsp;mM EDTA, pH 8.0) added for 60&nbsp;min at 4°C. Protein A- Sepharose beads and insoluble material were collected by centrifugation (20,000 xg, 6&nbsp;min, 4°C) and 100&nbsp;μL of the supernatant was transferred to fresh tubes containing Gq-specific anti-serum (Santa Cruz; sc393) and incubated overnight at 4°C. Protein A-Sepharose beads were added to samples, vortex mixed and rotated at 4°C for 90&nbsp;min before being centrifuged (10,000 xg, 1&nbsp;min, 4°C). Supernatants were aspirated and the protein A- Sepharose beads washed three times with ice-cold solubilisation buffer (without SDS). Recovered beads were then mixed with 1&nbsp;mL FloScint-IV scintillation cocktail and counted by liquid scintillation spectrometry.</div></section><section id="sec-4-4-20"><h4>Pharmacokinetic analyses of HTL9936 in animals undergoing fear conditioning</h4><div id="p0545" role="paragraph">Compounds were administered via intraperitoneal injection (in 5% glucose) 30&nbsp;min prior to blood collection. Mice were anesthetized with 3% isoflurane (2 L/min), and blood was collected by cardiac puncture of the left ventricle. Blood was immediately transferred to EDTA tubes and centrifuged at 1000&nbsp;g for 10&nbsp;min at 4°C; the supernatant was collected and frozen. Brains from each mouse were also dissected and snap-frozen on dry ice.</div><div id="p0550" role="paragraph">Brain samples were homogenized in three volumes of methanol/water [1:4 (v/v)] by weight. A 25&nbsp;mL aliquot of each study sample, calibration standard, and control sample was added to a 96-well plate and mixed with 180&nbsp;mL acetonitrile/methanol [1:1 (v/v)] containing internal standard. The samples were subsequently centrifuged, and the resulting supernatants were diluted 12.5-fold with methanol/water [1:1 (v/v)] prior to analyzing 10μl aliquots by liquid chromatography–tandem mass spectrometry as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref12-6" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-6" aria-controls="sref12-6">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-21"><h4>Novel object recognition behavioral test</h4><div id="p0555" role="paragraph">Male adult Wistar rats (Harlan, UK; approximately 11&nbsp;weeks of age) were handled for two days prior to the experiment. Rats were administered vehicle (acidified saline) or HTL9936 (3, 10 or 30&nbsp;mg/kg) by oral gavage 90&nbsp;min prior to training. Donepezil (0.1&nbsp;mg/kg) and galanthamine (3&nbsp;mg/kg) were administered via intraperitoneal injection (in saline) 60&nbsp;min prior to training. Following a 10-min habituation period, each rat was placed into the test arena comprising an open-field arena in the presence of two identical plastic shapes and allowed to explore for 5&nbsp;min. The rat was then returned to its home cage. After 24 hours, the rat was returned to the test arena in the presence of one familiar object, and one novel object. The time exploring each object was recorded using image analysis software (Ethovision XT, Noldus, UK).</div></section><section id="sec-4-4-22"><h4>Passive avoidance test behavioral test</h4><div id="p0560" role="paragraph">Male adult Wistar rats (Harlan, UK; approximately 11&nbsp;weeks of age) were acclimatised to the experimental rooms for three days (study days 1-3) and handled for a further two days (study days 4 and 5) prior to the experiment.</div><div id="p0565" role="paragraph">On study day 6, rats were administered vehicle (acidified saline) or HTL9936 (3, 10 or 30&nbsp;mg/kg) by oral gavage 90&nbsp;min prior to training. Donepezil (0.01 and 0.1&nbsp;mg/kg) was administered via intraperitoneal injection (in saline) 60&nbsp;min prior to training. Rats were trained in a single-trial, step-through, light-dark passive avoidance paradigm. The training apparatus consisted of a chamber 300&nbsp;mm in length, 260&nbsp;mm wide, and 270&nbsp;mm in height. The front and top were transparent, allowing the experimenter to observe the behavior of the animal inside the apparatus. The chamber was divided into two compartments, separated by a central shutter that contained a small opening (50&nbsp;mm wide and 75&nbsp;mm high) set close to the front of the chamber. The smaller of the compartments measured 90&nbsp;mm in width and contained a low-light (∼200 lux) illumination source. The larger compartment measured 210&nbsp;mm in width and was not illuminated. The floor of this dark compartment consisted of a grid of 16 horizontal stainless-steel bars that were 5&nbsp;mm in diameter and spaced 12.5&nbsp;mm apart. A current generator supplied 0.75 mA to the grid floor, which was scrambled once every 0.5&nbsp;s across the 16 bars.</div><div id="p0570" role="paragraph">Animals were placed facing the rear of the light compartment of the apparatus, immediately after which, spontaneous behavior was assessed. The timer was started once the animal completely turned to face the front of the chamber. Latency to enter the dark chamber was recorded, and having completely entered the dark compartment foot shock was administered to the animal, which immediately returned to the light compartment. Animals were then returned to their home cages. Between each training session, both compartments of the chamber were cleaned to remove any confounding olfactory cues. Vehicle (saline) or scopolamine (1&nbsp;mg/kg) was administered to rats 6 hours after training. Recall of the inhibitory stimulus was evaluated 24 hour post-training on study day 7, by returning the animal into the light chamber and recording their latency to enter the dark chamber, a criterion time of 600&nbsp;s was employed. Observation of the animals was made by overhead video camera linked to a monitor behind a screened area. Animal treatment was blinded to the observer.</div></section><section id="sec-4-4-23"><h4>Open field behavior behavioral test</h4><div id="p0575" role="paragraph">During the rat passive avoidance testing, open field exploratory behavior was measured on study days 4 and 5 (acclimatisation and handling), 6 (training) and 7 (recall). The open field apparatus consisted of black-painted Perspex 620&nbsp;mm<sup>2</sup> with walls 300&nbsp;mm high. Locomotor activity, measured as the distance traveled in a 300&nbsp;s period, as well as incidences of rearing and grooming were recorded, using Ethovision XT tracking software (Noldus UK).</div></section><section id="sec-4-4-24"><h4>Fear conditioning behavioral test</h4><div id="p0580" role="paragraph">C57BL/6J male mice (aged 8–12&nbsp;weeks) were acclimatized to the behavioral testing suite at least 2 hours prior to the test. Mice were injected (intraperitoneally) with vehicle (5% glucose) or scopolamine (1.5&nbsp;mg/kg, (i.p.)) alone or in combination with HTL9936 or donepezil at the doses indicated (i.p.) HTL9936 30&nbsp;min prior to training. Mice were placed in the conditioning chamber (ANY-maze Fear Conditioning System; Stoelting, Dublin, Ireland); after a 2-min adaptation period, they received three tone/foot shock pairings where the foot shock (un- conditioned stimulus; 2 s; 0.4 mA) always co-terminated with a tone (conditioned stimulus; 2.8 kH; 85 dB; 30 s). The conditioned stimulus–unconditioned stimulus pairings were separated by 1-min intervals. After the mice completed training, they remained in the conditioning chamber for 1&nbsp;min and were then returned to their home cages. The next day, the mice were placed back in the conditioning chamber, and time spent immobile was recorded for 3&nbsp;min to assess context-dependent learning. Data were analyzed using ANY-maze software (Stoelting).</div></section><section id="sec-4-4-25"><h4>Prion-infection of mice</h4><div id="p0585" role="paragraph">Tg37 hemizygous mice were inoculated by intracerebral injection into the right parietal lobe with 1% brain homogenate of RML prions aged 3 to 4&nbsp;weeks as described previously (<span class="dropBlock reference-citations"><a id="body-ref-sref12-7" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12-7" aria-controls="sref12-7">Bradley et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12-7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Control mice received 1% normal brain homogenate (NBH).</div></section><section id="sec-4-4-26"><h4>Delayed non-matching to position task (DNMP)</h4><div id="p0590" role="paragraph">The effects of HTL9936 on performance in a delayed non-matching to position (DNMP) task was conducted in aged Beagle dogs (aged &gt; 8 years of age). Animals were acclimatised in the testing facility for at least 3&nbsp;months. During baseline days (days −12 to −8), 50 dogs underwent DNMP testing once daily using delays of 20 and 90&nbsp;s equally dispersed over 12 trials per session. Mean performance over these 5 sessions was used to select 40 subjects that demonstrated both consistent responses and low levels of performance accuracy for subsequent testing.</div><div id="p0595" role="paragraph">These 40 subjects were tested on the DNMP using delays of 5, 55 and 105&nbsp;s equally dispersed over 18 trials per session over five once-daily sessions (days −6 to −2). Therefore, baseline testing was conducted for a total of 10&nbsp;days.</div><div id="p0600" role="paragraph">These dogs were then allocated into 5 groups, balanced for mean baseline performance accuracy at the longest delays (n&nbsp;= 8 per group). Treatment groups were vehicle (20% PEG400 in saline; s.c.), HTL9936 (0.3, 1 and 2&nbsp;mg/kg; s.c.) or donepezil (1.5&nbsp;mg/kg; p.o.; saline). Daily treatment administration began on day 0, and dogs were tested once daily on the DNMP at the same delays employed at baseline for a minimum of 10&nbsp;days. Each test consisted of two phases; in phase one, the dog is presented with an object over one of the three food wells. After the dog moves the object and obtains the food reward beneath, the tray is removed from the dog’s sight and the delay is initiated. The second phase occurs after the delay and consists of presenting the dog with two identical objects to that used in the first phase. One is in the same position as the first phase and the other covers a food reward in one of the two remaining food wells.</div></section><section id="sec-4-4-27"><h4>Quantitative EEG (qEEG) resting state in macaques</h4><div id="p0605" role="paragraph">6 adult male Cynomolgus macaques (Macaca fasicularis; 8-10&nbsp;kg; 12-15 years old) were used for EEG studies. These animals had been used previously on other studies and were not considered to be pharmacologically naive. Subjects were housed in a temperature-controlled recording room and are maintained on a 12-hour light/dark cycle. The animals had access to water <i>ad libitum</i> and were fed a full daily regimen of food each day (Purina Animal Nutrition, Gray Summit, MO) enriched with fresh fruit and/or vegetables. All studies are conducted in compliance with USDA, NIH and SRI International IACUC guidelines. SRI International is an AAALAC accredited institution. Animals were instrumented with an intra-abdominal telemetric EEG device (D70-EEE; DSI, St. Paul, MN) containing three biopotentials implanted in fully anesthetized animals by trained surgeons using a stereotactic frame over the left frontal cortex (Fp2; AP:+18.0mm ML:-15.0mm), central midline (Cz; AP:0.0mm ML:0.0mm) and posterior (P3; AP:-18.0mm ML:-16.0mm) locations and referenced to the occipital midline (Oz). On the day of dosing, animals were acclimatised in the recording chambers for approximately 5-10&nbsp;min. Following the acclimation period, animals were dosed subcutaneously with vehicle or compound and EEG activity was recorded for 120&nbsp;min. All EEG recordings were acquired at 2 kHz in DataQuest ART (Version 4.3) software (DSI, St Paul, MN).</div></section><section id="sec-4-4-28"><h4>Rat cardiovascular study of the effects of HTL9936 administration</h4><div id="p0610" role="paragraph">HTL9936 or vehicle were administered by gavage (4mL/kg) at time&nbsp;= 0. Summary profiles were generated representing the mean of HTL9936 across 4-6 animals at 3, 10, 30 and 100&nbsp;mg/kg on heart rate and mean arterial blood pressure. Arterial blood pressure and heart rate (determined from the pulsed blood pressure signal) were continuously measured 60&nbsp;min before administration of HTL9936 or vehicle. At each time point the results were averaged over the preceding 5&nbsp;min period. We performed pharmacokinetic analysis on a subset of the same animals used for the cardiovascular assessment on completion of all cardiovascular assessments (Table SIb).</div></section><section id="sec-4-4-29"><h4>Dog intravenous infusion GLP cardiovascular study</h4><div id="p0615" role="paragraph">Animals were implanted with calibrated sensors (DSI D70 Series) for arterial blood pressure (ABP). The signals were processed by the Open Art/ PoNeMah data acquisition/analysis software. Vehicle and test article were administered by intravenous infusion over 2 hours, using a constant dose volume of 10&nbsp;mL/kg (5&nbsp;mL/kg/hr) and data was continuously recorded at logging rates of 1&nbsp;min. Two pre-dose readings of the heart rate, blood pressure (Diastolic, systolic and mean arterial pressure) and ECG intervals (PR-, QRS-, QT- and QTCF) were taken 15&nbsp;min apart before administration of each dose. Following the start of the infusion, of vehicle or test article, readings were taken from the line averages at 15, 30, 45, 60, 75, 90, 105 and 120&nbsp;min (i.e during the infusion), 150 and 180&nbsp;min (i.e., 0.5 and 1 hour post infusion in sling) (additional recordings were continued to 12hours post-dose). The plasma concentrations of HTL9936 was determined in these experiments (Table Sc). Time given as minutes after the end of a 2hr intravenous infusion where 0&nbsp;min indicates the end of the infusion period. Blood samples of approximately 2&nbsp;mL were taken from the jugular vein of each animal at the end of infusion and again at the end of the 1 hour post-infusion observation period in sling following administration of vehicle and HTL9936.</div></section><section id="sec-4-4-30"><h4>Clinical drug administration</h4><div id="p0620" role="paragraph">For the healthy human volunteer single and multiple ascending studies HTL9936 oral solution was administered in a 100mL dose volume in amber, Type III glass bottles.HTL9936 was dissolved (low dose) or dispersed (high dose) in water and the solution adjusted to pH 5.2 ± 0.25. For intravenous (IV) administration a sterile 10mg/mL solution of HTL9936 was generate in citrate buffer (pH range5.5 ± 1). The required amount of sterile solution was subsequently injected into the infusion bag containing sodium chloride 0.9%w/v infusion fluid to provide the required dose for IV administration.</div></section><section id="sec-4-4-31"><h4>Clinical EEG recordings</h4><div id="p0625" role="paragraph">Routine EEG was performed for all subjects during screening enrolled in the multiple ascending dose study to avoid enrolling subjects showing clinically significant abnormalities. 19-lead EEG recordings were employed for quantitative (qEEG) analyses. qEEGs were are recorded in resting state with alternating 30&nbsp;s eyes open and 30&nbsp;s eyes closed for 5&nbsp;min first and then about 5&nbsp;min eyes closed. The P50 protocol employed a series of “click pairs.” The interval between click pairs is at random between 6 to 10&nbsp;s (Stimuli S1 and S2, 1000&nbsp;Hz, duration 3&nbsp;ms, 80 dB sound pressure level [SPL], stimulus onset asynchrony [SOA]&nbsp;= 500&nbsp;ms, The MMN protocol used twelve different frequencies ranging in 50&nbsp;Hz steps from 700 to 1250&nbsp;Hz delivered binaurally via special headphones or earphones. All stimuli were presented with a constant SOA of 300&nbsp;ms in a pseudo-randomized order assuming a frequency deviation of one train to another of at least 100&nbsp;Hz with three different lengths/durations of series which occurred evenly. For the P300 active auditory oddball paradigm sinusoidal tones of 90 dB SPL intensity and 50&nbsp;ms duration were delivered binaurally in an inter-stimulus-interval of 1000&nbsp;msec. The standard stimulus, a low frequency tone (1000&nbsp;Hz) appeared with a frequency of 85%. The target stimulus (higher frequency tone of 2000&nbsp;Hz) with a frequency of 15% was presented in a pseudo-randomized manner and in a way that it was never repeated immediately. The participant was instructed to press a corresponding button as quickly as they can after they recognized the target stimulus (high tone).</div></section><section id="sec-4-4-32"><h4>Clinical functional MRI</h4><div id="p0630" role="paragraph">All functional MRI images were acquired on a 3T scanner using gradient echo- echo planar imaging (GRE-EPI: TR: 300ms; TE: 30&nbsp;ms; 90-degree flip angle; slices: 53; voxel size 3.75x 3.75&nbsp;mm) and an 8-channel head coil. All data processing was done using Statistical Parameteric Mapping (SPM) version 5 software. All functional images were co-registered to subjects own T1 weighted structural image for anatomical localization, realigned using a least-squares approach and a 6 parameter (rigid body) spatial translation, normalized to Montreal neurological institute (MNI) using a high dimensional, non-linear transformation and smoothed using 3D 7&nbsp;mm Gaussian filter. A high pass filter was applied to remove low temporal frequency drift. Bilateral hippocampal and caudate masks based on previous publications using the Arena task were used for analysis (<span class="dropBlock reference-citations"><a id="body-ref-sref2-2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2-2" aria-controls="sref2-2">Antonova et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref2-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Age-related neural activity during allocentric spatial memory</strong></div><div><em>Memory.</em> 2009; <strong>17</strong>:125-143</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/09658210802077348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-60549116899" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18608980/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F09658210802077348&amp;pmid=18608980" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>, <span class="dropBlock reference-citations"><a id="body-ref-sref3-2" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" aria-label="Reference 2011" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-2" aria-controls="sref3-2">2011</a><div class="dropBlock__holder" data-db-target-of="sref3-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze</strong></div><div><em>J.&nbsp;Psychopharmacol.</em> 2011; <strong>25</strong>:1256-1265</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/0269881110379285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-80054041085" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20823079/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F0269881110379285&amp;pmid=20823079" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The masks consisted of spheres of radius 6mm centered on co-ordinates from these papers.</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analyses</h3><section id="sec-4-5-1"><h4>Radioligand Binding</h4><div id="p0635" role="paragraph">Data was analyzed using PRISM (GraphPad). For saturation binding, non-specific and total binding data were analyzed to a one site binding model. DPM was converted to fmol/mg to compare across constructs. Inhibition binding curves between [<sup>3</sup>H] 77-LH-28-1 and test compound were fitted to a one-site binding model. The Cheng Prusoff equation was used to estimate pK<sub>i</sub> (<span class="dropBlock reference-citations"><a id="body-ref-sref18" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18" aria-controls="sref18">Cheng and Prusoff, 1973</a><div class="dropBlock__holder" data-db-target-of="sref18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Cheng, Y. ∙ Prusoff, W.H.</div><div><strong>Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction</strong></div><div><em>Biochem. Pharmacol.</em> 1973; <strong>22</strong>:3099-3108</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0006-2952(73)90196-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0015861774" target="_blank" aria-label="Open Scopus in new tab">Scopus (12845)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4202581/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0006-2952%2873%2990196-2&amp;pmid=4202581" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-5-2"><h4>Crystallography Data processing</h4><div id="p0640" role="paragraph">X-ray diffraction data were measured on a Pilatus 6M detector at beamline I24 (Diamond Light Source). Complete datasets for M1<sub>StaR</sub>-HTL9936 or for M1StaR-GSK1034702 were acquired using diffraction data from six different crystals each whereas data from four crystals were assembled for M1-StaR-77-LH-28-1. Data from individual crystals were integrated using <i>XDS (</i><span class="dropBlock reference-citations"><a id="body-ref-sref47-2" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47-2" aria-controls="sref47-2"><i>Kabsch, 2010</i></a><div class="dropBlock__holder" data-db-target-of="sref47-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Kabsch, W.</div><div><strong>Xds</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909047337" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-76449099287" target="_blank" aria-label="Open Scopus in new tab">Scopus (12940)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124692/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909047337&amp;pmid=20124692" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><i>)</i> or <i>MOSFLM (</i><span class="dropBlock reference-citations"><a id="body-ref-sref8-2" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-2" aria-controls="sref8-2"><i>Battye et&nbsp;al., 2011</i></a><div class="dropBlock__holder" data-db-target-of="sref8-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Battye, T.G. ∙ Kontogiannis, L. ∙ Johnson, O. ...</div><div><strong>iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2011; <strong>67</strong>:271-281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910048675" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79953759821" target="_blank" aria-label="Open Scopus in new tab">Scopus (2515)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21460445/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910048675&amp;pmid=21460445" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><i>)</i> combined using <i>POINTLESS</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref33" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33" aria-controls="sref33">EVANS, 2006</a><div class="dropBlock__holder" data-db-target-of="sref33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Evans, P.</div><div><strong>Scaling and assessment of data quality</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2006; <strong>62</strong>:72-82</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444905036693" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-33644875355" target="_blank" aria-label="Open Scopus in new tab">Scopus (4016)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16369096/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444905036693&amp;pmid=16369096" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) from the <i>CCP4 suite (</i><span class="dropBlock reference-citations"><a id="body-ref-sref82-2" href="#" role="doc-biblioref" data-xml-rid="bib82" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref82-2" aria-controls="sref82-2"><i>Winn et&nbsp;al., 2011</i></a><div class="dropBlock__holder" data-db-target-of="sref82-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">82.</div><div>Winn, M.D. ∙ Ballard, C.C. ∙ Cowtan, K.D. ...</div><div><strong>Overview of the CCP4 suite and current developments</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2011; <strong>67</strong>:235-242</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910045749" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79953737180" target="_blank" aria-label="Open Scopus in new tab">Scopus (10209)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21460441/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910045749&amp;pmid=21460441" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><i>)</i> and merged and scaled using <i>AIMLESS (</i><span class="dropBlock reference-citations"><a id="body-ref-sref34-2" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-2" aria-controls="sref34-2"><i>Evans and Murshudov, 2013</i></a><div class="dropBlock__holder" data-db-target-of="sref34-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Evans, P.R. ∙ Murshudov, G.N.</div><div><strong>How good are my data and what is the resolution?</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2013; <strong>69</strong>:1204-1214</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444913000061" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84879367781" target="_blank" aria-label="Open Scopus in new tab">Scopus (3299)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23793146/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444913000061&amp;pmid=23793146" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><i>)</i> and the <i>STARANISO</i> procedure. Data collection statistics are reported in Table S2.</div></section><section id="sec-4-5-3"><h4>Structure solution and refinement</h4><div id="p0645" role="paragraph">The structures of the M1-StaR-T4L-ligand complexes were solved by molecular replacement (MR) with <i>Phaser</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref57-2" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-2" aria-controls="sref57-2">McCoy et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref57-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>McCoy, A.J. ∙ Grosse-Kunstleve, R.W. ∙ Adams, P.D. ...</div><div><strong>Phaser crystallographic software</strong></div><div><em>J.&nbsp;Appl. Cryst.</em> 2007; <strong>40</strong>:658-674</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0021889807021206" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-34447508216" target="_blank" aria-label="Open Scopus in new tab">Scopus (16093)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19461840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0021889807021206&amp;pmid=19461840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) using the structure of Turkey Beta1 adrenergic receptor in complex with Dobutamine (<span class="dropBlock reference-citations"><a id="body-ref-sref81" href="#" role="doc-biblioref" data-xml-rid="bib81" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref81" aria-controls="sref81">Warne et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref81"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">81.</div><div>Warne, T. ∙ Moukhametzianov, R. ∙ Baker, J.G. ...</div><div><strong>The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor</strong></div><div><em>Nature.</em> 2011; <strong>469</strong>:241-244</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature09746" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-78651405537" target="_blank" aria-label="Open Scopus in new tab">Scopus (548)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21228877/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature09746&amp;pmid=21228877" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) as the search model (PDB code: <a id="intref0135" href="http://firstglance.jmol.org/fg.htm?mol2Y00" target="_blank">2Y00</a>). Iterative rounds of model refinement performed using <i>BUSTER</i>, were interspersed with manual model building in <i>COOT (</i><span class="dropBlock reference-citations"><a id="body-ref-sref31-2" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31-2" aria-controls="sref31-2"><i>Emsley et&nbsp;al., 2010</i></a><div class="dropBlock__holder" data-db-target-of="sref31-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><i>)</i>. 2 TLS groups corresponding to the receptor and to the T4-lysozyme respectively were defined during refinement. The final models were validated using <i>MolProbity</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref17-2" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17-2" aria-controls="sref17-2">Chen et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref17-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Chen, V.B. ∙ Arendall, 3rd, W.B. ∙ Headd, J.J. ...</div><div><strong>MolProbity: all-atom structure validation for macromolecular crystallography</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:12-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909042073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-74549178560" target="_blank" aria-label="Open Scopus in new tab">Scopus (11100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20057044/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909042073&amp;pmid=20057044" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The final refinement statistics are presented in Table S2. Structure figures were generated using <i>PyMOL</i>.</div></section><section id="sec-4-5-4"><h4>Molecular dynamics simulations</h4><div id="p0650" role="paragraph">Molecular dynamics (MD) simulations were run for M<sub>1</sub> in complex with tiotropium (PDB <a id="intref0140" href="http://firstglance.jmol.org/fg.htm?mol5XCV" target="_blank">5XCV</a>) (<span class="dropBlock reference-citations"><a id="body-ref-sref74-3" href="#" role="doc-biblioref" data-xml-rid="bib74" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref74-3" aria-controls="sref74-3">Thal et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref74-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">74.</div><div>Thal, D.M. ∙ Sun, B. ∙ Feng, D. ...</div><div><strong>Crystal structures of the M1 and M4 muscarinic acetylcholine receptors</strong></div><div><em>Nature.</em> 2016; <strong>531</strong>:335-340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature17188" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84982308386" target="_blank" aria-label="Open Scopus in new tab">Scopus (261)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26958838/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature17188&amp;pmid=26958838" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), HTL9936, GSK1034702 or 77-LH-28-1. For M<sub>1</sub> in complex with tiotropium the cocrystallized FLAG peptide bound to the intracellular side of the receptor was included. Input PDB files were processed with Schrödinger Maestro’s Protein Preparation tool (2020-3) by adding hydrogen atoms, modeling missing side chains, and determining the most relevant protonation states of residues and ligands at pH 7.4. Fusion proteins inserted in the ICL3 of the constructs were removed and the long unstructured loop was truncated with a tetraglycine region between the Ballesteros-Weinstein positions 5.68-6.24, following similar approaches by Dror et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Dror et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Dror, R.O. ∙ Arlow, D.H. ∙ Borhani, D.W. ...</div><div><strong>Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2009; <strong>106</strong>:4689-4694</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0811065106" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-63849294621" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19258456/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0811065106&amp;pmid=19258456" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and Miszta et&nbsp;al. (<span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Miszta et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Miszta, P. ∙ Pasznik, P. ∙ Jakowiecki, J. ...</div><div><strong>GPCRM: a homology modeling web service with triple membrane-fitted quality assessment of GPCR models</strong></div><div><em>Nucleic Acids Res.</em> 2018; <strong>46</strong>:W387-W395</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gky429" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85050884398" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29788177/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgky429&amp;pmid=29788177" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The constructs were embedded in POPC phospholipids and solvated in TIP3P water and 150&nbsp;mM NaCl. The systems were parameterised using OPLS3e (<span class="dropBlock reference-citations"><a id="body-ref-sref68" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68" aria-controls="sref68">Roos et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref68"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Roos, K. ∙ Wu, C. ∙ Damm, W. ...</div><div><strong>OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules</strong></div><div><em>J.&nbsp;Chem. Theory Comput.</em> 2019; <strong>15</strong>:1863-1874</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jctc.8b01026" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85062820310" target="_blank" aria-label="Open Scopus in new tab">Scopus (711)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30768902/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jctc.8b01026&amp;pmid=30768902" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>)after optimization of the parameters of the ligands using Maestro’s Force Field Builder tool. Desmond 2020-3 was used for the&nbsp;MD simulations. Relaxation and equilibration to 300 K and 1&nbsp;bar were run using the standard protocol for membrane proteins. Production runs were performed for 100&nbsp;ns at 300 K and 1&nbsp;bar in the NPT ensemble. Temperature and pressure were controlled with Nose-Hoover chain thermostat (<span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Hoover, 1985</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Hoover, W.G.</div><div><strong>Canonical dynamics: Equilibrium phase-space distributions</strong></div><div><em>Phys Rev A Gen Physiol.</em> 1985; <strong>31</strong>:1695-1697</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1103/PhysRevA.31.1695" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0001538909" target="_blank" aria-label="Open Scopus in new tab">Scopus (18449)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9895674/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1103%2FPhysRevA.31.1695&amp;pmid=9895674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and the semiisotropic MTK barostat. The RESPA integrator was employed with timesteps of 2 fs, 2&nbsp;fs and 6&nbsp;fs for bonded, short-range nonbonded and long-range nonbonded interactions, respectively.</div></section><section id="sec-4-5-5"><h4>Extracellular cavity volume analysis</h4><div id="p0655" role="paragraph">The volume of the extracellular cavity of the proteins throughout the MD simulations was computed using Epock (<span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Laurent et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Laurent, B. ∙ Chavent, M. ∙ Cragnolini, T. ...</div><div><strong>Epock: rapid analysis of protein pocket dynamics</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:1478-1480</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu822" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84946174179" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25505095/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu822&amp;pmid=25505095" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) using the same cuboid box after alignment of the frames to a common reference.</div><section id="sec-4-5-5-1"><h5>Ligand Interaction Fingerprints</h5><div id="p0660" role="paragraph">Interactions between ligands and receptors over the MD simulations were calculated using Schrodinger’s Python API. Detected contacts were classified as either “polar” or “hydrophobic” and averaged over the MD simulations to obtain estimates of the occupancy of the interactions.</div></section></section><section id="sec-4-5-6"><h4>Bias factor calculations</h4><div id="p0665" role="paragraph">Bias factors were calculated by fitting an operation model (<span class="dropBlock reference-citations"><a id="body-ref-sref76" href="#" role="doc-biblioref" data-xml-rid="bib76" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref76" aria-controls="sref76">van der Westhuizen et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref76"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">76.</div><div>van der Westhuizen, E.T. ∙ Breton, B. ∙ Christopoulos, A. ...</div><div><strong>Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy</strong></div><div><em>Mol. Pharmacol.</em> 2014; <strong>85</strong>:492-509</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.113.088880" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84894090269" target="_blank" aria-label="Open Scopus in new tab">Scopus (193)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24366668/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.113.088880&amp;pmid=24366668" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) to all concentration response data in order to obtain τ/Κ<sub>Α</sub> values for ACh and HTL-9936 in each assay. Δτ/ΚΑ<sub>HTL-9936</sub> values were obtained by subtracting the τ/Κ<sub>Α</sub> obtained for Ach from the value for HTL-9936 in the same assay. ΔΔ τ/Κ<sub>Α</sub> values were obtained by calculating the difference between the Δ τ/ΚΑ<sub>HTL-9936</sub> in each assay.</div><section id="sec-4-5-6-1"><h5>Rat Cardiovascular Study</h5><div id="p0670" role="paragraph">At each time point the results were averaged over the preceding 5&nbsp;min period. For presentation only the 15min time points are presented Figure&nbsp;SIa,b and Table SIa. Data are expressed as mean ± SEM analyzed by repeated-measurement ANOVA and pairwise comparisons of each compound to vehicle by post hoc Dunnett’s test. Significant values are relative to the vehicle treatment only. Differences were considered to be significant by p&nbsp;&lt; 0.05 for 10&nbsp;mg/kg $, 30&nbsp;mg/kg <sup>∗</sup> and 100&nbsp;mg/kg&nbsp;+ respectively. Averaged time points over 0-300&nbsp;min time period presented as mean ± SEM analyzed by ANOVA and pairwise comparisons of each compound to vehicle by post hoc Dunnett’s test. Significant values are relative to the vehicle treatment only. a p&nbsp;&lt; 0.05, b p&nbsp;&lt; 0.01, c p&nbsp;&lt; 0.001.</div></section></section><section id="sec-4-5-7"><h4>Dog intravenous infusion GLP cardiovascular study</h4><div id="p0675" role="paragraph">For each variable, the mean of the pre-dose values recorded for each animal on each dose were taken as the baseline for that dose and that animal. Each time point was analyzed using ANOVA, fitting DOSE and ANIMAL as fixed effects with the baseline value as a covariate. Pairwise comparisons of each dose with control (Dose 1) were made using Dunnett’s test (Figure&nbsp;Sc,d).</div></section><section id="sec-4-5-8"><h4>Non-human primate qEEG measurments</h4><div id="p0680" role="paragraph">Data was analyzed using existing, customized MATLAB scripts with the EEGLAB toolbox. EEG traces were filtered using a finite impulse response windowed-sync filter with a Blackman window with the high-pass cutoff at 1Hz, with a 0.5Hz half amplitude transition band and the low-pass cutoff at 200Hz with a 10Hz transition band. Time frequency analysis was done by applying fast Fourier transform (FFT) was conducted on 4&nbsp;s periods filtered by a sliding Hanning window with a 92.75% overlap to calculate power with a 0.25Hz frequency resolution. For each frequency band, outliers were defined as the median ± eight times the median absolute deviation over the window of interest (i.e., 2, 5 or 10&nbsp;min), and removed from the subsequent analysis. Frequency bands were defined as follows: Delta: 1-4Hz, Theta: 4-8Hz, Alpha: 8-12Hz, Sigma: 12-16Hz, Beta: 16-24Hz, Low Gamma: 24-50Hz, High Gamma: 50-100Hz. Mean absolute power, log transformed absolute power, and relative power was calculated based on each frequency band’s contribution to the total absolute power (i.e., % power). The mean normalized power was subsequently calculated by dividing each frequency band’s absolute power in the drug condition with the corresponding power in the control condition for each individual animal (i.e., use each animal as its own control) and then average across subjects. Data was analyzed using a one-way repeated-measures ANOVA to identify treatment effects within a frequency band for all parameters followed by Fisher’s post hoc tests when applicable to identify individual differences and significance defined as p £ 0.05.</div></section><section id="sec-4-5-9"><h4>Clinical EEG measurements</h4><div id="p0685" role="paragraph">All EEG datasets were imported Into the Brainvision Analyzer software. The data was limited to the following 19 channels: Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4, T5, P3, Pz, P4, T6, O1 and O2. In addition, the vertical and horizontal EOG Channels (VEOG /HEOG) were retained for the purpose of ocular correction. Data was filtered with a band pass of 0.1 – 30&nbsp;Hz for the P300 paradigm. A slope of 12 dB/octave was applied. For the QEEG analysis a high pass filter with an edge frequency of 1&nbsp;Hz And 48 dB/octave was applied. The Gratton And Coles ocular correction algorithm was applied (<span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Gratton et&nbsp;al., 1983</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Gratton, G. ∙ Coles, M.G. ∙ Donchin, E.</div><div><strong>A new method for off-line removal of ocular artifact</strong></div><div><em>Electroencephalogr. Clin. Neurophysiol.</em> 1983; <strong>55</strong>:468-484</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2F0013-4694%2883%2990135-9&amp;cf=abstract" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2F0013-4694%2883%2990135-9&amp;cf=pdf" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0020583553" target="_blank" aria-label="Open Scopus in new tab">Scopus (4418)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/6187540/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0013-4694%2883%2990135-9&amp;pmid=6187540" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) that is available in the Analyzer Software VEOG and HEOG were used as reference channels and removed after ocular correction. The P300 data was segmented into epochs of 600&nbsp;ms duration including a pre-stimulus baseline of 100&nbsp;ms that was subtracted from each segment individually.</div><div id="p0690" role="paragraph">Statistical analysis was carried out in MATLAB. Because of the small sample sizes of the groups (N&nbsp;= 4 Placebo; N&nbsp;= 6 Cohort 1/low exposure; N&nbsp;= 6 Cohort 2/high exposure) only exploratory statistical analyses was carried out using paired t tests for within group comparisons and independent t tests for between group comparisons. Within groups, the baseline Day (Day 1) was compared against Day 4 and Day 9. This was done for pre- and post-dose measurements separately.</div></section><section id="sec-4-5-10"><h4>Clinical functional MRI</h4><div id="p0695" role="paragraph">A block design was used to assess functional activation during encoding, retrieval, and rest (control) conditions of the Arena task. Beta-estimates of functional response during each condition were created by modeling signal changes convolved with a double gamma hemodynamic response function with peak responses at 4 and 8&nbsp;s following stimulus onset for each individual. In the first level analysis, difference in beta estimates for encoding versus rest, and retrieval versus rest were derived. These images were used in a higher-level GLM analysis investigating treatment-group differences (placebo, 10.1&nbsp;mg HTL0016878, and 40.3&nbsp;mg HTL0016878) in functional activation during encoding and retrieval using study site as covariate. Treatment- group differences in functional response was considered significant if Z-values were greater than 3.2 with a small volume corrected cluster probably of p&nbsp;&lt; 0.05. Functional responses in the a-priori ROIs were extracted using hippocampal, ventral striatum, and caudate masks derived from subject own T1 weighted image. To test for drug effects in these pre-specified regions an ANOVA including fixed-effect terms representing treatment group, study site as a between subject factor, and baseline MMSE score as covariate was used.</div><div id="p0700" role="paragraph">Sample size was determined on the basis of previous studies which have either assessed the behavioral cognitive effects of M1 active compounds in humans (<span class="dropBlock reference-citations"><a id="body-ref-sref62-3" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62-3" aria-controls="sref62-3">Nathan et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref62-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Nathan, P.J. ∙ Watson, J. ∙ Lund, J. ...</div><div><strong>The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction</strong></div><div><em>Int J Neuropsychopharmacol.</em> 2013; <strong>16</strong>:721-731</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1017/S1461145712000752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84875697137" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22932339/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1017%2FS1461145712000752&amp;pmid=22932339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref73" href="#" role="doc-biblioref" data-xml-rid="bib73" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref73" aria-controls="sref73">Snyder et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref73"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">73.</div><div>Snyder, P.J. ∙ Bednar, M.M. ∙ Cromer, J.R. ...</div><div><strong>Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor</strong></div><div><em>Alzheimers Dement.</em> 2005; <strong>1</strong>:126-135</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jalz.2005.09.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-33644806571" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19595845/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jalz.2005.09.004&amp;pmid=19595845" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) or the effects of cholinergic compounds on BOLD signal (<span class="dropBlock reference-citations"><a id="body-ref-sref3-3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3-3" aria-controls="sref3-3">Antonova et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref3-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze</strong></div><div><em>J.&nbsp;Psychopharmacol.</em> 2011; <strong>25</strong>:1256-1265</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/0269881110379285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-80054041085" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20823079/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F0269881110379285&amp;pmid=20823079" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). These studies reported large effect sizes suggesting that setting the significance level to 0.05 (two tailed), 18 subjects would provide &gt; 90% power of identifying a similar effect.</div><div id="p0705" role="paragraph">Image data was converted from DICOM file format to NIfTI file format, an agreed standard format to facilitate transfer between different packages. Preprocessing was performed using the Statistical Parameteric Mapping (SPM) analyses package. Images were A representative realigned image was used to derive parameters for spatial normalization to a standard template (Montreal neurological institute (MNI)) using a higher dimensional, non-linear transformation. The realigned time-series and spatially normalized images were smoothed with an appropriate Gaussian kernel. High pass temporal filtering will be used. A slice timing correction procedure was used to account for variation in slice time</div></section></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0710" role="paragraph">We wish to acknowledge Andrew S. Doré for assistance with analysis of the crystallographic data, Alex Godwood for assistance with analysis of the efficacy data, and Geor Bakker for help with additional analysis of the fMRI and EEG data. This work is partially funded by a University of Glasgow Lord Kelvin Adam Smith Fellowship (S.J.B.); an MRC MICA, MR/P019366/1 (A.B.T., S.J.B.,); a Wellcome Trust Collaborative Award, 201529/Z/16/Z (A.B.T., A.C., P.M.S.); SULSA Dementia Seed Funding (A.B.T.). We acknowledge the BSU facilities at the Cancer Research UK Beatson Institute (C596/A17196) and the Biological Services at the University of Glasgow. We also thank Simon Brooke and Helen Sanger for conducting assays on the muscarinic receptor expressing cell lines.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0715" role="paragraph">A.J.H.B., G.A.B., M.S.C., R.M.C., A.J., C.J.L., F.H.M., T.T., B.G.T., M.W., and A.B.T. devised the program of work. A.B.T., A.J.H.B., and F.H.M. wrote the paper with assistance from all other authors. J.E.C., M.P., M.S.C., and G.A.B. devised and carried out the chemical syntheses. D.M.C., J.L., P.J.N., M.V., J.W., and T.T. developed and oversaw the clinical program. S.J.B. compiled and analyzed data, contributed to writing paper, and conducted prion mouse work and pharmacology. A.C. and P.M.S. contributed to mouse prion work and analysis of structural biology. L.M.B.; ligand synthesis, mouse pharmacokinetic studies. K.P., S.S., and L.M.B.; <i>in&nbsp;vivo</i> electrophysiology. C.B. and D.M.C.; pharmacokinetics. N.R., J.B., J.C.E., and J.C.P. devised and carried out the conformational thermostabilization and mutagenesis of the receptor, characterised expression constructs, and performed radioligand binding analysis of mutants. K.O. established protocols for expression, purification, mass spectrometry QC, and optimised protein concentration for LCP crystallization trials. Computational analysis of the structure and modeling was carried out by B.G.T. and R.T.S. J.F.W.D. and P.R. established the platform/protocols for LCP crystallization and solved the structure. K.A.B., J.B., E.H., and G.O. carried out and analyzed the <i>in&nbsp;vitro</i> pharmacology data. C.d.G. and G.M. conducted molecular dynamic analysis and contributed to structural biology analysis. B.D.H. and L.D. conducted biased ligand experiments. A.V.G. and S.R.M. developed and analyzed NHP EEG data. F.P., M.B., G.R.D., and J.F.W.D. supported development, oversight, and analysis of clinical fMRI study.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0720" role="paragraph">T.T. and M.W. are shareholders and board members of Sosei Heptares. The authors A.J.H.B., G.A.B., K.A.B., J.B., J.E.C., M.S.C., R.M.C., J.C.E., E.H., A.J., C.J.L., J.L., F.H.M., P.J.N., K.O., G.O., J.C.P., M.P., N.R., P.R., B.G.T., R.T.S., C.d.G., G.M., and B.T. are or have been employees of Heptares Therapeutics and are shareholders of Sosei Heptares.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental information (3)</h2><div id="p0730" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.11.001/attachment/ff1676b5-faf6-493e-ba51-d9c62155a185/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (241.86 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Document S1. Tables S1–S4</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.11.001/attachment/6c61c944-5e0d-4dfb-b5a4-af59e5889a59/mmc2.xlsx" download="mmc2.xlsx" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Spreadsheet (15.89 KB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Table S5. Functional potency and efficacy of ACh and HTL9936 in HEK293 cells transiently expressing rat, dog, and cynomolgus monkey M1-receptor, related to Figure 4</div><div id="espara0010a" role="paragraph"><sup>a</sup> Compound pEC50 values measured in a pERK signalling assay format. <sup>b</sup> Dynamic mass redistribution (DMR) responses were calculated from the maximum response in the 5 – 20 min time period post-addition of HTL9936 or ACh at the human M1-receptor. <sup>c</sup> The maximal response for both assay formats was defined relative to ACh run separately at 1µM in the same assay and is presented as a % of 1µM ACh response. All datasets were generated in the relevant species orthologue of the M1-receptor transiently expressed in HEK293 cells. Data are expressed as the means ± S.E.M. ∗ indicates insufficient replicates to assess S.E.M. ND indicates values not determined.</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.11.001/attachment/a47573ef-85cf-4cdb-a1e7-329708ffbe61/mmc3.xlsx" download="mmc3.xlsx" aria-labelledby="mmc3-heading mmc3-link"><span id="mmc3-link">Spreadsheet (36.90 KB)</span></a></div><div class="core-description"><div id="mmc3-heading" class="heading">Table S6. Overview of drug associated within-group changes on the P300 waveform for placebo, low, and high exposure groups and the pooled exposures treatment group from the MAD safety study, related to Figures 7G and 7H</div><div id="espara0010b" role="paragraph"><i>∗N: low exposure=6; high exposure =6; pooled exposures treatment group: 12; placebo= 4</i>.</div><div id="espara0010d" role="paragraph"><i>∗∗ trend significant</i>.</div><div id="espara0010c" role="paragraph"><i>Subjects enrolled in the multiple ascending dose study underwent EEG recording twice on a baseline day (Day -1) to match the “pre-dose” and “post-dose” (a time point corresponding to 2 hours after the pre-dose approximately at the time of the mean peak serum concentration of HTL9936 after morning dose). Assessments were performed according to the sequence qEEG, P50, Mismatch Negativity (MMN) and P300 active auditory oddball paradigm, starting with qEEG at 1.5 hours post-dose as first measure</i>.</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030a" role="paragraph"><div id="ulist0010a" role="list"><div id="u0010a" role="listitem"><div class="label">•</div><div class="content"><div id="p0010a" role="paragraph">The M1-StaR complex structure coordinates and structure factors are available via the Protein Data Bank, accession code (PDB: <a id="intref0010" href="http://firstglance.jmol.org/fg.htm?mol6ZFZ" target="_blank">6ZFZ</a>, PDB: <a id="intref0015" href="http://firstglance.jmol.org/fg.htm?mol6ZG4" target="_blank">6ZG4</a> and PDB: <a id="intref0020" href="http://firstglance.jmol.org/fg.htm?mol6ZG9" target="_blank">6ZG9</a>). Human Datasets generated have been filed in EUDRACT (EUDRACT.ema.europa.eu; ref: 2013-002307-34 and 2015-002490-38) and the U.S. National Library of Medicine (<a id="intref0025" href="http://Clinicaltrails.gov" target="_blank">Clinicaltrails.gov</a> ref: NCT02291783 and NCT02546310) and are not publicly available in accordance with regulations for Phase 1 data.</div></div></div><div id="u0015a" role="listitem"><div class="label">•</div><div class="content"><div id="p0015a" role="paragraph">This paper does not report original code.</div></div></div><div id="u0025a" role="listitem"><div class="label">•</div><div class="content"><div id="p0025a" role="paragraph">Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.</div></div></div></div></div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1-1" title="View in article">1.</a></div><div>Alt, A. ∙ Pendri, A. ∙ Bertekap, Jr., R.L. ...</div><div><strong>Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 2016; <strong>356</strong>:293-304</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/jpet.115.226910" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84959420309" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26582730/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fjpet.115.226910&amp;pmid=26582730" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2-1" title="View in article">2.</a></div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Age-related neural activity during allocentric spatial memory</strong></div><div><em>Memory.</em> 2009; <strong>17</strong>:125-143</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/09658210802077348" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-60549116899" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18608980/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F09658210802077348&amp;pmid=18608980" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3-1" title="View in article">3.</a></div><div>Antonova, E. ∙ Parslow, D. ∙ Brammer, M. ...</div><div><strong>Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze</strong></div><div><em>J.&nbsp;Psychopharmacol.</em> 2011; <strong>25</strong>:1256-1265</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1177/0269881110379285" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-80054041085" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20823079/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1177%2F0269881110379285&amp;pmid=20823079" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4" title="View in article">4.</a></div><div>Araujo, J.A. ∙ Greig, N.H. ∙ Ingram, D.K. ...</div><div><strong>Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs</strong></div><div><em>J.&nbsp;Alzheimers Dis.</em> 2011; <strong>26</strong>:143-155</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3233/JAD-2011-110005" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-80052845637" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21593569/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3233%2FJAD-2011-110005&amp;pmid=21593569" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">5.</a></div><div>Avlani, V.A. ∙ Langmead, C.J. ∙ Guida, E. ...</div><div><strong>Orthosteric and allosteric modes of interaction of novel selective agonists of the M1 muscarinic acetylcholine receptor</strong></div><div><em>Mol. Pharmacol.</em> 2010; <strong>78</strong>:94-104</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.110.064345" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77953777461" target="_blank" aria-label="Open Scopus in new tab">Scopus (59)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20413650/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.110.064345&amp;pmid=20413650" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6-1" title="View in article">6.</a></div><div>Bartus, R.T. ∙ Dean, 3rd, R.L. ∙ Beer, B. ...</div><div><strong>The cholinergic hypothesis of geriatric memory dysfunction</strong></div><div><em>Science.</em> 1982; <strong>217</strong>:408-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.7046051" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0019972810" target="_blank" aria-label="Open Scopus in new tab">Scopus (4969)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7046051/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.7046051&amp;pmid=7046051" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7" title="View in article">7.</a></div><div>Başar, E. ∙ Başar-Eroglu, C. ∙ Karakaş, S. ...</div><div><strong>Gamma, alpha, delta, and theta oscillations govern cognitive processes</strong></div><div><em>Int. J. Psychophysiol.</em> 2001; <strong>39</strong>:241-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0167-8760(00)00145-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0034518840" target="_blank" aria-label="Open Scopus in new tab">Scopus (933)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/11163901/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0167-8760%2800%2900145-8&amp;pmid=11163901" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8-1" title="View in article">8.</a></div><div>Battye, T.G. ∙ Kontogiannis, L. ∙ Johnson, O. ...</div><div><strong>iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2011; <strong>67</strong>:271-281</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910048675" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79953759821" target="_blank" aria-label="Open Scopus in new tab">Scopus (2515)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21460445/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910048675&amp;pmid=21460445" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">9.</a></div><div>Bender, A.M. ∙ Jones, C.K. ∙ Lindsley, C.W.</div><div><strong>Classics in Chemical Neuroscience: Xanomeline</strong></div><div><em>ACS Chem. Neurosci.</em> 2017; <strong>8</strong>:435-443</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acschemneuro.7b00001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85015182374" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28141924/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facschemneuro.7b00001&amp;pmid=28141924" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10" title="View in article">10.</a></div><div>Bodick, N.C. ∙ Offen, W.W. ∙ Levey, A.I. ...</div><div><strong>Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease</strong></div><div><em>Arch. Neurol.</em> 1997; <strong>54</strong>:465-473</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/archneur.1997.00550160091022" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0030902127" target="_blank" aria-label="Open Scopus in new tab">Scopus (600)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9109749/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Farchneur.1997.00550160091022&amp;pmid=9109749" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">11.</a></div><div>Bodick, N.C. ∙ Offen, W.W. ∙ Shannon, H.E. ...</div><div><strong>The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease</strong></div><div><em>Alzheimer Dis. Assoc. Disord.</em> 1997; <strong>11</strong>:S16-S22</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9339268/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=9339268" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12-1" title="View in article">12.</a></div><div>Bradley, S.J. ∙ Bourgognon, J.M. ∙ Sanger, H.E. ...</div><div><strong>M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2017; <strong>127</strong>:487-499</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI87526" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014118391" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27991860/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI87526&amp;pmid=27991860" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Bradley, S.J. ∙ Molloy, C. ∙ Bundgaard, C. ...</div><div><strong>Bitopic Binding Mode of an M<sub>1</sub> Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes</strong></div><div><em>Mol. Pharmacol.</em> 2018; <strong>93</strong>:645-656</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.118.111872" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85052534454" target="_blank" aria-label="Open Scopus in new tab">Scopus (26)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29695609/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.118.111872&amp;pmid=29695609" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14-1" title="View in article">14.</a></div><div>Bradley, S.J. ∙ Molloy, C. ∙ Valuskova, P. ...</div><div><strong>Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:240-249</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-019-0453-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85079780292" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32080630/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-019-0453-9&amp;pmid=32080630" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">15.</a></div><div>Brannan, S.K. ∙ Sawchak, S. ∙ Miller, A.C. ...</div><div><strong>Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2021; <strong>384</strong>:717-726</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa2017015" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85101606520" target="_blank" aria-label="Open Scopus in new tab">Scopus (162)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33626254/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa2017015&amp;pmid=33626254" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16-1" title="View in article">16.</a></div><div>Budzik, B. ∙ Garzya, V. ∙ Shi, D. ...</div><div><strong>Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists</strong></div><div><em>ACS Med. Chem. Lett.</em> 2010; <strong>1</strong>:244-248</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ml100105x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77956510685" target="_blank" aria-label="Open Scopus in new tab">Scopus (48)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24900202/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fml100105x&amp;pmid=24900202" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17-1" title="View in article">17.</a></div><div>Chen, V.B. ∙ Arendall, 3rd, W.B. ∙ Headd, J.J. ...</div><div><strong>MolProbity: all-atom structure validation for macromolecular crystallography</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:12-21</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909042073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-74549178560" target="_blank" aria-label="Open Scopus in new tab">Scopus (11100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20057044/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909042073&amp;pmid=20057044" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18" title="View in article">18.</a></div><div>Cheng, Y. ∙ Prusoff, W.H.</div><div><strong>Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction</strong></div><div><em>Biochem. Pharmacol.</em> 1973; <strong>22</strong>:3099-3108</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/0006-2952(73)90196-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0015861774" target="_blank" aria-label="Open Scopus in new tab">Scopus (12845)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4202581/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0006-2952%2873%2990196-2&amp;pmid=4202581" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19" title="View in article">19.</a></div><div>Cherezov, V. ∙ Rosenbaum, D.M. ∙ Hanson, M.A. ...</div><div><strong>High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</strong></div><div><em>Science.</em> 2007; <strong>318</strong>:1258-1265</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1150577" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36448995359" target="_blank" aria-label="Open Scopus in new tab">Scopus (2873)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17962520/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1150577&amp;pmid=17962520" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20" title="View in article">20.</a></div><div>Cohen, S.J. ∙ Stackman, Jr., R.W.</div><div><strong>Assessing rodent hippocampal involvement in the novel object recognition task. A review</strong></div><div><em>Behav. Brain Res.</em> 2015; <strong>285</strong>:105-117</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbr.2014.08.002" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84925439504" target="_blank" aria-label="Open Scopus in new tab">Scopus (405)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25169255/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbr.2014.08.002&amp;pmid=25169255" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21" title="View in article">21.</a></div><div>Congreve, M. ∙ Oswald, C. ∙ Marshall, F.H.</div><div><strong>Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs</strong></div><div><em>Trends Pharmacol. Sci.</em> 2017; <strong>38</strong>:837-847</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2017.05.010&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2017.05.010&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85021129087" target="_blank" aria-label="Open Scopus in new tab">Scopus (97)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28648526/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2017.05.010&amp;pmid=28648526" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">22.</a></div><div>Conn, P.J. ∙ Christopoulos, A. ∙ Lindsley, C.W.</div><div><strong>Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2009; <strong>8</strong>:41-54</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd2760" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-58149193205" target="_blank" aria-label="Open Scopus in new tab">Scopus (864)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19116626/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd2760&amp;pmid=19116626" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23-1" title="View in article">23.</a></div><div>Conn, P.J. ∙ Jones, C.K. ∙ Lindsley, C.W.</div><div><strong>Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders</strong></div><div><em>Trends Pharmacol. Sci.</em> 2009; <strong>30</strong>:148-155</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2008.12.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-61349093537" target="_blank" aria-label="Open Scopus in new tab">Scopus (255)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19201489/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2008.12.002&amp;pmid=19201489" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">24.</a></div><div>Courtney, C. ∙ Farrell, D. ∙ Gray, R. ..., AD2000 Collaborative Group</div><div><strong>Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial</strong></div><div><em>Lancet.</em> 2004; <strong>363</strong>:2105-2115</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2FS0140-6736%2804%2916499-4&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2FS0140-6736%2804%2916499-4&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-3042567016" target="_blank" aria-label="Open Scopus in new tab">Scopus (868)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15220031/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2804%2916499-4&amp;pmid=15220031" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25-1" title="View in article">25.</a></div><div>Davoren, J.E. ∙ Lee, C.W. ∙ Garnsey, M. ...</div><div><strong>Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2016; <strong>59</strong>:6313-6328</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.6b00544" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84978634494" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27275946/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.6b00544&amp;pmid=27275946" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26-1" title="View in article">26.</a></div><div>Davoren, J.E. ∙ Garnsey, M. ∙ Pettersen, B. ...</div><div><strong>Design and Synthesis of γ- and δ-Lactam M<sub>1</sub> Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M<sub>1</sub>-Selective PAM with Weak Agonist Activity</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2017; <strong>60</strong>:6649-6663</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.7b00597" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85027287269" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28598634/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.7b00597&amp;pmid=28598634" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">27.</a></div><div>Digby, G.J. ∙ Noetzel, M.J. ∙ Bubser, M. ...</div><div><strong>Novel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal models</strong></div><div><em>J.&nbsp;Neurosci.</em> 2012; <strong>32</strong>:8532-8544</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1523/JNEUROSCI.0337-12.2012" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84862864622" target="_blank" aria-label="Open Scopus in new tab">Scopus (93)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22723693/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.0337-12.2012&amp;pmid=22723693" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Doré, A.S. ∙ Robertson, N. ∙ Errey, J.C. ...</div><div><strong>Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine</strong></div><div><em>Structure.</em> 2011; <strong>19</strong>:1283-1293</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.str.2011.06.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.str.2011.06.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79960181417" target="_blank" aria-label="Open Scopus in new tab">Scopus (465)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21885291/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.str.2011.06.014&amp;pmid=21885291" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">29.</a></div><div>Douchamps, V. ∙ Mathis, C.</div><div><strong>A second wind for the cholinergic system in Alzheimer’s therapy</strong></div><div><em>Behav. Pharmacol.</em> 2017; <strong>28</strong>:112-123</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/FBP.0000000000000300" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85014038934" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28240674/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FFBP.0000000000000300&amp;pmid=28240674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">30.</a></div><div>Dror, R.O. ∙ Arlow, D.H. ∙ Borhani, D.W. ...</div><div><strong>Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2009; <strong>106</strong>:4689-4694</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.0811065106" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-63849294621" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19258456/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.0811065106&amp;pmid=19258456" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31-1" title="View in article">31.</a></div><div>Emsley, P. ∙ Lohkamp, B. ∙ Scott, W.G. ...</div><div><strong>Features and development of Coot</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:486-501</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910007493" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-77949535720" target="_blank" aria-label="Open Scopus in new tab">Scopus (20218)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20383002/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910007493&amp;pmid=20383002" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Engers, J.L. ∙ Childress, E.S. ∙ Long, M.F. ...</div><div><strong>VU6007477, a Novel M<sub>1</sub> PAM Based on a Pyrrolo[2,3-<i>b</i>]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events</strong></div><div><em>ACS Med. Chem. Lett.</em> 2018; <strong>9</strong>:917-922</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acsmedchemlett.8b00261" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85053240025" target="_blank" aria-label="Open Scopus in new tab">Scopus (11)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30258541/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facsmedchemlett.8b00261&amp;pmid=30258541" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33" title="View in article">33.</a></div><div>Evans, P.</div><div><strong>Scaling and assessment of data quality</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2006; <strong>62</strong>:72-82</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444905036693" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-33644875355" target="_blank" aria-label="Open Scopus in new tab">Scopus (4016)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16369096/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444905036693&amp;pmid=16369096" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34-1" title="View in article">34.</a></div><div>Evans, P.R. ∙ Murshudov, G.N.</div><div><strong>How good are my data and what is the resolution?</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2013; <strong>69</strong>:1204-1214</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444913000061" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84879367781" target="_blank" aria-label="Open Scopus in new tab">Scopus (3299)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23793146/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444913000061&amp;pmid=23793146" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35-1" title="View in article">35.</a></div><div>Felder, C.C. ∙ Goldsmith, P.J. ∙ Jackson, K. ...</div><div><strong>Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases</strong></div><div><em>Neuropharmacology.</em> 2018; <strong>136</strong>:449-458</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2018.01.028" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85046631768" target="_blank" aria-label="Open Scopus in new tab">Scopus (65)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29374561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2018.01.028&amp;pmid=29374561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">36.</a></div><div>Fish, I. ∙ Stößel, A. ∙ Eitel, K. ...</div><div><strong>Structure-Based Design and Discovery of New M<sub>2</sub> Receptor Agonists</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2017; <strong>60</strong>:9239-9250</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.7b01113" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85035068873" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29094937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.7b01113&amp;pmid=29094937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37-1" title="View in article">37.</a></div><div>Francis, P.T. ∙ Palmer, A.M. ∙ Snape, M. ...</div><div><strong>The cholinergic hypothesis of Alzheimer’s disease: a review of progress</strong></div><div><em>J.&nbsp;Neurol. Neurosurg. Psychiatry.</em> 1999; <strong>66</strong>:137-147</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1136/jnnp.66.2.137" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0032910197" target="_blank" aria-label="Open Scopus in new tab">Scopus (1838)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10071091/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1136%2Fjnnp.66.2.137&amp;pmid=10071091" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">38.</a></div><div>Ghoshal, A. ∙ Rook, J.M. ∙ Dickerson, J.W. ...</div><div><strong>Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model</strong></div><div><em>Neuropsychopharmacology.</em> 2016; <strong>41</strong>:598-610</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/npp.2015.189" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84949575416" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26108886/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnpp.2015.189&amp;pmid=26108886" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39" title="View in article">39.</a></div><div>Goodwin, J.A. ∙ Hulme, E.C. ∙ Langmead, C.J. ...</div><div><strong>Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands</strong></div><div><em>Mol. Pharmacol.</em> 2007; <strong>72</strong>:1484-1496</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.107.038265" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36349016730" target="_blank" aria-label="Open Scopus in new tab">Scopus (39)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17848601/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.107.038265&amp;pmid=17848601" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">40.</a></div><div>Gratton, G. ∙ Coles, M.G. ∙ Donchin, E.</div><div><strong>A new method for off-line removal of ocular artifact</strong></div><div><em>Electroencephalogr. Clin. Neurophysiol.</em> 1983; <strong>55</strong>:468-484</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2F0013-4694%2883%2990135-9&amp;cf=abstract" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2F0013-4694%2883%2990135-9&amp;cf=pdf" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0020583553" target="_blank" aria-label="Open Scopus in new tab">Scopus (4418)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/6187540/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2F0013-4694%2883%2990135-9&amp;pmid=6187540" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">41.</a></div><div>Hamilton, S.E. ∙ Loose, M.D. ∙ Qi, M. ...</div><div><strong>Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 1997; <strong>94</strong>:13311-13316</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.94.24.13311" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0030708762" target="_blank" aria-label="Open Scopus in new tab">Scopus (319)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9371842/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.94.24.13311&amp;pmid=9371842" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">42.</a></div><div>Harmony, T.</div><div><strong>The functional significance of delta oscillations in cognitive processing</strong></div><div><em>Front. Integr. Nuerosci.</em> 2013; <strong>7</strong>:83</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fnint.2013.00083" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84889655088" target="_blank" aria-label="Open Scopus in new tab">Scopus (433)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24367301/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffnint.2013.00083&amp;pmid=24367301" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">43.</a></div><div>Hoover, W.G.</div><div><strong>Canonical dynamics: Equilibrium phase-space distributions</strong></div><div><em>Phys Rev A Gen Physiol.</em> 1985; <strong>31</strong>:1695-1697</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1103/PhysRevA.31.1695" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0001538909" target="_blank" aria-label="Open Scopus in new tab">Scopus (18449)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9895674/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1103%2FPhysRevA.31.1695&amp;pmid=9895674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">44.</a></div><div>Inglis, F.</div><div><strong>The tolerability and safety of cholinesterase inhibitors in the treatment of dementia</strong></div><div><em>Int. J. Clin. Pract. Suppl.</em> 2002; 45-63</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12139367/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=12139367" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45" title="View in article">45.</a></div><div>Isberg, V. ∙ de Graaf, C. ∙ Bortolato, A. ...</div><div><strong>Generic GPCR residue numbers - aligning topology maps while minding the gaps</strong></div><div><em>Trends Pharmacol. Sci.</em> 2015; <strong>36</strong>:22-31</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2014.11.001&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.tips.2014.11.001&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84920166693" target="_blank" aria-label="Open Scopus in new tab">Scopus (345)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25541108/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2014.11.001&amp;pmid=25541108" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Jazayeri, A. ∙ Andrews, S.P. ∙ Marshall, F.H.</div><div><strong>Structurally Enabled Discovery of Adenosine A<sub>2A</sub> Receptor Antagonists</strong></div><div><em>Chem. Rev.</em> 2017; <strong>117</strong>:21-37</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.chemrev.6b00119" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85020139339" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27333206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.chemrev.6b00119&amp;pmid=27333206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47-1" title="View in article">47.</a></div><div>Kabsch, W.</div><div><strong>Xds</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2010; <strong>66</strong>:125-132</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444909047337" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-76449099287" target="_blank" aria-label="Open Scopus in new tab">Scopus (12940)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20124692/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444909047337&amp;pmid=20124692" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">48.</a></div><div>Kenakin, T. ∙ Christopoulos, A.</div><div><strong>Measurements of ligand bias and functional affinity</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2013; <strong>12</strong>:483</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd3954-c2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84880675341" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23681003/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd3954-c2&amp;pmid=23681003" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49" title="View in article">49.</a></div><div>Kooistra, A.J. ∙ Leurs, R. ∙ de Esch, I.J. ...</div><div><strong>Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study</strong></div><div><em>J.&nbsp;Chem. Inf. Model.</em> 2015; <strong>55</strong>:1045-1061</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jcim.5b00066" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84930227130" target="_blank" aria-label="Open Scopus in new tab">Scopus (46)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25848966/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jcim.5b00066&amp;pmid=25848966" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50" title="View in article">50.</a></div><div>Kooistra, A.J. ∙ Vischer, H.F. ∙ McNaught-Flores, D. ...</div><div><strong>Function-specific virtual screening for GPCR ligands using a combined scoring method</strong></div><div><em>Sci. Rep.</em> 2016; <strong>6</strong>:28288</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/srep28288" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84975721733" target="_blank" aria-label="Open Scopus in new tab">Scopus (77)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27339552/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fsrep28288&amp;pmid=27339552" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">51.</a></div><div>Langmead, C.J. ∙ Austin, N.E. ∙ Branch, C.L. ...</div><div><strong>Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1</strong></div><div><em>Br. J. Pharmacol.</em> 2008; <strong>154</strong>:1104-1115</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/bjp.2008.152" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-46249084634" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18454168/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fbjp.2008.152&amp;pmid=18454168" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">52.</a></div><div>Laurent, B. ∙ Chavent, M. ∙ Cragnolini, T. ...</div><div><strong>Epock: rapid analysis of protein pocket dynamics</strong></div><div><em>Bioinformatics.</em> 2015; <strong>31</strong>:1478-1480</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/bioinformatics/btu822" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84946174179" target="_blank" aria-label="Open Scopus in new tab">Scopus (69)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25505095/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbioinformatics%2Fbtu822&amp;pmid=25505095" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53-1" title="View in article">53.</a></div><div>Lebon, G. ∙ Langmead, C.J. ∙ Tehan, B.G. ...</div><div><strong>Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors</strong></div><div><em>Mol. Pharmacol.</em> 2009; <strong>75</strong>:331-341</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.108.050963" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-59449090754" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19001633/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.108.050963&amp;pmid=19001633" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">54.</a></div><div>Magnani, F. ∙ Serrano-Vega, M.J. ∙ Shibata, Y. ...</div><div><strong>A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies</strong></div><div><em>Nat. Protoc.</em> 2016; <strong>11</strong>:1554-1571</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nprot.2016.088" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84979929935" target="_blank" aria-label="Open Scopus in new tab">Scopus (82)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27466713/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnprot.2016.088&amp;pmid=27466713" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55" title="View in article">55.</a></div><div>Maksymetz, J. ∙ Joffe, M.E. ∙ Moran, S.P. ...</div><div><strong>M<sub>1</sub> Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder</strong></div><div><em>Biol. Psychiatry.</em> 2019; <strong>85</strong>:989-1000</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.biopsych.2019.02.020&amp;cf=fulltext&amp;site=bps-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=10.1016%2Fj.biopsych.2019.02.020&amp;cf=pdf&amp;site=bps-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85064313667" target="_blank" aria-label="Open Scopus in new tab">Scopus (23)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31003787/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.biopsych.2019.02.020&amp;pmid=31003787" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56-1" title="View in article">56.</a></div><div>Mallucci, G. ∙ Dickinson, A. ∙ Linehan, J. ...</div><div><strong>Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis</strong></div><div><em>Science.</em> 2003; <strong>302</strong>:871-874</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1090187" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0242363656" target="_blank" aria-label="Open Scopus in new tab">Scopus (621)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14593181/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1090187&amp;pmid=14593181" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57-1" title="View in article">57.</a></div><div>McCoy, A.J. ∙ Grosse-Kunstleve, R.W. ∙ Adams, P.D. ...</div><div><strong>Phaser crystallographic software</strong></div><div><em>J.&nbsp;Appl. Cryst.</em> 2007; <strong>40</strong>:658-674</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0021889807021206" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-34447508216" target="_blank" aria-label="Open Scopus in new tab">Scopus (16093)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19461840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0021889807021206&amp;pmid=19461840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">58.</a></div><div>Miszta, P. ∙ Pasznik, P. ∙ Jakowiecki, J. ...</div><div><strong>GPCRM: a homology modeling web service with triple membrane-fitted quality assessment of GPCR models</strong></div><div><em>Nucleic Acids Res.</em> 2018; <strong>46</strong>:W387-W395</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/nar/gky429" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85050884398" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29788177/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fnar%2Fgky429&amp;pmid=29788177" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-1" title="View in article">59.</a></div><div>Moran, S.P. ∙ Dickerson, J.W. ∙ Cho, H.P. ...</div><div><strong>M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition</strong></div><div><em>Neuropsychopharmacology.</em> 2018; <strong>43</strong>:1763-1771</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41386-018-0033-9" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85044465425" target="_blank" aria-label="Open Scopus in new tab">Scopus (52)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29581537/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41386-018-0033-9&amp;pmid=29581537" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">60.</a></div><div>Myhrer, T.</div><div><strong>Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks</strong></div><div><em>Brain Res. Brain Res. Rev.</em> 2003; <strong>41</strong>:268-287</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0165-0173(02)00268-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0037343932" target="_blank" aria-label="Open Scopus in new tab">Scopus (408)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12663083/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0165-0173%2802%2900268-0&amp;pmid=12663083" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61-1" title="View in article">61.</a></div><div>Namkung, Y. ∙ Le Gouill, C. ∙ Lukashova, V. ...</div><div><strong>Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:12178</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms12178" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84978431584" target="_blank" aria-label="Open Scopus in new tab">Scopus (200)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27397672/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms12178&amp;pmid=27397672" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62-1" title="View in article">62.</a></div><div>Nathan, P.J. ∙ Watson, J. ∙ Lund, J. ...</div><div><strong>The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction</strong></div><div><em>Int J Neuropsychopharmacol.</em> 2013; <strong>16</strong>:721-731</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1017/S1461145712000752" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84875697137" target="_blank" aria-label="Open Scopus in new tab">Scopus (90)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22932339/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1017%2FS1461145712000752&amp;pmid=22932339" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63-1" title="View in article">63.</a></div><div>Olsen, R.H.J. ∙ DiBerto, J.F. ∙ English, J.G. ...</div><div><strong>TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome</strong></div><div><em>Nat. Chem. Biol.</em> 2020; <strong>16</strong>:841-849</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41589-020-0535-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85085073530" target="_blank" aria-label="Open Scopus in new tab">Scopus (274)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32367019/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41589-020-0535-8&amp;pmid=32367019" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64" title="View in article">64.</a></div><div>Porter, A.C. ∙ Bymaster, F.P. ∙ DeLapp, N.W. ...</div><div><strong>M1 muscarinic receptor signaling in mouse hippocampus and cortex</strong></div><div><em>Brain Res.</em> 2002; <strong>944</strong>:82-89</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0006-8993(02)02721-X" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-0037135123" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12106668/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0006-8993%2802%2902721-X&amp;pmid=12106668" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">65.</a></div><div>Rasmussen, S.G. ∙ Choi, H.J. ∙ Rosenbaum, D.M. ...</div><div><strong>Crystal structure of the human beta2 adrenergic G-protein-coupled receptor</strong></div><div><em>Nature.</em> 2007; <strong>450</strong>:383-387</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature06325" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36248970132" target="_blank" aria-label="Open Scopus in new tab">Scopus (1712)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17952055/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature06325&amp;pmid=17952055" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">66.</a></div><div>Robertson, N. ∙ Jazayeri, A. ∙ Errey, J. ...</div><div><strong>The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery</strong></div><div><em>Neuropharmacology.</em> 2011; <strong>60</strong>:36-44</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.neuropharm.2010.07.001" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-78149501282" target="_blank" aria-label="Open Scopus in new tab">Scopus (132)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20624408/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuropharm.2010.07.001&amp;pmid=20624408" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">67.</a></div><div>Rook, J.M. ∙ Abe, M. ∙ Cho, H.P. ...</div><div><strong>Diverse Effects on M<sub>1</sub> Signaling and Adverse Effect Liability within a Series of M<sub>1</sub> Ago-PAMs</strong></div><div><em>ACS Chem. Neurosci.</em> 2017; <strong>8</strong>:866-883</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acschemneuro.6b00429" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85018529314" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28001356/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facschemneuro.6b00429&amp;pmid=28001356" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68" title="View in article">68.</a></div><div>Roos, K. ∙ Wu, C. ∙ Damm, W. ...</div><div><strong>OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules</strong></div><div><em>J.&nbsp;Chem. Theory Comput.</em> 2019; <strong>15</strong>:1863-1874</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jctc.8b01026" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85062820310" target="_blank" aria-label="Open Scopus in new tab">Scopus (711)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30768902/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jctc.8b01026&amp;pmid=30768902" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">69.</a></div><div>Rosenbaum, D.M. ∙ Cherezov, V. ∙ Hanson, M.A. ...</div><div><strong>GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function</strong></div><div><em>Science.</em> 2007; <strong>318</strong>:1266-1273</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1150609" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-36448978229" target="_blank" aria-label="Open Scopus in new tab">Scopus (1224)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17962519/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1150609&amp;pmid=17962519" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">70.</a></div><div>Shekhar, A. ∙ Potter, W.Z. ∙ Lightfoot, J. ...</div><div><strong>Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia</strong></div><div><em>Am. J. Psychiatry.</em> 2008; <strong>165</strong>:1033-1039</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1176/appi.ajp.2008.06091591" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-48949095543" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18593778/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1176%2Fappi.ajp.2008.06091591&amp;pmid=18593778" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">71.</a></div><div>Shirey, J.K. ∙ Brady, A.E. ∙ Jones, P.J. ...</div><div><strong>A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning</strong></div><div><em>J.&nbsp;Neurosci.</em> 2009; <strong>29</strong>:14271-14286</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1523/JNEUROSCI.3930-09.2009" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-70449640543" target="_blank" aria-label="Open Scopus in new tab">Scopus (206)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19906975/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1523%2FJNEUROSCI.3930-09.2009&amp;pmid=19906975" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib72" class="citations"><div id="sref72" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref72" title="View in article">72.</a></div><div>Smith, J.S. ∙ Lefkowitz, R.J. ∙ Rajagopal, S.</div><div><strong>Biased signalling: from simple switches to allosteric microprocessors</strong></div><div><em>Nat. Rev. Drug Discov.</em> 2018; <strong>17</strong>:243-260</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nrd.2017.229" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_72_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85044178621" target="_blank" aria-label="Open Scopus in new tab">Scopus (501)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29302067/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnrd.2017.229&amp;pmid=29302067" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib73" class="citations"><div id="sref73" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref73" title="View in article">73.</a></div><div>Snyder, P.J. ∙ Bednar, M.M. ∙ Cromer, J.R. ...</div><div><strong>Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor</strong></div><div><em>Alzheimers Dement.</em> 2005; <strong>1</strong>:126-135</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jalz.2005.09.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_73_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-33644806571" target="_blank" aria-label="Open Scopus in new tab">Scopus (108)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19595845/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.jalz.2005.09.004&amp;pmid=19595845" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib74" class="citations"><div id="sref74" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref74-1" title="View in article">74.</a></div><div>Thal, D.M. ∙ Sun, B. ∙ Feng, D. ...</div><div><strong>Crystal structures of the M1 and M4 muscarinic acetylcholine receptors</strong></div><div><em>Nature.</em> 2016; <strong>531</strong>:335-340</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature17188" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_74_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84982308386" target="_blank" aria-label="Open Scopus in new tab">Scopus (261)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26958838/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature17188&amp;pmid=26958838" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib75" class="citations"><div id="sref75" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref75" title="View in article">75.</a></div><div>Thompson, S. ∙ Lanctôt, K.L. ∙ Herrmann, N.</div><div><strong>The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease</strong></div><div><em>Expert Opin. Drug Saf.</em> 2004; <strong>3</strong>:425-440</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1517/14740338.3.5.425" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_75_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-4544248755" target="_blank" aria-label="Open Scopus in new tab">Scopus (89)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15335298/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1517%2F14740338.3.5.425&amp;pmid=15335298" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib76" class="citations"><div id="sref76" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref76" title="View in article">76.</a></div><div>van der Westhuizen, E.T. ∙ Breton, B. ∙ Christopoulos, A. ...</div><div><strong>Quantification of ligand bias for clinically relevant β2-adrenergic receptor ligands: implications for drug taxonomy</strong></div><div><em>Mol. Pharmacol.</em> 2014; <strong>85</strong>:492-509</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1124/mol.113.088880" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_76_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-84894090269" target="_blank" aria-label="Open Scopus in new tab">Scopus (193)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24366668/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1124%2Fmol.113.088880&amp;pmid=24366668" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib77" class="citations"><div id="sref77" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref77-1" title="View in article">77.</a></div><div>Vass, M. ∙ Podlewska, S. ∙ de Esch, I.J.P. ...</div><div><strong>Aminergic GPCR-Ligand Interactions: A Chemical and Structural Map of Receptor Mutation Data</strong></div><div><em>J.&nbsp;Med. Chem.</em> 2019; <strong>62</strong>:3784-3839</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jmedchem.8b00836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_77_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85058134004" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30351004/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.jmedchem.8b00836&amp;pmid=30351004" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib78" class="citations"><div id="sref78" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref78" title="View in article">78.</a></div><div>Voss, T. ∙ Li, J. ∙ Cummings, J. ...</div><div><strong>Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer’s disease</strong></div><div><em>Alzheimers Dement (N Y).</em> 2018; <strong>4</strong>:173-181</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.trci.2018.03.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_78_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85047000461" target="_blank" aria-label="Open Scopus in new tab">Scopus (42)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29955661/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.trci.2018.03.004&amp;pmid=29955661" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib79" class="citations"><div id="sref79" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref79" title="View in article">79.</a></div><div>Vuckovic, Z. ∙ Gentry, P.R. ∙ Berizzi, A.E. ...</div><div><strong>Crystal structure of the M<sub>5</sub> muscarinic acetylcholine receptor</strong></div><div><em>Proc. Natl. Acad. Sci. USA.</em> 2019; <strong>116</strong>:26001-26007</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1073/pnas.1914446116" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_79_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-85076692249" target="_blank" aria-label="Open Scopus in new tab">Scopus (50)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31772027/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1073%2Fpnas.1914446116&amp;pmid=31772027" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib80" class="citations"><div id="sref80" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref80-1" title="View in article">80.</a></div><div>Warne, T. ∙ Serrano-Vega, M.J. ∙ Baker, J.G. ...</div><div><strong>Structure of a beta1-adrenergic G-protein-coupled receptor</strong></div><div><em>Nature.</em> 2008; <strong>454</strong>:486-491</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature07101" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_80_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-47949129742" target="_blank" aria-label="Open Scopus in new tab">Scopus (1254)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18594507/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature07101&amp;pmid=18594507" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib81" class="citations"><div id="sref81" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref81" title="View in article">81.</a></div><div>Warne, T. ∙ Moukhametzianov, R. ∙ Baker, J.G. ...</div><div><strong>The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor</strong></div><div><em>Nature.</em> 2011; <strong>469</strong>:241-244</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature09746" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_81_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-78651405537" target="_blank" aria-label="Open Scopus in new tab">Scopus (548)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21228877/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature09746&amp;pmid=21228877" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib82" class="citations"><div id="sref82" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref82-1" title="View in article">82.</a></div><div>Winn, M.D. ∙ Ballard, C.C. ∙ Cowtan, K.D. ...</div><div><strong>Overview of the CCP4 suite and current developments</strong></div><div><em>Acta Crystallogr. D Biol. Crystallogr.</em> 2011; <strong>67</strong>:235-242</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1107/S0907444910045749" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_82_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.11.001&amp;key=2-s2.0-79953737180" target="_blank" aria-label="Open Scopus in new tab">Scopus (10209)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21460441/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1107%2FS0907444910045749&amp;pmid=21460441" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (15)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/3100697d-2571-4f5f-b5e1-1f302dfcdc6c/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/b64422de-18c8-4d22-b891-aa7d55dfbe38/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/de4ff4ed-cc1f-43b7-bfee-ee70c39a4a6c/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/37cf4902-8b9a-41f9-8063-38a1fafed5e3/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/831ec24b-d6b3-4614-95db-24509ad8c96f/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/847de518-76a3-47c0-85fd-24cf4b7dc48b/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/f9748c3b-eeb5-4992-a28f-33351b9e3218/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/0d3b1ea4-82b0-47df-837f-289f57f9adf7/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/32e5d1d3-1631-42f3-918a-6c2d28071f5e/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/3526bf25-7474-4d0e-97f7-e7abd985a6a2/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/3a770916-f493-4ac4-af41-346a9e402d56/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/7d5e49d5-5e32-4dae-98be-c4eaba5b1a1f/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/004bd7c7-00b9-4edd-ab43-15c9906fbd03/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/e68836ca-d1cc-4511-b1d4-258b21899ef7/main.assets/figs7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#undfig2" aria-label="Go to "><img src="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/asset/9145535a-f7b1-44ef-8293-c9a05e8742d2/main.assets/fx2.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867420X00250%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3Apii%5C%3AS0092867421013167" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (3)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/attachment/ff1676b5-faf6-493e-ba51-d9c62155a185/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (241.86 KB)</span></a><div class="core-description">Document S1. Tables S1–S4</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/attachment/6c61c944-5e0d-4dfb-b5a4-af59e5889a59/mmc2.xlsx" download="mmc2.xlsx"><span id="mmc2-link">Spreadsheet (15.89 KB)</span></a><div class="core-description">Table S5. Functional potency and efficacy of ACh and HTL9936 in HEK293 cells transiently expressing rat, dog, and cynomolgus monkey M1-receptor, related to Figure 4</div></div></div><div class="core-supplementary-material" data-category="spreadsheet"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.11.001/attachment/a47573ef-85cf-4cdb-a1e7-329708ffbe61/mmc3.xlsx" download="mmc3.xlsx"><span id="mmc3-link">Spreadsheet (36.90 KB)</span></a><div class="core-description">Table S6. Overview of drug associated within-group changes on the P300 waveform for placebo, low, and high exposure groups and the pooled exposures treatment group from the MAD safety study, related to Figures 7G and 7H</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867421013167" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.11.001","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.11.001/asset/3100697d-2571-4f5f-b5e1-1f302dfcdc6c/main.assets/gr1.jpg" height="258" width="656" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/92a7cebb-21ee-4707-8df8-2a9aaced4d21/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.11.001/asset/b64422de-18c8-4d22-b891-aa7d55dfbe38/main.assets/figs1.jpg" height="582" width="750" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/565674cd-c813-425c-9037-27565ff1d8af/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.11.001/asset/de4ff4ed-cc1f-43b7-bfee-ee70c39a4a6c/main.assets/gr2.jpg" height="531" width="656" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/fe3651c1-3632-4e73-b132-fdfc8be987eb/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.11.001/asset/37cf4902-8b9a-41f9-8063-38a1fafed5e3/main.assets/figs2.jpg" height="576" width="506" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/634b3d83-fda6-459c-98c3-a02dcb2b1a9b/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.11.001/asset/831ec24b-d6b3-4614-95db-24509ad8c96f/main.assets/gr3.jpg" height="665" width="752" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/bb2e56ce-f388-4179-92de-872bc60464ce/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.11.001/asset/847de518-76a3-47c0-85fd-24cf4b7dc48b/main.assets/figs3.jpg" height="242" width="497" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/f01124a0-b2c2-4f91-9ace-d33a0a3094ea/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.11.001/asset/f9748c3b-eeb5-4992-a28f-33351b9e3218/main.assets/gr4.jpg" height="513" width="750" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/f4028846-06cc-4e19-9165-8ee66bf82386/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.11.001/asset/0d3b1ea4-82b0-47df-837f-289f57f9adf7/main.assets/figs4.jpg" height="217" width="497" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/46bee298-2dfe-4183-bbd7-cb338790d570/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.11.001/asset/32e5d1d3-1631-42f3-918a-6c2d28071f5e/main.assets/figs5.jpg" height="763" width="506" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/c78cccca-b77f-4020-9fcc-86f95c354789/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.11.001/asset/3526bf25-7474-4d0e-97f7-e7abd985a6a2/main.assets/gr5.jpg" height="360" width="750" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/1f7006e1-d443-4167-95fe-ff36d5fa9a89/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.11.001/asset/3a770916-f493-4ac4-af41-346a9e402d56/main.assets/figs6.jpg" height="214" width="506" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/2dfe8e00-ce11-4b9a-a8f3-5117eb6b132f/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.11.001/asset/7d5e49d5-5e32-4dae-98be-c4eaba5b1a1f/main.assets/gr6.jpg" height="443" width="497" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/9507409c-2885-4baf-84f2-2879ce892be3/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.11.001/asset/004bd7c7-00b9-4edd-ab43-15c9906fbd03/main.assets/gr7.jpg" height="439" width="750" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/530a955e-7fea-490e-a74f-2fcb3fcebc8c/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.11.001/asset/e68836ca-d1cc-4511-b1d4-258b21899ef7/main.assets/figs7.jpg" height="429" width="750" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/998dae1d-f366-4eb0-af3e-7fc86e9c12b7/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="fx2" alt="Figure undfig2" src="/cms/10.1016/j.cell.2021.11.001/asset/9145535a-f7b1-44ef-8293-c9a05e8742d2/main.assets/fx2.jpg" height="487" width="659" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/043ac9b6-ef29-4c72-afc7-e5a778b2289b/main.assets/fx2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.11.001/asset/3100697d-2571-4f5f-b5e1-1f302dfcdc6c/main.assets/gr1.jpg" height="258" width="656" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/92a7cebb-21ee-4707-8df8-2a9aaced4d21/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.11.001/asset/b64422de-18c8-4d22-b891-aa7d55dfbe38/main.assets/figs1.jpg" height="582" width="750" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/565674cd-c813-425c-9037-27565ff1d8af/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.11.001/asset/de4ff4ed-cc1f-43b7-bfee-ee70c39a4a6c/main.assets/gr2.jpg" height="531" width="656" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/fe3651c1-3632-4e73-b132-fdfc8be987eb/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.11.001/asset/37cf4902-8b9a-41f9-8063-38a1fafed5e3/main.assets/figs2.jpg" height="576" width="506" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/634b3d83-fda6-459c-98c3-a02dcb2b1a9b/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.11.001/asset/831ec24b-d6b3-4614-95db-24509ad8c96f/main.assets/gr3.jpg" height="665" width="752" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/bb2e56ce-f388-4179-92de-872bc60464ce/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.11.001/asset/847de518-76a3-47c0-85fd-24cf4b7dc48b/main.assets/figs3.jpg" height="242" width="497" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/f01124a0-b2c2-4f91-9ace-d33a0a3094ea/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.11.001/asset/f9748c3b-eeb5-4992-a28f-33351b9e3218/main.assets/gr4.jpg" height="513" width="750" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/f4028846-06cc-4e19-9165-8ee66bf82386/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.11.001/asset/0d3b1ea4-82b0-47df-837f-289f57f9adf7/main.assets/figs4.jpg" height="217" width="497" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/46bee298-2dfe-4183-bbd7-cb338790d570/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.11.001/asset/32e5d1d3-1631-42f3-918a-6c2d28071f5e/main.assets/figs5.jpg" height="763" width="506" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/c78cccca-b77f-4020-9fcc-86f95c354789/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.11.001/asset/3526bf25-7474-4d0e-97f7-e7abd985a6a2/main.assets/gr5.jpg" height="360" width="750" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/1f7006e1-d443-4167-95fe-ff36d5fa9a89/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.11.001/asset/3a770916-f493-4ac4-af41-346a9e402d56/main.assets/figs6.jpg" height="214" width="506" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/2dfe8e00-ce11-4b9a-a8f3-5117eb6b132f/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.11.001/asset/7d5e49d5-5e32-4dae-98be-c4eaba5b1a1f/main.assets/gr6.jpg" height="443" width="497" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/9507409c-2885-4baf-84f2-2879ce892be3/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.11.001/asset/004bd7c7-00b9-4edd-ab43-15c9906fbd03/main.assets/gr7.jpg" height="439" width="750" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/530a955e-7fea-490e-a74f-2fcb3fcebc8c/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.11.001/asset/e68836ca-d1cc-4511-b1d4-258b21899ef7/main.assets/figs7.jpg" height="429" width="750" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/998dae1d-f366-4eb0-af3e-7fc86e9c12b7/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure</div><div class="thumbnail"><div class="thumbnail__image"><img id="fx2" alt="Figure undfig2" src="/cms/10.1016/j.cell.2021.11.001/asset/9145535a-f7b1-44ef-8293-c9a05e8742d2/main.assets/fx2.jpg" height="487" width="659" data-viewer-src="/cms/10.1016/j.cell.2021.11.001/asset/043ac9b6-ef29-4c72-afc7-e5a778b2289b/main.assets/fx2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01316-7';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01316-7';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749591933224","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"184","issueNumber":"24","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867421013167","coverDate":"202111","type":"XOCS-JOURNAL:SCOPE-FULL","title":"From structure to clinic Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimerx2019s disease","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc0e681f3252eb',t:'MTc0OTU5MTkzMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dc0e681f3252eb&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.11.001&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>